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Abstract
Purpose: People living with HIV (PLWH) struggle with medication adherence. Antiretroviral
therapy (ART) requires greater than 95% adherence to prevent HIV drug resistance and
treatment failure. Motivational interviewing (MI) is an effective counseling method designed to
enhance health behavior change. This project determined the effectiveness of a two-day
introductory MI training course on participant MI knowledge, perception of MI effectiveness,
perception of client behavior change, and likelihood of MI use in a Midwest outpatient HIV
clinic.
Participants: Seven clinical and non-clinical members of the multidisciplinary care team
completed the two-day MI training course. Approximately 82% of the participants had never
used MI previously.
Methods and Materials: This evidence-based practice project used a one-group, pretestposttest design using the Motivational Interviewing Survey.
Analysis: Data analysis included descriptive statistics, Wilcoxon signed-ranks test for matched
pairs, and Kendall’s tau rank correlation coefficient.
Results: Forty-one percent of the 17 care team members participated in the MI educational
intervention. There was a significant change in the MI Survey score after completion of the
training course (Mdn Δ = 13.00, Z = -2.375, p = .018). All seven participants reported that they
would use MI in their daily work after attending MI training.
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Impact: These findings suggest that a two-day introductory MI course is effective in improving
MI knowledge, perception of MI effectiveness, perception of behavior change, and likelihood of
MI use. The findings from the MI Survey and the implementation process contributed
sustainability recommendations to use MI to promote ART adherence within this practice
setting.
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CHAPTER 1
Introduction
The advancement in antiretroviral therapy (ART) has had a profound impact on the
quality and duration of life of people living with human immunodeficiency virus (HIV). Global
ramifications of HIV infection are estimated to affect 35 million people (Joint United Nations
Programme on HIV/AIDS, 2014). According to the Centers for Disease Control and Prevention
(CDC; 2015), approximately 1.2 million people are infected with HIV in the United States.
Although ART has contributed to an 80% decrease in the age-adjusted HIV mortality rate since
1995, challenges still exist with the medical treatment of this disease (Kaiser Family Foundation,
2012). It is reported that only 36 of 100 persons infected with HIV in the United States are on
ART and only 28 of l00 persons have achieved low-level viremia (CDC, 2011). Medication
adherence is a vital component to the success of ART in decreasing viral replication; however, it
is estimated that 40% to 60% of clients prescribed ART are less than 90% adherent to their
regimen (Battaglioli-DeNero, 2007). Maximum adherence of greater than 95% is essential in
preventing the development of drug-resistant HIV strains and treatment failure (DiIorio et al.,
2003; DiIorio et al., 2008; Krummenacher, Cavassini, Bugnon, & Schneider, 2011). The
Department of Health and Human Services (DHHS; 2014) reported that, “achieving adherence to
ART is a critical determinant of long-term outcome in HIV infected patients” (p. k-1). Unlike
other chronic diseases, such as hypertension or diabetes mellitus, ART may not remain effective
following a period of interruption (DHHS, 2014). In fact, inconsistent use of ART leads to
uncontrolled HIV replication, drug resistance, and limitations in future pharmacologic options
(DHHS, 2014). The indefinite nature of HIV treatment necessitates behavioral interventions as
people living with HIV are faced with complex factors hindering medication adherence.
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The purpose of this chapter is multifaceted. First, the objective is to provide a brief
introduction to the pathophysiology of HIV infection. Second, an overview of ART will be
introduced. Next, this chapter will discuss HIV drug resistance and its role in treatment failure.
Moreover, the implications of untreated HIV infection will be explored, and the health care issue
of ART nonadherence will be highlighted. This chapter will conclude with the significance of
this health care issue to nursing and introduce the proposed scholarly project to address ART
nonadherence in a local HIV clinic.
HIV Infection
An understanding of the implications of nonadherence to ART in a person living with
HIV is essential. Therefore, it is paramount to have a foundational comprehension of the virus,
transmission, and the disease progression of HIV. Human immunodeficiency virus is a retrovirus
belonging to the Lentivirus genus of the Retroviridiae family. There are two strains of HIV,
HIV-1 and HIV-2. HIV-1 is responsible for most human infections throughout the world, while
HIV-2 infection is predominately found in West Africa (Lashley, 2010, p.4). HIV-1 infects
human cells that contain the CD4 receptor and one of the co-receptors, CCR5 or CXCR4.
Human cells containing the CD4 receptor include T cells, macrophages, monocytes, and
dendritic cells. These cells can be found in rectal, penile, vaginal, and oral mucosa (Kirton,
2011, p.74). HIV has been found in the following bodily fluids and tissues: peripheral blood,
lymph nodes, cerebrospinal fluid, brain tissue, bone marrow, semen, seminal fluid, cervical cells,
and breast milk (Durham & Lashley, 2010, p.8). Transmissibility of HIV from these fluids and
tissues depends on the quantity of virus present, as well as the characteristics of the virus itself
“such as the viral phenotype, clades and subtypes, its tropism, and the viral load” (Durham &
Lashley, 2010, p.8). The most common modes of HIV transmission include unprotected vaginal
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and anal sexual intercourse, exposure to infected blood through needle sharing, perinatal
transmission, and breastfeeding (Durham & Lashley, 2010, p.8).
In the absence of treatment, HIV symptomatic disease will lead to acquired
immunodeficiency syndrome. The lymphoid tissue of the infected individual has been replaced
by fibroid tissue. This results in the inability of the immune system to trap the virus; therefore
the amount of serum HIV RNA is critically elevated. The CD4 level is below 200 cells/ml, and
the infected individual is now susceptible to opportunistic infections. The most frequent
opportunistic infections include Pneumocystis jirovecii pneumonia, Mycobacterium avium
complex, cytomegalovirus, toxoplasmosis, and candidiasis (Kirton, 2011, p.84). The
development of neoplasms, such as Kaposi sarcoma, non-Hodgkin lymphoma, and cervical
cancer, is also a risk for individuals with AIDS. Death will ultimately occur within two to five
years of an AIDS diagnosis if left untreated (Kirton, 2011, p.84).
Implications of Untreated HIV Infection
The implications of untreated HIV infection are not limited to the individual. In fact,
adherence to ART can have profound population and economic effects. The following sections
will further discuss the impact of ART adherence on individual health, population health, and the
economy.
Individual Health
One of the most beneficial aspects of ART to the individual is a significant increase in the
longevity of life. Kithara et al. (2009) reported a reduction in mortality risk with the use of ART.
They reported results of the effect of early versus late initiation of ART on survival in HIV
infection. This study found that initiating ART in patients with CD4 cells counts between 351 to
500 cells/ml increased their prognosis as compared to deferring treatment. The deferral of
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treatment for patients with CD4 levels in this range led to a 69% increase in risk for death
(p.1821). These findings strongly support the significance of ART initiation.
Population Health
The medical treatment of an individual living with HIV has potential benefits for the
general population. It is thought that suppression of the individual plasma viral load has
potential in reducing the overall transmissibility and incidence rate of HIV in the community
(Machtinger & Bangsberg, 2006). There is evidence of diminished incidence of mother-to-child
and sexual transmission when HIV viral suppression is maintained (CDC, 2009; Machtinger &
Bangsberg, 2006; McDonnell Holstad, DiIorio, Kelley, Resnicow, & Sharma, 2010).
Additionally, increasing the ART adherence rate may reduce the development of HIV drug
resistance, resulting in a decrease of the spread of resistant HIV strains (Machtinger &
Bangsberg, 2006). It is evident that the sequel of uncontrolled HIV infection extends beyond
individual consequences.
Economic Burden
From the economic perspective, ART nonadherence can create severe financial burden to
the U. S. health care system. The annual direct cost of nonadherence to all medications, in
addition to HIV medications, ranges between $100 billion to $289 billion in the U. S.
(Viswanathan et al., 2012). Hutchinson et al. (2006) conducted an incidence-based cost-ofillness analysis to estimate the economic burden of HIV/AIDS in the U. S. During the time of
the Hutchinson et al. study, the annual incidence of HIV infection was approximately 40,000
cases. It was estimated that treatment of the 40,000 newly diagnosed individuals with HIV would
result in a $3 billion reduction in productivity losses annually (Hutchinson et al., 2006).
Calculating the financial cost of productivity loss for current HIV incidence rates would result in
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greater economic burden. The HIV incidence rates have increased to approximately 50,000 new
cases yearly since the 2002 data reported by Hutchinson et al. (CDC, 2013). The economic
significance of investing in ART adherence interventions becomes apparent given the indication
that treating all newly diagnosed persons would lead to financial savings.
ART Initiation
There is no curative treatment for the eradication of HIV infection. The primary goals of
treatment are to:
•

Reduce HIV-associated morbidity and prolong the duration and quality of survival,

•

Restore and preserve immunologic function,

•

Maximally and durably suppress plasma HIV viral load, and

•

Prevent HIV transmission (DHHS, 2014).
The initiation of ART is based on clinical evidence and guideline recommendations. The

Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for
Adults and Adolescents (2014) provides the following recommendations for initiating ART:
•

All HIV-infected individuals to reduce the risk of disease progression. The evidence is
strong, originating from randomized controlled trials (RCT), for individuals with a
pretreatment CD4 count of less than 350 cells/mm3. Data from well designed,
nonrandomized trials also provided strong evidence for the use of ART in individuals
with pretreatment CD4 counts between 350 and 500 cells/mm3. The Panel also supports
the initiation of ART in persons with a pretreatment CD4 count greater than 500
cells/mm3. The evidence in support of this recommendation is based on expert opinion
and is of moderate strength (DHHS, 2014).
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•

ART is also recommended for all HIV-infected individuals to prevent the transmission of
HIV. The evidence to support this recommendation for the prevention of perinatal and
heterosexual transmission is rated as strong. For other transmission risk groups, expert
opinion strongly supports this recommendation (DHHS, 2014).

•

Expert opinion strongly recommends that patients initiating ART should be willing and
able to commit to the treatment. They should also have an understanding of the risks and
benefits of ART, as well as, the importance of adherence with this therapy. The patient
and/or provider may elect to defer or postpone therapy on the basis of patient choice,
clinical, or psychosocial factors (DHHS, 2014).
Based on these recommendations, all persons living with HIV at some point during the

course of the disease will require ART to prevent immunologic deterioration.
ART Adherence
Medication adherence in chronic disease management is a common health care problem.
Viswanathan et al. (2012) reported that as many as 30% of prescriptions are never filled, and
approximately 50% of chronic disease medications are taken incorrectly. Estimating the average
rate of nonadherence to ART can be difficult because factors, such as, the method of assessment
and the study population, may influence findings (Machtinger & Bangsberg, 2006). BattaglioliDeNero (2007) estimated the rate of ART adherence to range between 40% and 60%, while
Machtinger and Bangsberg (2006) reported an average rate of 70% adherence in people living
with HIV. These adherence rates are not sufficient to therapeutically manage this disease. In
fact, it is essential that all persons taking ART are adherent to greater than 95% of the prescribed
daily doses (DiIorio et al., 2002; DiIorio et al., 2008; Krummenacher, Cavassini, Bugnon, &
Schneider, 2011).
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Theoretically, the benefits of ART have promising outcomes, however, without
interventions addressing the barriers of adherence, the theoretical benefits cannot be translated
into practice. Cooperman and Arnsten (2005) and Raper (2010) identified barriers to ART
adherence. These barriers included regimen complexities, poor health literacy, inadequate social
support, substance abuse, mental illness, and nonreadiness to alter health-related behavior.
Health care providers have the opportunity to intervene and assist people living with HIV
with the intricacies of sustaining optimal adherence levels. Assessment of the client’s readiness
and motivation to initiate ART is a fundamental action of the health care provider. Raper (2010)
offered clinically important conditions that should be present to facilitate adherence. These
included the establishment of a trusting provider-client relationship, effective communication,
client-tailored regimens, and the identification and removal of personal barriers to adherence.
Furthermore, it was emphasized that motivation to initiate or continue ART should be clientdriven rather than provider-driven.
Project Proposal
In the clinical practice setting, it is not uncommon for HIV health care providers to
encounter patients struggling with medication adherence. Despite cumulative efforts of HIV
case managers, clinical pharmacists, nurses, and health care providers, a proportion of patients
remains inconsistent with ART adherence. As mentioned previously, this poses great risk to the
individual, community, and economy. This project aligns with the National HIV/AIDS Strategy
goals of decreasing the incidence of HIV and improving health outcomes for people living with
HIV (White House, 2010). There appears to be a gap in available evidence-based adherence
interventions and their clinical utilization in the practice setting. The following sections will
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describe the proposed project intervention, implementation site, target population, and study
objectives.
Intervention: Motivational Interviewing
The development and trial of various intervention methods have been discussed in the
literature as potential mechanisms for increasing medication adherence with chronic medical
conditions. Direct observation therapy, cognitive-behavioral strategies, and behavioral
approaches are some examples. Motivational interviewing (Miller & Rollick, 2002) is a clientfocused counseling method that has been researched and utilized to assist with health behavior
change. It is intentionally directed toward resolving ambivalence to promote behavior change
and has been successful with health-related problems such as substance abuse, smoking
cessation, and treatment adherence (Lundahl & Burke, 2009). With respect to medication
adherence, motivational interviewing (MI) has produced positive outcomes as an intervention for
clients struggling with hypertension, glaucoma, and osteoporosis (Cook, Bremer, Ayala, &
Kahook, 2010; Solomon et al., 2009). Golin et al. (2006) reported, “the individually tailored
nature of motivational interviewing (MI), an effective theory-based, client-centered approach,
makes it a promising strategy for addressing the complex, multidimensional features of ART
adherence” (p.42). Hence, the focus of this project was to introduce an evidence-based
behavioral intervention to the multidisciplinary care team of an HIV clinic.
Project Site
The chosen project site was a Midwest outpatient HIV clinic. This federally funded,
outpatient health clinic was founded in 1990 and provides health care to approximately 900
persons living with HIV. This organization is staffed by the clinic supervisor, four physicians,
one nurse practitioner, one clinical pharmacist, three registered nurses, four non-medical case
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managers, three medical assistants, and two business office assistants. The specific services
provided include medical and pharmaceutical care, non-medical case management,
transportation and financial assistance, referrals, and HIV/AIDS education.
Prior to the project implementation, the current assessment of medication readiness was
assessed through client self-report of medication recall. The Treatment Assessment Readiness
Tool (TART) had also been used inconsistently to assess client readiness to start ART
(Treatment for Life, 2009). This 30-item assessment tool captures HIV knowledge, previous
history of ART use, and perceived readiness to start ART. Previously, HIV case managers had
administered the TART during the clinical intake process for newly diagnosed clients and for
clients transferring their HIV care from a different medical facility. The tool was also used prior
to beginning ART at any point during client medical care. However, the HIV case managers
reported an inconsistent use of this tool due to its length, changes in care processes, and the
limitations in client dialogue when administering the TART. Medication adherence assessment
was also addressed at every provider visit utilizing self-report methods of recall.
This health clinic had established methods to address the identified barriers to ART
adherence. Such methods include financial drug assistance, medication regimen education,
incorporation of medication reminder methods, and in extreme cases, direct observation therapy.
Despite these efforts, there still remained a portion of clients who intermittently struggle with
ART adherence.
Target Population
The intended recipients of the MI intervention are people living with HIV struggling with
ambivalence to ART. Clients in the precontemplation, contemplation, and preparation stages of
the Transtheoretical Model of behavior change (DiClemente et al., 1991) are most amenable to
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behavior change through the use of MI. Clear identification of these clients may potentiate the
linkage of a client-centered intervention with the intended target population in this clinic.
During the initial phase of this implementation initiative, the target population will be the health
care professionals engaged with clients at this clinical practice site.
Statement of Purpose
This translational research initiative aims to answer the following questions:
1. What is the influence of a two-day introductory MI course on staff MI knowledge,
perception of MI effectiveness, perception of client behavior change, and likelihood of
MI use?
2. Within the context of the Promoting Action on Research Implementation in Health
Services (PARIHS) framework, to what extent is the incorporation of a MI intervention
into a local HIV clinic a successful implementation?
Nature of the Project
The project design will be a one-group pretest-posttest design to assess the within-group
effect of introductory MI training. The pretest-posttest design is appropriate when the project
leader aims to assess change within groups and “when the focus of the intervention is on change
(e.g. behaviors, attitudes)” (Polit & Beck, 2012, p.212).
Significance to Nursing
This project may provide valuable information regarding the effectiveness of MI training
and the feasibility of a client-centered intervention aimed at promoting health behavior change.
Health promotion is within the nursing paradigm. In fact, optimization of health “in the presence
of chronic disease or disability” is an essential public health goal (Pender, Murdaugh, & Parsons,
2011, p. 1). Health care providers working with people living with HIV may benefit from an
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evidence-based intervention that provides a systematic approach to addressing medication
adherence. With the advent of the Doctor of Nursing Practice degree, the translation of
evidence-based interventions into the health care setting creates a new paradigm for nursing
research. This implementation project aimed to contribute to this knowledge base.
Conclusion
This chapter provided an introduction to the health care issue of medication
nonadherence in people living with HIV and the advantages associated with achievement of viral
suppression. The complexities surrounding the commitment to indefinite ART treatment adds to
the clinical importance of this issue. It is not sufficient to prescribe ART without providing
evidence-based interventions to support adherence. Motivational interviewing is the proposed
intervention in this implementation project. The PARIHS framework is an ideal process for the
inception of a MI intervention in this local HIV clinic. The following chapter will provide an indepth integrative review of MI in promoting health behavior change, treatment adherence in
chronic disease, and ART adherence in people living with HIV.
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CHAPTER 2
Literature Review
The case for the need of effective ART adherence interventions has been presented. The
purpose of this chapter is to present the evidence in support of MI as effective for ART
adherence. First, an overview of MI will be provided to better comprehend its origins and
process. With this understanding, the inquiries guiding this review will be discussed. Finally, a
presentation of the evidence will ensue. This thorough integrative review will support the use of
MI as a practical, cost-effective therapy in the HIV clinical setting.
Motivational Interviewing
As previously mentioned, MI is a client-focused counseling method designed to assist
with health behavior change (Miller & Rollnick, 2002). It is paramount that an ART adherence
intervention is client-focused and client-driven, thus, the decision to further explore the concept
of MI. This section will focus on the origins and evolution of MI, as well as, discuss the guiding
principles of this intervention. Finally, a brief overview of the MI process will be introduced.
MI Origin and Evolution
Motivational interviewing came to fruition unintentionally through the behavioral
counseling work of William Miller in the early 1980s. There was great focus placed on
accurately empathizing with clients (Rogers, 1959), a skill Miller was trying to demonstrate to a
group of young psychologists in Norway (Miller & Rose, 2009). Through this role-play learning
process, it was recognized that Miller had a unique, intuitive manner of eliciting behavior change
talk from clients (Kinetic Streaming, 2012). This launched an investigative endeavor into what
is now known as motivational interviewing. Since the inception of MI approximately 30 years
ago, there has been an exponential growth of its use in research and clinical practice worldwide.
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This counseling style is utilized in an estimated 38 languages (Miller & Rollnick, 2009) with
greater than 200 published clinical trials (Miller & Rose, 2009). Motivational interviewing has
evolved into a universal, adaptable counseling approach to behavior change, such that, a theory
has emerged from this conceptual approach (Hettema, Steele, & Miller, 2005). The three
hypotheses of this theory are as follows:
1. Counselors who practice MI will elicit increased levels of change talk and decreased
level of resistance from clients, relative to more overtly directive or confrontational
counseling styles.
2. The extent to which clients verbalize arguments against change (resistance) during
MI will be inversely related to the degree of subsequent behavior change.
3. The extent to which clients verbalize change talk (arguments for change) during MI
will be directly related to the degree of subsequent behavior change (Hettema et al.,
2005).
MI Definition and Principles
The evolutional course of MI has not been limited to its rapid dissemination. The
defining characteristics of MI have also evolved into three categorical definitions. According to
Miller and Rollnick (2013), the three MI definitions are as follows:
Layperson’s definition: Motivational interviewing is a collaborative style for
strengthening a person’s own motivation and commitment to change.
Practitioner’s definition: Motivational interviewing is a person-centered counseling style
for addressing the common problem of ambivalence about change.
Technical definition: Motivational interviewing is a collaborative, goal-oriented style of
communication with particular attention to the language of change. It is designed to
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strengthen personal motivation for and commitment to a specific goal by eliciting and
exploring the person’s own reasons for change within an atmosphere of acceptance and
compassion (p. 29).
Furthermore, Miller and Rollnick (2013) explained that MI incorporates a guiding
counseling style overall, but includes directive and following styles in its approach as well. The
manner, in which, these styles are utilized assist the client to overcome ambivalence. It is
believed that “ambivalence is a normal part of preparing for change and a place where a person
can remain stuck for some time” (p. 12). An ambivalent person commonly utilizes both “change
talk and sustain talk” when discussing a personal problem behavior (p. 7). Change talk is
described as a client’s own personal reasons to change the behavior, while sustain talk is a
person’s argument for not changing the behavior (Miller & Rollnick). A practitioner
incorporating a directive style of counseling with ambivalent clients will often provoke
arguments for not changing the behavior. The underlying belief is that people are autonomous
and behavior change, in an ambivalent person, will occur through intrinsic motivation evoked
through the use of MI.
MI Process
There are four overlapping and sequential processes utilized during MI, engaging,
focusing, evoking, and planning (Miller & Rollnick, 2013). These processes are essential to the
overall flow of a MI conversation and lay the groundwork for resolving client ambivalence. The
following sections will provide a brief description of each process.
Engaging. While not exclusive to MI, therapeutic engagement is the required first step.
Engagement is “the process of establishing a mutually trusting and respectful helping
relationship” (Miller & Rollnick, 2013, p. 47). There are many factors that can influence
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positive or negative engagement, such as the service system, the provider’s emotional state, and
the client’s circumstances and emotional well-being (Miller & Rollnick, 2013). Suggestions for
reducing negative engagement are to avoid the use of provider-driven assessment that
encourages client passivity and the use of directive counseling.
Focusing. The process of focusing occurs next and can be described as developing and
maintaining “a specific direction in the conversation about change” (Miller & Rollnick, 2013,
p. 27). The provider is interested in the client’s anticipated goals and hopes from attending the
consultation. This process is one of clarification.
Evoking. Once the established change goal has been identified by the client, the
provider’s intention is to elicit “the client’s own motivation for change” and how the client might
implement the change (Miller & Rollnick, 2013, p. 28). It is apparent that this process differs
from the traditional didactic approach of instructing clients what to avoid and educating them on
how to correct their problem (Miller & Rollnick, 2013). An important point noted by Miller and
Rollnick (2013) is that the didactic approach is appropriate for a very small proportion of clients
with personal change problems, particularly, those that have resolved their ambivalence and are
ready to move forward with change. Whether the clients have resolved ambivalence entirely on
their own or have been expertly guided to resolve ambivalence, they have reached a level of
readiness to change.
Planning. The client conversation in the planning phase changes from one of exploring
the reasons for change to that of inquiring how to change (Miller & Rollnick, 2013). This
process is focused on the development of commitment to change and an action plan. Important
concepts during this process include maintaining patient autonomy and eliciting the client’s
personal solutions to the behavior problem, as well as, supporting continued change talk

29"

"
(Miller & Rollnick, 2013). The authors observed from early research that, many times, clients
proceeded to change entirely on their own once they experienced the focusing and evoking
processes. These clients had remained ambivalent about behavior change, and once this was
resolved through the preceding three MI processes, they were able to move forward with change.
The Integrative Literature Review: Purpose, Design, and Literature Search
There is a substantial amount of evidence supporting the use of MI as a client-centered
intervention for health behavior change. The aim of this integrative review was multifaceted.
The primary concern was to determine if MI is an effective intervention for increasing
medication adherence levels among adults with HIV. The second query sought to clarify the
optimal MI dose needed to produce a positive effect on medication adherence. Additionally, this
review aimed to explore which professional disciplines have been utilized to deliver MI sessions.
Finally, the last objective was to determine an appropriate method of measuring medication
adherence in this clinical practice setting.
This integrative review attempted to be inclusive of MI evidence from a broad to narrow
perspective. With this focus, the literature search was divided into three domains. The first
domain centered on reviewing meta-analyses and systematic reviews addressing MI as an
intervention for health behavior change. The second domain reviewed quantitative studies
designed to test the effect of MI on treatment adherence in clients with chronic disease.
The third domain focus was narrowed to research studies reporting the effect of MI on ART
adherence in people living with HIV. The overall goal of this review was to gather and search a
substantial amount of evidence to address the proposed inquiries concerning MI.
This integrative review utilized the methodology proposed by Whittemore and Knafl
(2005) to guide the focus of the review while maintaining study boundaries. Whittemore and
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Knafl included five stages in their integrative review methodology: problem identification,
literature search, data evaluation, data analysis, and presentation. These five stages provide the
framework for this review.
As previously mentioned, three search domains were incorporated into the review
process. Although the underlying focus was the effect of MI on medication adherence, each
domain slightly differed in problem identification. Whittemore and Knafl (2005) suggested that
this initial stage also include the sampling frame of the research, thus the search parameters
within each search domain will also be discussed.
Search Domain 1
There is a flourishing body of research reporting the effect of MI on behavior change. It
is imperative to explore this evidence when attempting to translate this research-based
intervention into clinical practice. Therefore, the focus of this search domain was to determine
the effectiveness of MI with improving health behavior change within an extensive parameter of
health problems. To accomplish this, meta-analyses and systematic reviews were collected
because they “yield the strongest level of evidence on which to base practice decisions” (Melnyk
& Fineout-Overholt, 2011, p. 13). The inclusion criteria concentrated on meta-analyses,
systematic reviews, or studies including both meta-analytic and systematic review methods that
focused on MI as described by Miller and Rollnick (2002). The exclusion criteria were as
follows: primary study population less than 18 years old, language other than English, MI
combined with other intervention, studies focused solely on MI delivered in a group setting,
studies with a primary focus of addiction, such as alcohol and tobacco abuse. Meta-analyses and
systematic reviews that included smoking cessation along with other health behaviors were
included in this review. Motivational interviewing was the key search term used to explore the
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Cochrane Library and PubMed databases. This search produced 195 articles resulting in 12
meta-analyses and systematic reviews to be analyzed.
Search Domain 2
The next investigative endeavor sought to determine the effectiveness of MI on treatment
adherence among clients with chronic medical conditions. Because HIV is considered a chronic
disease, it was thought that inclusion of these data would enhance the knowledge base for
developing a MI intervention for people living with HIV. The inclusion criteria were
quantitative research studies, adult population, MI as described by Miller and Rollnick (2002),
and the outcome measure of adherence. Studies were excluded based on the following criteria:
MI combined with another intervention, MI delivered in a group setting, language other than
English, and studies focused solely on smoking cessation or substance abuse. The key search
terms were motivational interviewing, adherence, treatment adherence, and medication
adherence. A literature search of four databases, the Cumulative Index to Nursing and Allied
Health Literature (CINAHL), PsychArticles, Medline, and PubMed, yielded a total of 630
articles. After application of the inclusion and exclusion criteria, 12 articles remained for
analysis.
Search Domain 3
As described above, the identified clinical problem was suboptimal medication adherence
among the target population of adult men and women living with HIV. Another variable of
interest was the intervention of MI. The predetermined inclusion criteria were primary, English
language research articles that included MI as an intervention, HIV-positive adults, and an
outcome measure of medication adherence. Studies were excluded if the target population
included HIV-positive adults with substance abuse issues. Exclusion was also based on the
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delivery of the MI intervention. Studies that delivered MI in a group setting were not included.
This review included research articles within the time span of the years 2003 to 2014. It was
thought that data from this time frame would provide the most relevant research without
narrowing the investigation significantly, resulting in an insufficient number of articles. The
following databases were reviewed: CINAHL, Medline, PsychArticle, PsychInfo, and Proquest
Psychology. An ancestry search was also conducted from a meta-analysis, which produced two
articles that were not duplicative of research found in the database search. Keywords significant
to this literature search were motivational interviewing, adherence, human immunodeficiency
syndrome, and HIV. Nine studies were retrieved for inclusion in this review.
The Integrative Review: Data Evaluation, Analysis, and Presentation
The evaluation and analysis of data are considered paramount to the rigor of integrative
review. Evaluation of the systematic reviews and meta-analyses followed the guidelines within
the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement
(Moher, Liberati, Tetzlaff, Altman, and The PRISMA Group, 2009). Although Moher et al.
reported that the PRISMA checklist is not designed as a quality assessment instrument, its utility
extends beyond reporting guidelines to a framework for critically appraising systematic reviews.
The PRISMA checklist items adopted for the first search domain are as follows: study
objective(s), eligibility criteria, variables analyzed, databases searched, study selection, summary
measure, synthesis of results, and summary of evidence. The data collected from the 12 metaanalyses, systematic reviews, and combined meta-analytic and systematic reviews have been
aggregated in Table A1 (see Appendix A).
The process of data evaluation and analysis for the second and third search domains
adhered to critical appraisal recommendations of Melnyk and Fineout-Overholt (2011) for the
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specific type of research study performed. Utilization of a standardized format to condense data
from multiple studies allows for comparative analysis and identification of significant themes
(Stubbings, Chaboyer, & McMurray, 2012). Data from the studies were extracted to create a
summary of descriptive and objective information necessary to address the objectives of this
review. Tables A2 and A3 (see Appendix A) provide the study details, intervention details, and
results.
Data abstraction and evaluation of the literature revealed relevant findings pertinent to the
objectives of this review. This author found studies with high levels of evidence contributing to
the validity and reliability of the present review. The presentation of the data is available in
Tables A1, A2, and A3 (see Appendix A). The following sections will present the available
evidence to address the objectives of this integrative review.
Search Domain 1: MI Effectiveness in Health Behavior Change
This integrative review produced four meta-analyses (Burke, Arkpowitz, & Menchola,
2003; Hettema, Steele, & Miller, 2005; Lundahl, Kuntz, Brownell, Tollefson, & Burke, 2010;
Ren, Yang, Browning, Thomas, & Liu, 2014), four systematic reviews (Knight, McGowan,
Dickens, & Bundy, 2006; Lundahl & Burke, 2009; Martins & Mcneil, 2009; Mulimba & ByronDaniels, 2014), and four studies incorporating both research methods (Armstrong et al., 2011;
Lundahl et al., 2013; Rubak, Sandbaek, Lauritzen, & Christinsen, 2005; VanBuskirk &
Wetherell, 2013) to investigate the effect of MI on health behavior change. Overall, the results
of the meta-analyses revealed positive MI effects on influencing health behaviors.
Meta-analyses. Burke et al. (2003) conducted a meta-analysis of 30 randomized
controlled trials (RCT) to examine the efficacy of adaptations of MI as proposed by Miller and
Rollnick (2002). The 30 RCTs consisted of health behaviors such as adherence, diet and
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exercise, smoking and alcohol abuse, HIV risk, and eating disorders. Burke et al. reported their
results in subgroups of combined effect sizes according to clinical problem area and design type.
In RCTs comparing MI with no treatment, the combined effect sizes were statistically significant
and ranged from small to moderate effects for the problem areas of alcohol abuse, drug
addiction, and diet/exercise (Burke et al., 2003). Studies focused on smoking cessation and HIVrisk behavior resulted in nonsignificant combined effect sizes.
Furthermore, Burke et al. (2003) reported nonsignificant findings when they combined
RCTs comparing MI to active treatment, such as skills-behavior counseling, non-directive
reflective listening, confrontative feedback, and cognitive behavioral therapy. These RCTs
included the problem areas of alcohol abuse and smoking cessation. Results of a multiple
regression analysis conducted on 23 of the 30 studies revealed that MI dose and the behavioral
problem area accounted for 38% of the variance in outcomes. Despite these findings, the authors
were able to report a combined within-MI effect size of 0.82 for the 11 RCTs that used MI as the
sole intervention across all problem areas.
The within-treatment effect size reported above was one method Burke et al. (2003)
utilized to determine the clinical impact of MI. They were also able to calculate the percentage
of improved estimates from seven studies with a total sample size of 616 clients. Following a MI
intervention, 51% of clients displayed an improvement in behavior outcome compared to 37% of
clients that received no treatment or treatment as usual (Burke et al., 2003). This finding was
statistically significant. Burke et al. concluded that MI appears to be effective whether
administered as a single intervention or in addition to standard treatment. The estimated overall
client success rate improved from approximately 33% to 50% for those clients partaking in the
MI intervention (Burke et al., 2003).
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The second meta-analysis included in this review was conducted to provide “an up-todate summary of the evidence base for MI” (Hettema, Steele, & Miller, 2005, p. 94). This metaanalysis included 72 studies targeting health problems of alcohol, tobacco, and substance abuse,
treatment adherence, eating disorders, diet and exercise, gambling, and water safety. Hettema et
al. (2005) reported combined effect sizes by target health problem across all follow-up points.
The authors observed variability in effect sizes across target problems and among studies within
each target problem. The authors predicted this variability was attributed to discrepancies in the
delivery of MI across studies; however, meta-regression analysis revealed that two factors
contributed to the differences in combined effect sizes (Hettema et al., 2005). The presence of a
MI manual in the original studies accounted for 8.5% of the variance, while ethnicity accounted
for 19% of the variance in the combined effect size. Further analysis revealed that the minority
population in the samples displayed significantly larger MI effect sizes than non-minority
samples. This finding suggested MI might have better outcomes in minority populations.
Additionally, Hettema et al. (2005) separated the clinical trials comparing MI to untreated
control groups from the trials adding MI to standard treatment or comparing MI to the standard
treatment. Standard treatment modalities included education, self-help manuals, stress
management, skills training, and cognitive therapy. The authors sought to explore the effect of
MI as an additive component to standard treatment compared to MI as the sole intervention.
This inquiry was based on the meta-analytic findings of Burke et al. (2003) that reported
insignificant results when MI alone was compared to standard treatment. The findings displayed
a gradual decline in MI effect from approximately one month to 12-month post-intervention.
This finding was evident in the studies that compared MI to an untreated control group and in the
studies comparing MI to a control group receiving standard treatment (Hettema et al., 2005). The

36"

"
group of studies comparing MI coupled with standard treatment versus standard treatment alone,
however, displayed a persistent positive effect of MI across all follow-up periods. The combined
effect size for this group of studies across the five data collection periods was relatively
consistent at approximately dc = 0.60 (Hettema et al.). This finding is paramount as it suggests
that an MI intervention might produce sustainable positive effects when added to current
treatment practices.
Overall, the meta-analysis conducted by Hettema et al. (2005) provide useful findings.
First, the effect of MI combined with active treatment appears to endure across time. Second,
the synergistic effect of MI coupled with active treatment may stem from the effect of MI on
treatment adherence and retention (Hettema et al., 2005). Finally, MI alone may produce
positive outcomes over time with MI booster sessions.
Lundahl, Kuntz, Brownell, Tollefson, and Burke (2010) examined the extent to which MI
can assist clients toward change and sought to investigate the unique effect of MI compared with
other treatment or controls on a diversity of health-related behaviors. Their meta-analytic study
consisted of 119 quantitative trials. A distinctive component to their study criteria was inclusion
of studies utilizing MI or motivational enhancement therapy (MET), described as “a subdivision
of MI” (Lundahl et al., 2010, p. 139). Motivational enhancement therapy is based on the
principles of MI, however, adds the component of feedback from standardized assessment
measures (Lundahl et al.). The researchers utilized MET as a potential moderator of differences
in MI effect size because it was hypothesized that MET could affect the outcome of MI.
The Lundahl et al. (2010) study shares similar findings to that of Burke et al. (2003) and
Hettema et al. (2005). First, the authors concluded the use of a MI intervention results in a small,
yet significant, positive effect in outcomes. Second, the authors observed a wide variability in
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effect sizes across studies. It was reported that 25% of the studies produced negative or neutral
effect sizes, 50% of the studies resulted in slightly larger than small effect sizes, and 25% of the
effect sizes were classified as larger than a medium effect (Lundahl et al., 2010).
Moderator analyses resulted in significant findings as well. Lundahl et al. (2010) utilized
findings from Burke et al. (2003) and Hettema et al. (2005) to determine how to categorize
potential moderators of MI effect size variability. As previously mentioned, one of the potential
moderators included was MET. Findings indicated that MI produces a larger effect size when it
is compared to a weak control group versus when compared to a strong control group.
Furthermore, among the studies comparing MI against a weak control group, MET produced a
larger effect size compared to MI. In sum, MET might produce better results than MI alone in
promoting behavior change (Lundahl et al.).
The clinical significance of the Lundahl et al. (2010) findings may have compelling
implications for MI use in the practice setting. First, their review reveals that MI does produce
small, significant positive effects in promoting behavioral change. Second, MI may promote
behavior change in less time compared to other effective interventions. Moreover, there may be
an indication for the use of MET, rather than MI, in certain clinical settings. Finally, MI appears
to generate longstanding positive outcomes.
Combined meta-analyses and systematic reviews. This literature search also produced
four studies combining meta-analytic and systematic processes to evaluate the intervention of
MI. Rubak, Sandbaek, Lauritzen, and Christinsen (2005) conducted this type of mixed-method
analysis with 72 RCTs. The meta-analysis included 19 RCTs, while all studies were
systematically reviewed. The RCTs were grouped based on health-related outcome before
calculating combined effect estimates. Significant combined effect sizes were reported for the

38"

"
effect of MI on reducing body mass index, total blood cholesterol, systolic blood pressure, blood
alcohol content, and standard alcohol content (Rubak et al., 2005). There were two combined
effect sizes failing to reach significance in demonstrating a reduction in hemoglobin A1c levels
and the number of cigarettes smoked per day. Despite this, Rubak et al. reported that 74% of the
72 RCTs demonstrated significant MI effects on the target outcome. In addition, MI appears to
be successful when implemented in different interventional areas, such as adherence and
behavior change, and “outperforms traditional advice giving” in the clinical setting (p. 310).
Armstrong et al. (2011) systematically reviewed 12 RCTs and analyzed 11 RCTs to
investigate the effectiveness of MI on decreasing body mass. Motivational interviewing had a
medium effect on body mass reduction; however, this finding resulted in significant
heterogeneity in the pooled effect size. This study adds strength to the Hettema et al. (2005)
finding that MI plus standard treatment results in greater outcomes than MI alone. In this metaanalysis, the studies incorporating MI as an additive component to the standard treatment of a
weight loss program demonstrate the most amount of weight reduction. This factor played a
partial role in the significant heterogeneity in the pooled effect size.
The next mixed method review focused on MI effectiveness in the primary care
population. VanBuskirk and Wetherell (2013) examined 12 RCTs incorporating health
behaviors, such as blood pressure reduction, substance use, body weight reduction, physical
activity, and adherence. Seventy-five percent of the studies demonstrated a statistically
significant MI effect on the selected outcome. VanBuskirk and Wetherell also found MI to have
a small, significant combined effect size with significant heterogeneity found among the studies.
The MI deliverer accounted for 26% of the variance in outcomes across all 12 RCTs.
VanBuskirk and Wetherell also reported meta-analytic findings for the two studies in their
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sample that addressed the outcome of adherence. Despite the small sample size in this subgroup,
MI had a small, statistically significant effect on adherence.
The last study in this section also focused on MI efficacy in the medical setting (Lundahl
et al., 2013). The authors used an odds ratio to calculate the overall effect of MI on health
behavior outcome, producing an odds ratio of 1.55 (n = 48), 95% CI [1.40, 1.71], z = 8.67,
p < 0.001. Therefore, a client participating in MI has a greater likelihood of positively altering
health behavior than participants undertaking a comparison intervention (Lundahl et al., 2013).
Furthermore, this study reveals that MI is successful in producing favorable outcomes with a
variety of medical problems. These outcomes include reductions in cholesterol, HIV viral load,
and blood pressure. On the contrary, MI did not have a statistically significant effect on
lowering blood glucose, heart rate, and increasing medication adherence (Lundahl et al., 2013).
The Lundahl et al. (2013) findings are interesting. MI was successful in decreasing HIV
viral load, but yet unable to demonstrate positive outcomes with medication adherence. This
result should be taken with caution because the three studies utilizing HIV viral load as the
outcome measure (Golin et al., 2006; Naar-King et al., 2006; Naar-King et al., 2008) may not
have included medication adherence as a secondary outcome in their studies. In fact, one of the
RCTs included in Lundahl et al.’s (2013) review reported that HIV viral load “was considered a
proxy measure of adherence” (Naar-King et al., 2006, p.7). This was attributed to the fact that
HIV viral load is the main outcome of ART adherence (Naar-King et al.; Murphy et al., 2001).
Despite the less than positive outcomes in medication adherence reported in this meta-analysis,
MI appears to still have a positive effect on medication adherence when indirect outcomes
dependent upon adherence, such as HIV viral load, are measured.
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Systematic reviews. Systematic reviews were the final type of study researched within
this search domain. Although unable to provide cumulated statistical findings, systematic
reviews serve to provide an unbiased, aggregated review of the evidence adhering to strict
procedural guidelines (Polit & Beck, 2012). Knight, McGowan, Dickens, and Bundy (2006)
reviewed eight studies, including four RCTs, three pilot studies, and one non-randomized
controlled trial, to evaluate the effectiveness of MI in the physical health care setting. The health
domains included diabetes, asthma, hypertension, hyperlipidemia, and heart disease. They
concluded that MI had a positive effect on psychological, physiological, and lifestyle change
outcomes in the majority of the eight studies (Knight et al., 2006). The authors did express
concern, however, with low internal content validity of the eight studies included in their review.
Specifically, only 81% of the psychological and health behavior change outcomes, across all
studies, were measured with a validated instrument (Knight et al., 2006). As a result, the authors
were not able to confidently suggest the implementation of MI across health facilities based on
the evidence gathered. This systematic review was published seven years prior to
systematic/meta-analytic reviews conducted by VanBuskirk and Wetherell (2013) and Lundahl
et al. (2013). These three studies focused on MI efficacy within the medical setting. It appears
that MI research has flourished since Knight et al.’s study. The two reviews conducted in 2013
yielded samples purely consisting of RCTs with greater rigor and larger sample sizes than the
studies included in the Knight et al. review.
In 2009, Lundahl and Burke compiled four meta-analyses for the purpose of
systematically reviewing the MI evidence for use by practitioners in the clinical practice setting.
Three of these meta-analyses (Burke et al., 2003; Hettema et al., 2005; Lundahl et al., 2010) have
been previously mentioned in this review. The Lundahl and Burke (2009) systematic review is

41"

"
unique, in that, it is the only review identified by this author that specifically focuses on metaanalytical findings of MI effectiveness. It was reported that when MI is compared to weak
comparison groups (no treatment, waitlist, and information only groups), the effect size ranges
from d = 0.27 to d = 0.40 (Lundahl & Burke, 2009). The authors converted the effect sizes to
percentages and found that MI is 14% to 20% more effective in improving health behavior
outcomes after two to three sessions compared to receiving no treatment or health information
(Lundahl & Burke, 2009). This means for every 100 persons that improve in the health behavior
outcome without treatment, it could be estimated that 114 to 120 persons will improve in the
health behavior outcome with MI (Lundahl & Burke, 2009). Across these four meta-analyses,
Lundahl and Burke reported that the overall MI effect is “as effective but not greatly more so
than other active treatments” (p. 1236). Examples of these active treatments included cognitive
behavioral therapy and 12-step programs. Interestingly, MI produces these equal effects in a
shorter time frame compared to the active treatments. It was estimated that MI spent
approximately 101 to 180 minutes less than comparative treatments to produce positive
behavioral change outcomes (Lundahl & Burke, 2009).
Summation of the level one research evidence presented in this section reveals that MI
has substantial potential as an effective treatment modality for behavior change. Coupled with
treatment as usual, MI may augment the effects of usual treatment methods (Armstrong et al.,
2011; Hettema et al., 2005). Motivational enhancement therapy, however, appears to outperform
MI in clinical situations where there is no active treatment in place. While MI may produce a
small, significant effect size, MET may potentially produce a medium effect size in this type of
situation (Lundahl et al., 2010). Hence, both MI and MI plus problem feedback (MET) are
efficacious modalities in health behavior change. Nevertheless, future studies are necessary to
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determine the superiority of MET over classic MI in health problems beyond addiction (Lundahl
& Burke, 2009).
Further findings from this search domain are enlightening. First, MI is as efficacious as
other behavior treatment modalities in modifying behavior (Lundahl et al., 2009). Second, MI
requires less time to achieve intended outcomes, and these outcomes are durable across time
(Burke et al., 2003; Hettema et al., 2005; Lundahl et al., 2009; Lundahl et al., 2010; Rubak et al.,
2005). Finally, the potential contributors to variability in MI effect size include MI dose, MI
deliverer, behavior outcome, ethnicity, and the utilization of a MI manual (Burke et al., 2003;
Hettema et al., 2005; VanBuskirk & Wetherell, 2013).
Search Domain Two: MI Effectiveness in Chronic Disease Treatment Adherence
There is a growing body of research aimed at exploring MI effect on treatment adherence
among clients with chronic medical conditions. These investigations have centered on health
conditions, such as, major depressive disorder, schizophrenia, hypertension, chronic kidney
disease, diabetes mellitus, obstructive sleep apnea, and osteoporosis (Barkhof, Meijer,
deSonneville, Linzen, & deHaan, 2013; Chen, Creedy, Lin, & Wollin, 2012; Chlebowy et al.,
2014; Cook, Emiliozzi, & McCabe, 2007; Garcia-Llana, Remor, delPeso, Celadilla, & Selgas,
2014; Interian, Lewis-Fernández, Gara, & Escobar, 2013; Lewis-Fernández et al., 2013; Ma,
Zhou, Zhou, & Huang, 2014; Ogedegbe et al., 2008; Olsen, Smith, Oei, & Douglas, 2011;
Russell et al., 2011; Solomon et al., 2012; Welch, Zagarins, Feinberg, & Garb, 2010). The
previous section described the positive effect of MI with health behavior change. The following
review will examine the influence of MI on treatment adherence in populations living with
chronic disease.
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Mental health conditions. Recent studies in the field of MI have focused on mental
health conditions (Interian et al., 2013; Lewis-Fernández et al., 2013; Barkhof et al., 2013).
There were two RCTs and one pilot study focusing on major depressive disorder and
schizophrenia. Two of these studies (Interian et al., 2013; Lewis-Fernández, 2013) reported
statistically significant improvements in antidepressant adherence and retention in an
antidepressant therapy program after the MI intervention. Interian et al. (2013) reported that
limitations to their RCT include a small sample size and the inability to capture the long-term
effects of MI.
The RCT utilizing a sample of patients with schizophrenia was unable to produce a
statistically significant increase in medication adherence after six months of MI (Barkhof et al.,
2013). In fact, the MI group and the health education comparison group displayed similar results
on the Medication Adherence Questionnaire and the Life Chart Schedule. A possible
contributing factor to this finding is that the self-report measures of medication adherence may
not have captured the true adherence level (Barkhof et al., 2013). This supposition derived from
findings of lower hospitalization rates in the MI group compared to the comparison group. It
was thought that increased adherence rates were associated with decreased relapse rates, thus,
fewer hospitalizations (Barkhof et al., 2013). The researchers were unclear that there was an
actual improvement in adherence, “but that measures used in this study are not reliable or
sensitive enough” to capture this finding (Barkhof et al., 2013, p. 1248).
Hypertension. The next two RCTs focused on hypertension control. Ogedegbe et al.
(2008) and Ma, Zhou, Zhou, and Huang (2014) evaluated the effectiveness of MI on improving
medication adherence, systolic blood pressure (SBP), and diastolic blood pressures (DBP) in
samples of African Americans and participants from China. Both studies were able to
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demonstrate positive findings in favor of MI. Specifically, Ogedegbe et al. were able to
demonstrate long-term effects after a 12-month MI study resulting in adherence rates of 60% in
the MI group compared to 47% in the control group. Furthermore, Ma et al. reported statistically
significant improvements in adherence, SBP, and DBP after six months of an MI intervention.
Chronic kidney disease. Motivational interviewing research in chronic kidney disease
includes two studies conducted in 2011 and 2013. Russell et al. (2011) conducted a three-month
pilot study with a convenience sample of 29 patients. Although statistical significance was not
achieved, 26% of the sample improved in the number of missed hemodialysis appointments after
the MI intervention. Russell et al. also used length of hemodiaylsis treatment to measure
adherence. Patients who shortened their treatment by 10 minutes or greater were categorized as
nonadherent. After the MI intervention, 47% of the sample improved in this area. Russell et al.
noted their study was limited by a small sample size.
García-Llana, Remor, del Peso, Celadilla, and Selgas (2014) were also limited by a small
sample size of 42 pre-dialysis patients in their pretest-posttest, quasi-experimental study to
improve medication adherence. A unique component of this study was the inclusion of the
Stages of Behavior Change related to Oral Medication Compliance Assessment Scale as one of
three adherence measurements. Inclusion of this scale allowed the researchers to explore any
movement of participants along the continuum of behavior change after the MI intervention.
García-Llana et al. (2014) reported statistically significant results. Thirty-nine percent of
participants were in the action stage at the start of the study, while 60% of the participants were
in the action stage six months post-intervention (García-Llana et al.). In addition, the researchers
found positive effects of MI on the mean change of the Survey of Adherence to Treatment score
and improvement in medication adherence according to the Medication Adherence
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Questionnaire. Overall, there is promising utility of a MI program in progressing clients through
the continuum of behavior change and with adherence to oral medications in pre-dialysis
patients.
Type 2 diabetes mellitus. There are three recent RCTs testing the effectiveness of MI in
patients with type 2 diabetes mellitus (T2DM). These studies have focused on adherence with
medication, physical activity, and glucose monitoring and have produced inconsistent findings
(Chen et al., 2012; Chlebowry et al., 2014; Welch et al., 2011).
Welch et al. (2011) conducted the first RCT with a sample size of 234 patients with
T2DM, of which, 118 patients were allocated to the MI intervention group. Although the MI
group showed a statistically significant improvement in change in hemoglobin A1c (HbA1c) level
six months post-intervention, the two control groups utilizing diabetes self-management
education (DSME) showed a greater significant change in HbA1c level (Welch et al.). Moreover,
multiple regression analysis displayed a significant negative effect of MI on change in HbA1c
level, with the MI group demonstrating a significantly lower change in HbA1c than the DSME
group (Welch et al.).
Welch et al. (2011) noted their study was limited by lack of MI proficiency skills of the
interventionists. Proficiency criteria set forth by the Motivational Interviewing Network of
Trainers requires a minimum score of five to be proficient in delivering MI, whereas, the four
interventionists in this RCT scored below this level (Welch et al.). Feedback given at study
termination from the MI trainers revealed that the interventionists did not incorporate “complex
reflection skills or consistently explore patient ambivalence around behavior change” (p. 59).
Assisting clients to resolve ambivalence is the very nature of MI. Failure to consistently address
this ambivalence for change may have affected the outcome of this study.
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The next RCT included a sample of 215 diabetic patients from Taiwan (Chen et al.,
2012). The primary adherence outcome measure was HbA1c level. The MI and control groups
received one diabetes education session weekly and participated in a diabetes club monthly
during the three-month study period. In addition, the MI group received one MI session two
weeks after the baseline data collection period. While both groups demonstrated a decrease in
HbA1c levels at termination, the HbA1c difference within the MI group reached statistical
significance (Chen et al., 2012).
Chlebowry et al. (2014) was also able to demonstrate the success of MI in a sample 62
African Americans. There was 66.7% of the MI group adherent to physical activity compared to
38.8% of the control group adherent at the end of 12 weeks. On the contrary, improvements in
medication adherence did not result in statistical significance. In fact, the intervention and
control group shared similar adherence rates at study termination. Several limitations, however,
were noted in the Chlebowry et al. (2014) study. First, there was a high attrition rate in both the
MI group (53.8%) and in the control group (50%), making the final sample size for data analysis
relatively small (n = 30). Second, this study did not report the measurement tool used for
medication adherence, nor its reliability and validity. This makes it difficult to determine
whether the measurement tool used in the study adequately measured medication adherence.
Furthermore, Chlebowry et al. noted that their findings might have been hindered by “factors
such as patient income, medication cost, and availability of generic medications” (p. 12). It was
reported that approximately 85% of the study participants in the MI group had a monthly income
of $1,000 or less (Chlebowry et al.). Prior to implementing a MI intervention for medication
adherence, availability of the medication to the participant is an important factor that may
influence the efficacy of the intervention.
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Obstructive sleep apnea. The next study included in this section focused on obstructive
sleep apnea (OSA). Olsen, Smith, Oei, and Douglas (2011) conducted a RCT with a sample of
100 participants to test the effect of MI on continuous positive airway pressure (CPAP)
adherence. After the delivery of three monthly MI sessions to the experimental group, there was
a positive influence of MI on the number of hours per night the MI group used CPAP. Olsen et
al. (2011) compared the MI group to the control group at months one, two, three, and twelve.
Statistically significant results were demonstrated at the one, two, and three-month data
collection points. At the 12-month collection period, the MI group used CPAP for an average of
4.21 hours per night, while the control group used CPAP for an average of 3.00 hours per night.
There were no significant results at the 12-month collection period. Despite this, MI still had a
medium effect size 12 months after baseline, indicating potential long-term benefits of MI in
assisting clients with OSA to adhere to CPAP treatment (Olsen et al.).
Osteoporosis. Two research studies explored the utility of MI with influencing
medication adherence rates in clients with osteoporosis (Cook, Emiliozzi, & McCabe, 2007;
Solomon et al., 2012). Cook et al. conducted a quasi-experimental study with a sample of 402
participants with osteoporosis. Their findings demonstrated statistical significance and revealed
that telephone-based MI sessions were effective in improving medication adherence six months
post-intervention. The MI group was 68.8% adherent compared to the national comparison rate
of 40.5% (Cook et al., 2007). They concluded that MI had an overall medium effect size on
medication adherence in this sample of patients with osteoporosis.
Solomon et al. (2012) were also interested in the impact of a telephone-administered MI
intervention on medication adherence in a sample of 2,087 clients with osteoporosis. This largescale RCT was conducted over 12 months and delivered ten MI phone sessions. The primary
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outcome measure was the medication possession ratio (MPR), which was calculated “as the
number of days with filled prescriptions during the observation period X 100 divided by the
number of days in the observation period” (p. 478). The results of the primary outcome measure
did not reach statistical significance; however, the intervention group had a median MPR of 49%
compared to 41% in the control group (Solomon et al.). Subgroup analysis found a significant
difference in medication adherence between age groups, with participants aged 65 to 74 years
benefiting from the MI intervention. Solomon et al. reported a median MPR of 48% in the MI
group compared to 31% in the control group for participants in this age group.
Notable limitations to the Solomon et al. (2012) study may have affected their findings.
The authors reported concern with methodology and outcome measure. First, methodology was
problematic due to an unintended lag time between the date the participants received their first
prescription and the first MI session. Solomon et al. reported a median of 113 days between
these two time periods. Second, the authors noted that pharmacy refill history does not ensure
the consumption of medication by the participant. This suggests the MPR may not be the most
effective measure of medication adherence. These combined factors had potential influences on
study outcomes.
In summary, this review produced 12 quantitative studies focused on the effectiveness of
MI with treatment adherence in chronic disease management. There were eight RCTs, two
quasi-experimental designs, and two pilot studies comprising the evidence for this search
domain. Across the 12 studies, the sample size ranged from 29 to 2,087 participants with a
median sample size of 110. Overall, 75% of the studies reported a positive MI effect on
treatment adherence. Based on the presented evidence, it appears that MI has the potential
capacity to promote client adherence to treatment modalities for long-term illnesses. Because
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HIV is now considered a chronic, manageable disease, these data are pertinent to people living
with HIV. The following section will discuss the findings pertaining to the association of MI
and the chronic disease of HIV.
Search Domain 3: MI Effectiveness in ART adherence
Motivational interviewing is a relatively novel intervention in the HIV setting. MI has
predominantly been implemented to address health behavior change in the prevention of disease
through reduction of risky sexual behavior (Chen, Murphy, Naar-King, & Parsons, 2010; Golin
et al., 2012; Lovejoy et al., 2011; Yeagley et al., 2012). Literature pertaining to MI and ART
adherence is still evolving and includes one observational study, one quasi-experiment, two
randomized controlled pilot studies, four RCTs, and one systematic review. The results of the
nine studies provide ample evidence of the potential role of MI in this clinical practice setting.
Observational study. Krummenacher, Cavassini, Bugnon, and Schneider (2011)
completed a four-year, retrospective, observational study for the purpose of testing an ART
adherence intervention based on the Information-Motivation-Behavioral Skills model (Fisher,
Amico, Fisher, & Harman, 2008) in a sample of 104 HIV positive patients in Switzerland. Fiftynine percent of the sample were women, and 42% of the participants were of black ethnicity.
The median age of the participants was 39 years. Seventy-seven percent of the sample were
ART-experienced. There were 63% of participants on a twice daily ART regimen, while 36% of
participants were taking a once daily regimen. At baseline, the median HIV viral load was 9,210
copies/mL and the median CD4 count was 283 cells/mm3.
This ART adherence intervention model incorporated cognitive, motivational, behavioral,
and affective components. The motivational component involved semi-structured motivational
interviews. Results of this observational study are promising toward the inclusion of a structured
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intervention that includes the use of MI skills. Overall, the proportion of patients who achieved
HIV-1 viral suppression increased during and after the intervention. Eighty-eight percent of the
ART treatment-naive group achieved viral suppression upon exiting the program, while the ART
treatment-experienced groups achieved statistically significant decreases in viral load.
Furthermore, Krummenacher et al. reported an overall adherence rate of 83% at the end of the
study period.
Although an overall benefit resulted from this intervention program, careful attention
must be made to the fact that motivational interviewing was one of four components of this
intervention. This makes it difficult to discern whether the change in adherence was a result of
motivational interviewing counseling. Nevertheless, this study adds some support for the role of
MI in HIV adherence counseling.
Quasi-experimental study. Next, a quasi-experimental study conducted by Cook,
McCabe, Emiliozzi, and Pointer (2009) included a sample of 98 men and women living with
HIV across the United States. The average age of the participants was 43.5 years, SD = 9.3, and
38.8% of the sample were female. Race and ethnicity were not collected in this study. The
mean number of comorbid diagnoses in this sample was 1.4, SD = 0.7, and 73% of the
participants were taking at least two medications. The objective of this pretest-posttest, nonequivalent control group study was to determine the efficacy of the Script Assist program in
increasing medication adherence. Script Assist is an intervention program utilizing telephonebased MI counseling. Results at the six-month endpoint demonstrated 76% of the participants
achieved medication adherence rates greater than or equal to 95% compared to the expected
population adherence rate of 50% (Cook et al.). Despite these positive findings, limitations of
this study included a 58% attrition rate, high baseline adherence, and limitations to
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generalizability of findings, as people living with HIV without consistent telephone access may
not benefit from the intervention.
Pilot studies. Two randomized controlled pilot studies were included in this integrative
review. While pilot studies are not conducted to demonstrate intervention effectiveness (Polit &
Beck, 2012), Connelly (2008) reported that data obtained from pilot studies “may suggest the
intervention is likely to be effective based on preliminary data” (p. 411). DiIorio et al. conducted
the first pilot study in 2003 as a prelude to a larger intervention trial. There were 20 participants
in their sample. The characteristics of the intervention group, n = 10, are as follows: age,
M = 46.8 years, SD = 4.8; gender, 62.5% male; race, 87.5% African American; years since HIV
diagnosis, M = 12.13, SD = 4.19; number of medications, M = 2.63, SD = 0.74. There were no
significant differences in the characteristics of the control group compared to the intervention
group, except for the mean age, M = 38.4, SD = 8.4. In response to how often the participant
was unable to adhere to medication in the previous 30 days, the intervention group had a
significantly lower proportion of nonadherent individuals compared to the control group at the
six-week study endpoint. Despite the small sample size, these preliminary findings are
suggestive of disparate results among a larger sample favoring the MI intervention.
Furthermore, MI was calculated to have a medium to large effect on medication adherence
(DiIorio et al., 2003).
Findings from the randomized controlled pilot study conducted by Konkle-Parker, Erlen,
Dubbert, and May (2012) enhance support for MI in increasing medication adherence. This
study had a sample of 56 participants from the southern United States. The total sample, N = 56,
had the following characteristics: age, M = 34.6 years, SD = 8.4; gender, 62% male; race, 89%
African American. Greater than half of the sample had never taken ART prior to the
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intervention, and the average HIV viral load level was approximately 50,000 copies/mL. Guided
by the Information-Motivation-Behavior Skills model, Konkle-Parker et al. sought to test an
adherence intervention comprised of HIV education, a peer video, and motivational interviewing.
The researchers utilized the Visual Analog Scale and prescription refill rate as adherence
measures. This study did not produce statistical significance in adherence outcomes; however,
calculated effect sizes demonstrated that the intervention had a small effect on improving
medication adherence. Some factors contributing to these findings were the high percentage of
baseline medication adherence, high attrition, and low statistical power (Konkle-Parker et al.,
2012).
Randomized controlled trials. This literature search resulted in four RCTs investigating
the effect of MI on medication adherence among patients living with HIV. Golin et al. (2006)
conducted the only RCT in this review that did not produce statistically significant findings. The
researchers sought to test the effectiveness of a MI adherence program against HIV education to
enhance ART adherence. This sample consisted of 140 patients living with HIV from North
Carolina. The intervention group had the following characteristics: age, M = 39.91 years,
SD = 8.77; gender, 69.4% male; ethnicity, 76.8% African American; baseline viral load,
M = 5,012 copies/mL, SD = 13. The control group was similar to the intervention group in age
and gender; however, ethnicity, 54.6% African American, and baseline viral load, M = 7,943
copies/mL, SD = 16, differed slightly.
The results of this study may not have demonstrated statistical significance in favor of
MI; nevertheless, the positive effect of MI on ART adherence should not be discredited. Mean
adherence improved by 4.5% in the MI group compared to a 3.8% decrease in ART adherence
experienced by the control group at week 12 (Golin et al.). Furthermore, 29% of the MI group
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achieved greater than 95% adherence compared to 17% of the control group. After controlling
for ethnicity, participants in the MI group had a 2.75% higher odds of achieving greater than
95% adherence compared to the control group (Golin et al.). There was no significant difference
based on ethnicity in the percentage of participants achieving greater than 95% adherence. The
researchers noted that a limitation to their study was the small sample size that produced a
relatively low powered study to detect small statistical differences (Golin et al.). Moreover, the
MI intervention included two MI sessions, which may not be sufficient to positively influence
medication adherence.
Further MI research has yielded evidence in support of MI implementation to increase
ART adherence. A RCT in southeastern France utilized MI with HIV education to increase ART
adherence in a sample of 244 patients (Pradier et al., 2003). There were no significant
differences in baseline sociodemographic and clinical characteristics between the intervention
and control groups. The MI group, n = 123, had a median age of 40 years, and the control group,
n = 121, had a median age of 38 years. Seventy-one percent of the MI group and 75% of the
control group were males. At baseline, the mean HIV viral load of the MI group was 501
copies/mL, SD = 16, and the median CD4 count was 340 cells/mm3. The control group had a
mean HIV viral load of 398 copies/mL, SD = 13, and the median CD4 count was 361 cells/mm3.
Compared to the standard care group, the intervention group had a higher proportion of
participants achieving 100% medication adherence at the study endpoint. In fact, the researchers
noted that adherence was significantly higher for the participants who completed three sessions
compared to those that only completed one or two sessions (Pradier et al., 2003). The
intervention group had a significant decrease in mean viral load from baseline to the six-month
study endpoint; while, the control group experienced a slight increase in mean viral load in the
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same study period. When comparing the mean change in viral load between the intervention and
the control group at six months, results favored the combined MI and HIV education intervention
(Pradier et al., 2003). On the contrary, both the control and intervention groups had similar
proportions of patients achieving an HIV viral load less than 40 copies/mL at the end of the
study. A subgroup analysis of patients with HIV viral load levels above 40 copies/mL at
baseline demonstrated a significant mean change in viral load at six months for the intervention
group.
Overall, the Pradier et al. (2003) findings indicate that a MI-based intervention may be
more beneficial when delivered in greater than two sessions. Also, when considering HIV viral
load as a measurement outcome of adherence, it may be valuable to conduct separate analyses on
the participants with abnormal HIV viral load levels at baseline. This may especially be true for
study samples with relatively high baseline proportions of participants with undetectable viral
load levels. It is questionable whether the participants with baseline undetectable viral loads
were the correct target population for MI. Motivational interviewing is for the patient
ambivalent about taking medications. Clients achieving undetectable HIV viral loads at baseline
may be actively adhering to ART, as an undetectable HIV viral load is an indicator of ART
adherence (DHHS, 2014). This study is limited by its inability to discern the true effect of MI on
medication adherence, as this was a dual intervention. Nevertheless, MI appears to have played
a significant role in boosting ART adherence levels in this sample.
The support for MI as a facilitator of ART adherence continues with findings retrieved
from a RCT conducted in Atlanta, Georgia. DiIorio et al. (2008) followed their pilot study
(DiIorio et al., 2003) with a RCT to test the effect of the Get Busy Living program, a five-session
MI-based intervention. This study had a total sample of 213 HIV-positive participants for their
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main analysis. Thirty-four participants were either lost to attrition or had insufficient data for
analysis inclusion (DiIorio et al., 2008). The average age of the total sample was m = 41.6 years,
SD = 7.1, and 65% of the sample was African American. The MI group, n = 107, had a baseline
mean HIV viral load of 11,000 copies/mL, SD = 21.9, and the control group, n = 106, had a
baseline mean viral load of 9,200 copies/mL, SD = 19.9. The CD4 count was similar among the
MI group and control group, M = 250.3 cells/mm3, SD = 192.5, and M = 243.0 cells/mm3,
SD = 183.1, respectively.
This study produced statistically significant results. At the 12-month data collection
point, the MI intervention group consumed 64% of prescribed doses compared to 55% of
medication doses consumed by the control group. The MI group also exceeded in the percentage
of doses taken on schedule compared to the control group (DiIorio et al., 2008). Finally, sixmonth data demonstrated a higher percentage of participants with an undetectable HIV viral load
in the MI group compared to the control group. The importance of this RCT extends beyond its
statistical support for the use of MI to boost ART adherence. The DiIorio et al. (2008) study is
the only RCT in this review that demonstrated the potential positive long-term effects of MI in
promoting ART adherence.
Maneesriwongul, Prajanket, and Saengcharnchai (2012) conducted the most recent RCT
in Thailand. This study included 90 HIV-positive participants who were randomly assigned to
one of three groups, MI plus usual care, an educational video plus usual care, and usual care
alone. The average age of the MI group, educational video group, and usual care group was
m = 40 years, range = 23 – 52; m = 42.3 years, range = 25 – 61; and m = 39.3 years, range = 2267, respectively. These authors did not report standard deviations. The majority of the
participants in the three study groups were male. There were no baseline HIV viral load or CD4
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count data collected; however, 80% of the participants in each study group were on a single-pill
ART regimen.
The objective the Maneesriwongul et al. (2012) study was to determine the effect of the
three intervention groups on ART adherence. The MI group and the educational video group
both demonstrated statistically significant within-group mean differences in adherence from
baseline to the four-week study endpoint (Maneesriwongul et al., 2012). In addition, results of
the between-group posttest mean adherence scale scores were significantly different for the three
treatment groups. However, Maneesriwongul et al. reported nonsignificant differences in
posttest adherence scores between the MI plus usual care and the educational video plus usual
care groups.
This study demonstrated the superiority of MI over usual care in the increase of
adherence levels in this population. In fact, MI was found to be comparable to delivering an
HIV educational video coupled with usual medical care. A limiting factor to this study is its
inability to evaluate the long-term effects of MI. The authors commented that it may be more
cost-effective to use the HIV educational video plus usual care as this intervention produced
comparably significant results as MI (Maneesriwongul et al., 2012). However, it is unclear if
these findings from Thailand can be generalized to HIV populations in the United States.
Systematic review. The final study included in search domain three of this integrative
review is a systematic review. Hill and Kavookjian (2012) included five RCTs (DiIorio et al.,
2008; Golin et al., 2006; Parsons, Rosof, Punzalan, & Maria, 2005; Pradier et al., 2003; Samet et
al., 2005) in their systematic review. Three of these RCTs (DiIorio et al., 2008; Golin et al.,
2006; Pradier et al., 2003) were included in this integrative review. Two studies were excluded
based on the alcohol dependency of the study populations. The primary research inquiry was the
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effect of MI on patient adherence to ART. The population of interest was HIV positive adults
recently prescribed ART or patients already on ART with adherence issues. The targeted
outcomes included in this review were HIV viral load, CD4 count, and ART adherence. The
search methods of this systematic review included 11 databases in a 20-year time span.
Hill and Kavookjian (2012) concluded that three of the five RCTs (DiIorio et al., 2008;
Parsons et al., 2005; Pradier et al., 2003) reported significant changes in medication adherence in
the intervention group compared to the control group. The two studies (Golin et al., 2006; Samet
et al., 2005) that did not report significant findings in medication adherence after MI intervention
cited methodological concerns. The authors also reported the overall risk of bias in all five
RCTs was relatively low. Furthermore, it was concluded that current evidence could not direct
researchers and clinicians to the MI characteristics most effective in HIV medication adherence
(Hill & Kavookjian, 2012). This was largely due to the discrepancies in MI dose and duration.
Recommendations for future MI research to enhance medication adherence with this specific
population included the incorporation of larger sample sizes with an equal distribution of
genders, standardization of MI training and intervention fidelity, and consistency in medication
adherence measures (Hill & Kavookjian, 2012). Despite these limitations, the authors
determined that MI has potential benefits in the enhancement of ART adherence; however, there
is a need for high-quality research in people living with HIV (Hill & Kavookjian, 2012).
A synopsis of the presented evidence reveals compelling findings regarding the use of MI
in the HIV practice setting. While this area of research is still progressing, greater than half of
the studies produced statistically significant findings supporting MI use to increase ART
adherence. The eight primary research studies produced a sample size range of 20 to 247
participants. For those studies reporting effect sizes, the range displayed great variability,
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d = 0.04 – 0.75. This heterogeneity in effect size is similar to the meta-analytical findings
reported by Burke et al. (2003), Hettema et al. (2005), and Lundahl et al. (2010). In fact, these
researchers described probable factors attributing to the variance in MI outcomes, some of which
included MI dose and delivery. Hill and Kavookjian (2012) also noted the lack of
standardization in adherence measurement. Further exploration of these moderator variables
between MI intervention and adherence outcome may guide the implementation of this
intervention.
Objective Two: MI Dose
Motivational interviewing dose has not been consistent throughout the aforementioned
intervention studies, leaving health care providers in a quandary regarding the most beneficial
dosage to provide in clinical practice settings. Research has demonstrated that MI interventions
have included as few as one MI session to as many as 10 sessions (Chen et al., 2012; Ma et al.,
2014; Solomon et al., 2012). Specific guidance is needed as to the number of MI sessions and
the session length required to promote ART adherence.
Number of MI sessions. It is proposed that MI dose is related to the behavior change
outcome (Miller & Rollnick, 2002); however, there is no evidence-based consensus as to the
prescriptive dosage needed to elicit medication adherence. The findings from the meta-analysis
by Burke et al. (2003) revealed MI has a significant dose-effect relationship. Motivational
interviewing intervention studies delivering a greater number of sessions resulted in “better study
outcomes” compared to MI studies with fewer sessions (Burke et al., 2003, p. 858). In fact, the
authors noted that MI is intended to promote behavior change “in a small number of sessions”;
however, the role of added sessions is to assist clients with the initiation and maintenance of the
behavior change (Burke et al., 2003, p. 858). Furthermore, Rubak et al. (2005) observed that
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greater than one MI session increased the probability of the intended effect. Two of the reviews
considered MI dose to be a significant moderator of adherence outcome (Burke et al., 2003;
Hettema et al., 2005). The Lundahl and Burke (2009) systematic review of four MI metaanalyses strongly supports this notion. They concurred that better adherence outcomes could be
achieved with more MI sessions; however, they were unable to provide a numerical value for the
upper limit of the MI dose to administer. Lundahl et al. (2010) conducted a meta-analysis of 119
RCTs and reached a similar conclusion as Burke et al. (2003). They concluded that, “more
treatment time was related to better outcomes for MI” (p. 153).
It is also suggested that MI dose requirement may differ among target outcomes
(VanBuskirk & Wetherell, 2013). For example, target outcomes such as weight loss and
medication adherence may require a higher MI dose compared to outcomes of reduction in
alcohol intake and cigarette smoke exposure (VanBuskirk & Wetherell, 2013). Of the 12 studies
included in their review, VanBuskirk and Wetherell (2013) reported between four and eleven MI
sessions were conducted for target behaviors associated with diet and exercise and medication
adherence, whereas, one session was the minimum effective dose to reduce alcohol use and
passive smoke exposure. While not precise, this information provides some prescriptive
guidance towards the MI dosage inquiry.
Data retrieved from the HIV research studies (see Table A3 in Appendix A) evaluating
the effect of MI on ART adherence may also provide practical suggestions for the number of MI
doses needed to enhance ART adherence. Of the nine total studies, seven studies provided data
regarding MI dose. The number of sessions ranged between two and eight (Golin et al., 2006;
Konkle-Parker et al., 2012), with three sessions being the most frequently cited (Cook et al.,
2009; DiIorio et al., 2003; Maneesriwongul et al., 2012; Pradier et al., 2003). One study
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delivered five sessions and reported positive adherence outcomes (DiIorio et al., 2008). Four
studies delivered three MI sessions, and 75% of these studies reported positive statistical
findings. The studies delivering two and eight MI sessions (Golin et al., 2006; Konkle-Parker et
al., 2012) were not able to demonstrate statistically significant changes in ART adherence. This
is an interesting finding because previously presented evidence from a meta-analysis (Burke et
al., 2003) commented on the significant dose-effect relationship between MI and targeted
outcomes. Therefore, it may be expected that more intervention sessions would produce
favorable adherence outcomes. It must be noted, however, that the study (Konkle-Parker et al.,
2012) delivering eight MI sessions utilized MI as one component of a larger intervention
program. The fact that MI was not the sole intervention of Golin et al.’s study diminishes the
application of study findings to this implementation project.
In summary, evaluation of the data from the seven HIV quantitative studies in this review
resulted in compelling findings. According to the presented evidence, it appears that people
living with HIV may experience treatment adherence benefits from a minimum of three MI
sessions. However, the only RCT (DiIorio et al., 2008) delivering five MI sessions demonstrated
persistent ART adherence at 12 months. Adherence persisted nine months beyond the delivery
of the last MI session. Considering that HIV treatment management requires > 95% of indefinite
adherence, a greater number of MI sessions may be needed to produce lasting adherence results.
Moreover, the number of MI sessions needed may depend on the client’s risk for nonadherence.
This was demonstrated in the Cook et al. (2009) quasi-experimental study as participants
screened as low-risk for nonadherence, according to the transtheoretical model of behavior
change, were offered fewer MI sessions compared to participants at higher risk. All participants
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receiving the MI intervention, regardless of risk type, demonstrated an overall significant
improvement in ART adherence after six months (Cook et al.).
Available evidence for MI with the target population of people living with HIV at risk for
ART nonadherence has produced the following dosage recommendations:
1. A minimum of three sessions may be needed to produce positive ART adherence
outcomes (Cool et al., 2009; Maneesriwongul et al., 2012; Pradier et al., 2003).
2. The range of MI sessions that has been effective to promote ART adherence in
people living with HIV is three to five sessions (Cool et al., 2009; DiIorio et al.,
2008; Maneesriwongul et al., 2012; Pradier et al., 2003).
3. A greater number of sessions may be required to produce positive, long-term
ART adherence outcomes (DiIorio et al., 2008).
4. A greater number of sessions may be required for people living with HIV with
higher risk for nonadherence (Cook et al, 2009).
MI session length. There is a substantial amount of variability in the length of time
spent in each MI session. Among the 12 meta-analyses and systematic reviews included in this
integrative review, five studies reported findings pertinent to MI session length (Hettema et al.,
2005; Lundahl & Burke, 2009; Lundahl et al., 2010; Rubak et al., 2005; VanBuskirk &
Wetherell, 2013). Hettema et al. (2005) and Lundahl et al. (2010) reported the total average time
spent in MI counseling was 134.4 minutes and 207 minutes, respectively. Rubak et al. (2005)
provided a time range between 10 minutes and 120 minutes per session, with the most frequently
reported time of 60 minutes among the 72 RCTs in their review.
Despite the evidence for adherence improvement with brief MI encounters of 15 to 20
minutes duration (Rubak et al., 2005; Vasilaki, Hosier, & Cox, 2006), Lundahl et al. concluded,
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“it is unreasonable to assume that a very short MI intervention will lead to lasting change” (p.
153). In fact, Lundahl and Burke (2009) systematically reviewed four meta-analyses (Burke et
al., 2003; Hettema et al., 2005; Lundahl et al., 2010; Vasilaki, Hosier, & Cox, 2006) regarding
MI efficacy in behavior change outcomes with an aggregate sample of 236 RCTs. They
concluded that, “more MI sessions will likely result in better outcomes, although the upper limit
on dose is unknown at this juncture” (Lundahl & Burke, 2009, p. 1240). Furthermore, Lundahl
and Burke provided evidence for the superiority of MI over comparison treatments, such as
cognitive behavioral therapy, in achieving positive outcomes within less treatment time.
The total MI treatment period was an average of 101 minutes to 180 minutes shorter in duration
compared to alternative treatments. Despite the conclusion that more MI is superior, it appears
that this can be achieved in less time compared to alternate successful therapies.
Further investigation of the nine HIV-specific studies reveals less variance in the range of
MI session lengths. Seven studies provided data regarding session length. Two studies (Cooke
et al., 2009; Krummenacher et al., 2011) reported average lengths of 7.5 minutes and 35 minutes
per session, respectively. The remaining five studies (DiIorio et al., 2003; DiIorio et al., 2008;
Maneesriwongul et al., 2012; Pradier et al., 2003; Konkle-Parker et al., 2012) delivered an
overall MI session length ranging between 10 minutes and 90 minutes. Konkle-Parker et al.
(2012) delivered six of eight total MI sessions over brief 10-minute periods; however, this study
was not able to achieve statistically significant adherence outcomes at the end of six months.
Three RCTs (DiIoirio et al., 2008; Maneesriwongul et al., 2012; Pradier et al., 2003) reported
positive ART adherence outcomes with MI session lengths ranging between 25 minutes to 60
minutes.
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The success of MI is apparent, whether delivered within a half or full hour session. It is
evident that there is no concise recommendation as to the optimal length of this intervention.
Considering that MI is a client-centered approach to behavior change, it may explain why some
patients respond to shorter lengths of therapy while others to longer sessions. Clients are clearly
unique in their barriers and motivations to behavior change. An interesting observation
throughout this integrative review is the lack of screening for stage of behavior change
(Prochaska & DiClemente, 1992) within the MI intervention studies. While all studies measured
the outcome of adherence, very few studies measured baseline and endpoint stage of behavior
change (Konkle-Parker et al., 2012). It would seem paramount to include this variable in MI
intervention studies as MI coincides well with guiding clients through the stages of behavior
change (Miller & Rollnick, 2002; Prochaska & DiClemente, 1992). In fact, it may be possible
that the length of MI needed to achieve ART adherence may depend upon the client’s baseline
stage of behavior change. Assessment for a client’s readiness to change may be an important
factor in determining appropriate MI dose. Future MI intervention research may benefit from
including a client’s stage of behavior change (Prochaska & DiClemente, 1992) as a study
variable.
Objective Three: Delivery of MI
The third aim of this integrative review was to determine any differences or similarities in
the delivery of MI across studies. Specifically, the inquiry focused on the interventionist and the
format of the individual MI session. It is also imperative to determine if the findings of metaanalytical reviews share similarities with current available evidence pertinent to people living
with HIV"and ART adherence.
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MI interventionist. Motivational interviewing has been successfully versatile in its
implementation. Large meta-analytic and systematic reviews (Lundahl et al., 2009; Lundahl et
al., 2010; Lundahl et al., 2013; Rubak et al., 2005) have examined whether the profession of the
MI administrator influences behavior change outcome. MI sessions have been led by nurses,
mental health providers, dieticians, nurse practitioners, physicians, and health promotion
educators with similar efficacious results. In fact, only one meta-analytic review (VanBuskirk &
Wetherell, 2013) concluded the type of MI interventionist negatively influenced adherence
outcomes. Although their meta-regression analysis resulted in this finding, the authors were not
clear as to the clinical significance of this result. VanBuskirk and Wetherell (2013) observed
that many of the studies in their review did not provide specific details about the qualifications of
the interventionist nor the description of the MI training. Differentiating between “provider’s
educational attainment and degree of proficiency with MI” may clarify this finding (VanBuskirk
& Wetherell, 2013, p. 11). Nevertheless, the majority of the evidence supports the notion that
MI can be administered by a variety of health care providers.
Within the HIV clinical setting, nurses have been the main MI interventionists. Nursing
professionals, inclusive of nurse practitioners, delivered the MI sessions in 75% of the eight
primary studies (Cook et al., 2009; DiIorio et al., 2003; DiIoirio et al., 2008; Manessriwongul et
al., 2012; Pradier et al., 2003; Konkle-Parker et al., 2012). The remaining two studies utilized
pharmacists and master-prepared health educators (Krummenacher et al., 2011; Golin et al.,
2006). Approximately two-thirds of the studies utilizing nursing professionals reached
statistically significant adherence outcomes (Cook et al., 2009; DiIoirio et al., 2008;
Manessriwongul et al., 2012; Pradier et al., 2003).
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Overall, this small sample of eight quantitative HIV studies demonstrated that positive
ART adherence outcomes could be achieved with various health professions. This is similar to
the previously mentioned meta-analytic and systematic review findings. Nevertheless, it is
particularly compelling that nursing professionals were the most prevalent profession delivering
MI sessions to people living with HIV. No study commented on the rationale for the chosen MI
interventionist, nor did the primary HIV research studies statistically evaluate the effect of the
profession of the MI interventionist on adherence outcomes.
The evaluation of the evidence has led to an overwhelming consensus that MI delivery is
not specific to one profession. High-quality MI training of the MI interventionist may have a
greater influence on adherence outcomes. Motivational interviewing is unique in that it can be
successfully delivered by a broad scope of health care professionals.
MI session format. There have been two common formats for delivering an individual
MI session to clients. The first is the traditional face-to-face counseling style in the office
setting. The second MI delivery style is via the telephone. There have also been combined MI
formats of in-person and telephone appointments. The research literature addressing MI delivery
format includes meta-analytical, systematic, and randomized controlled studies.
MI session format has been evaluated in two combined systematic and meta-analytic
reviews conducted by Lundahl et al. (2013) and VanBuskirk and Wetherell (2013). Lundahl et
al. utilized the results of 48 RCTs to evaluate the effect of MI session format on behavioral
change outcomes. They found no significant effect of MI session delivered in person or via
telephone sessions on the intended outcomes. VanBuskirk and Wetherell concluded from their
systematic review that it is not imperative to deliver MI sessions in person to achieve positive
outcomes. Among the 12 RCTs in their review, 50% of the RCTs included telephone-based MI
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sessions. Approximately 83% of the six RCTs utilizing telephone-based MI sessions reported
positive and statistically significant results. The same was evident among the six RCTs
delivering MI in-person, with only one RCT unable to achieve favorable outcomes.
Thus far, it appears that MI session format is not a moderator of behavior change
outcome within diverse problem areas and populations (Lundahl et al., 2013; VanBuskirk &
Wetherell, 2013). Lundahl et al.’s (2013) meta-analysis only included one of the eight HIVspecific studies (Golin et al., 2006) from this integrative review. Therefore, it is important to
explore this matter within HIV-specific quantitative studies to determine if the data reveal
similar findings.
The current evidence indicates that people living with HIV"are receiving MI sessions with
similar formats as clients with other health conditions. Approximately 63% of the HIV-specific
RCTs in this review (Golin et al., 2006; DiIorio et al., 2003; Pradier et al., 2003; Konkle-Parker
et al., 2012; Krummenacher et al., 2011) administered MI sessions in person, while 25% of the
studies (Maneesriwongul et al., 2012; DiIorio et al., 2008) utilized a combined telephone and
face-to-face approach. Cook et al. (2009) delivered their MI intervention via telephone.
Interestingly, 60% of the studies providing in-person MI sessions were not able to reach desired
adherence outcomes. It must be noted, however, that two of these unsuccessful studies were
small, randomized pilot studies with low statistical power (DiIorio et al., 2003; Konkle-Parker et
al., 2012). Contrarily, all three HIV studies incorporating either, telephone-based MI or
combined telephone and in-person MI, reached statistically significant ART adherence outcomes
(Cook et al., 2009; Maneesriwongul et al., 2012; DiIorio et al., 2008).
There are noteworthy similarities and differences in these findings compared to the
broader scope of MI research in behavior change outcomes. In comparison to the VanBuskirk
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and Wetherell (2013) systematic review of 12 RCTs exploring MI and health behavior outcomes,
the majority of the HIV-specific studies delivered MI sessions in person, while the proportion of
studies with in-person and telephone-based MI sessions were equal in the VanBuskirk and
Wetherell systematic review. Nevertheless, both reviews provide evidence affirming the ability
of MI to promote treatment adherence, whether delivered as a telephone-based or face-to-face
intervention.
In summary, motivational interviewing is not limited to the traditional in-person
counseling style as other effective behavioral change interventions are. This quality may be
beneficial with non-adherent people living with HIV"struggling from lack of transportation, busy
work schedules, or the perceived-stigma associated with coming to the HIV clinic. This subset
of patients may be more receptive to telephone-based MI sessions. This aspect of MI makes it a
beneficial, yet versatile, clinical intervention.
Objective Four: Measurement of Medication Adherence
The final interest in conducting this integrative review was to determine the measures
utilized for the concept of adherence to ART. Hill and Kavookjian (2012) observed from their
meta-analysis that adherence measures have varied between MI intervention studies. This
integrative review has resulted in similar findings.
Overall, there were three forms of indirect, primary adherence measures employed in the
nine quantitative HIV-specific studies. The first and most prevalent was the self-report adherence
measure. All studies, except for that of DiIorio et al. (2008) and Krummenacher et al. (2011),
included a self-report measure to quantify an adherence level. Each self-report measure was
distinct and included the Antiretroviral General Adherence Scale (DiIorio et al.; McDonnell et
al., 2001), the Adherence to Antiretroviral Therapy Visual Analog Scale (Maneesriwongul et al.,
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2012), a linear Visual Analog Scale of the percent of adherence in the previous four weeks
(Konkle-Parker et al., 2012), and various adherence recall questionnaires (Cook et al, 2009;
Golin et al., 2006; Pradier et al., 2003). All authors reported on the validation of their
measurement tools. The second type of adherence measure was the prescription refill rate via
pharmacy data and was used by Konkle-Parker et al. (2012). Finally, the third mechanism was
the Medication Electronic Monitoring System. This electronic system was utilized in two studies
as the only mechanism for quantifying adherence (DiIorio et al., 2008; Krummenacher et al.,
2011).
The majority of the HIV-specific studies also incorporated secondary forms of adherence
measures. Laboratory markers, such as HIV viral load and CD4 count, were commonly used as
determinants of treatment success. Approximately 63% of the studies utilized HIV viral load as
a secondary adherence measure (DiIorio et al., 2008; Golin et al., 2006; Konkle-Parker et al.,
2012; Krummenacher et al., 2011; Pradier et al., 2003).
There is not a standard ART adherence measurement tool that has been consistently
utilized in the HIV-specific studies included in this review. A large proportion of these studies
have been successful in promoting adherence through MI. However, the challenge still remains
in making direct comparisons of ART adherence outcomes between studies. Hill and
Kavookjian (2013) attributed this challenge to the lack of consensus in defining and measuring
adherence. At this point, the MI literature does not support that the use of a precise adherence
measure is superior to available measurement tools for people living with HIV. It appears that
this is a future prospect in MI and ART adherence research.
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Conclusion
This integrative review brought forth practical information regarding the dynamics of
MI as an intervention to increase ART adherence. First, MI is an effective intervention
appropriate for clients ambivalent about taking ART. Despite the novelty of MI in the HIV
clinical setting, there is sufficient evidence suggesting it is transferable across various chronic
diseases. Second, this review has demonstrated that there is no standard MI dose criterion
needed to produce effective adherence results. However, a greater number of MI sessions may
be needed for people living with HIV"at greater risk for nonadherence and to produce long-term
ART adherence results. Next, it appears that MI can be delivered by a variety of health
professions provided that appropriate MI training has been received and fidelity to intervention
maintained. This broadens the scope of practice for this intervention as certain HIV clinics
utilize nurses, pharmacists, or medical case managers to address ART adherence issues with
clients. Finally, the literature demonstrates consistent variability in the utilization of medication
adherence measurement tools.
Effective adherence intervention methods are paramount to the quality and longevity of
life of clients with HIV"as they face the daily struggles of this chronic disease. This integrative
review sought to examine the current evidence base for the implementation of MI into a HIV
clinical practice setting. The following chapter will introduce the theoretical foundations guiding
this practice initiative.
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CHAPTER 3
Conceptual Framework
This chapter focuses on the underlying theoretical frameworks supporting the
implementation of MI into the HIV clinical practice setting. The Information-MotivationBehavioral (IMB) Skills model of ART adherence was one of two chosen frameworks to
comprehend the role of MI in medication adherence (Fisher & Fisher, 2000). The
Transtheoretical Model (TTM) of behavior change also supported the use of this behavioral
intervention (Prochaska & DiClemente, 1984). Finally, the revised Promoting Action on
Research Implementation in Health Services (PARIHS) framework was the chosen method for
the process of implementing this evidence-based intervention (Kitson, Harvey, & McCormack,
1998; Rycroft-Malone, 2004; Stetler, Damschroder, Helfrich, & Hagedorn, 2011). The following
sections describe the basic components and postulates of each conceptual framework.
Information-Motivation-Behavioral Model of ART Adherence
The IMB model of ART adherence was derived from the general IMB model of health
behavior, however, focuses specifically on the determinants of health behavior related to ART
adherence (Fisher & Fisher, 2000). The IMB model of ART adherence is a conceptual model
utilized “to understand, predict, and promote adherence” to HIV medication (Fisher, Fisher,
Amico, & Harman, 2006, p. 463). The major concepts include adherence information, adherence
motivation, adherence behavioral skills, and adherence behavior. The relationships between the
concepts and their elements are presented in Figure 1. This model postulates that people living
with HIV are more likely to adhere to ART “to the extent that HIV-positive individuals are wellinformed, motivated to act, and possess the behavioral skills required to act effectively” (Fisher
et al., 2006, p. 463).
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Motivational interviewing addresses the concept of adherence motivation. The IMB
model of ART adherence asserts that personal adherence motivation and social motivation
contribute to an individual’s motivation towards ART adherence (Fisher et al., 2006).
Specifically, the MI intervention is aimed at eliciting an individual’s personal motivation for
adherence behavior. There were current interventions in place at the project site that addressed
the IMB model concepts of adherence information and behavioral skills. Thus, the addition of
an intervention aimed toward the missing component of adherence motivation would contribute
to the success of achieving the intended health outcomes of the IMB model.

Figure 1. The information-motivation-behavioral skills model of ART adherence (2006). From “An
Information-Motivation-Behavioral Skills Model of Adherence to Antiretroviral Therapy” by J. D. Fisher,
W. A. Fisher, K. R. Amico, & J. J. Harman, 2006, Health Psychology, 4, 462-473. Copyright 2006 and
reprinted with permission from Jeffrey D. Fisher, PhD from the University of Connecticut (see Appendix
B).
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Transtheoretical Model of Behavior Change
The TTM of behavior change is a prime conceptual model upon which to focus a MI
intervention (Prochaska & DiClemente, 1984). The TTM was developed “to integrate principles
and processes of change from across leading theories of psychotherapy and behavior change”
(Prochaska, 2008, p. 845). The aim of this model is to direct the timing and type of intervention
utilized to assist clients with achieving healthy behavior changes (Wright, Velicer, & Prochaska,
2008).
There are 15 constructs forming the TTM. These include the stage of change, two
decisional balance constructs, two self-efficacy constructs, five experiential change processes,
and five behavioral processes (Wright et al., 2008). The core concept of the TTM is stage of
behavior change. This stage is a developing process across five behavior stages that occur over
time (Prochaska, 2008). The five stages include precontemplation, contemplation, preparation,
action, and maintenance. It is postulated that people do not change habitual behavior in a
sudden, decisive manner, but rather, progress “in a linear or cyclical fashion” through the five
behavior stages (Prochaska, 2008; Wright et al., 2008). The movement between stages may
include relapses to previous stages. According to the TTM, the experiential and behavioral
constructs are independent variables that facilitate the behavior change; while, the decisional
balance and self-efficacy constructs are considered the outcome measures (Velicer et al., 2000).
The stage and process constructs encompassing the TTM are displayed in Figure 2.
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Figure 2. Stages and processes of change. Adapted from “Prochaska’s stage model of
change” retrieved from https://pc3coachingtoolkit.pbworks.com/w/page/54072360/Prochaska's Stage
Model of Change

Interconnections Between the IMB Skills Model, the TTM, and MI
The utility of the IMB skills model of ART adherence within this implementation project
will provide the fundamental framework to understand the concept of ART adherence and its
relationship to motivation. The TTM fits within the IMB skills model by providing an
understanding of the mechanism of behavior change. Specifically, the TTM will be applied to
the relationship between the IMB constructs of adherence motivation and adherence behavior.
Motivational interviewing will function within this model as a type of behavioral process
intervention as described by the TTM (Prochaska, 2008). Hence, the role of MI is to facilitate
the transition along the behavior change continuum with the intention to promote increased
adherence behavior leading to the health outcome of HIV viral suppression. A depiction of the
interconnections of the IMB, TTM, and MI is displayed in Figure 2.
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Figure 3. A depiction of the interconnections between the IMB skills model of ART
adherence, the TTM stages of behavior change, and motivational interviewing. Adapted from
Fisher, Fisher, Amico, and Harman (2006), Prochaska and DiClemente (1984), and Miller and
Rollnick (2002).
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Promoting Action on Research Implementation in
Health Services Framework
The information presented thus far has provided evidence in support of the use of MI to
promote ART adherence, as well as, the conceptual models with which to understand the
behavioral components of adhering to ART. However, evidence alone does not support the
transition of interventions into routine clinical practice (Kitson, Harvey, & McCormack, 1998.)
To support the success of implementing a MI intervention into the clinical practice setting of this
HIV clinic, the revised PARIHS framework (Kitson et al., 1998; Rycroft-Malone, 2004; Stetler,
Damschroder, Helfrich, & Hagedorn, 2011) will serve as the guiding framework.
The revised PARIHS framework consists of three main interacting elements that are
proposed to influence successful implementation of evidence-based practices into the clinical
setting. These elements include evidence, context, and facilitation. It is furthered hypothesized
that the PARIHS framework is best utilized in two stages (Kitson et al., 2008). In the first stage,
evidence and context can be used as preliminary diagnostic and evaluative measures. The results
of these measures would then guide the development of the facilitation method in the second
stage (Kitson et al., 2008). Knowledge of the conceptual definitions of each core element will
enhance the understanding of the propositions of the PARIHS framework.
The concept of evidence extends beyond research evidence in the PARIHS framework.
To fully understand the evidence for a practice initiative, evidence must include the combination
of research, clinical expertise, patient experience, and local data (Rycroft-Malone et al., 2004).
Successful implementation is more likely to occur when the sub-elements of evidence, research,
clinical expertise, patient experience, and local data are high on the evidence continuum
(Rycroft-Malone, 2004). In the revised version of the framework, the characteristics of the
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targeted evidence-based intervention was added as a subelement of the evidence construct
(Stetler et al., 2011).
Context is the second element of the PARIHS framework and is defined as “the
environment or setting in which people receive healthcare services, or in the context of getting
research into practice, the environment or setting in which the proposed change is to be
implemented” (Rycroft-Malone, 2004, p. 299). There are three contextual factors, or
subelements, that contribute to successful implementation. These factors include culture,
leadership, and evaluation. It is proposed that an environment with a strong context (culture,
leadership, and evaluation) will foster successful implementation of evidence-based practice
change versus low contextual environments (Rycroft-Malone, 2004).
The final core element of the PARIHS framework is facilitation. Facilitation “refers to
the process of enabling (making easier) the implementation of evidence into practice” (RycroftMalone, 2004, p. 300). The facilitator is postulated to play an integral role in promoting
successful implementation by affecting the context of the practice environment and by
collaborating with the health care workers within the environment. Facilitation is organized into
the subelements of purpose, role, skills, and attributes. Similar to evidence and context,
facilitation is measured on a low to high continuum, with successful implementation more likely
to occur in the presence of high facilitation. Figure 4 displays the core elements and subelements
of the PARIHS framework, while Figure 5 depicts the influence of evidence, context, and
facilitation toward successful implementation.
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Figure 4. Elements of the PARIHS framework. Adapted from “The PARIHS framework:
A framework for guiding the implementation of evidence-based practice”, by J. RycroftMalone, 2004, Journal of Nursing Care Quality,19, p. 301-302. Copyright 2004 by Lippincott
Williams & Wilkins, Inc.
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Figure 5. The role of evidence, context, and facilitation in achieving successful implementation. A threedimensional depiction of the positive and negative influences of evidence,
context, and facilitation toward successful implementation. Adapted from “Enabling the implementation
of evidence-based practice: A conceptual framework” by A. Kitson, G. Harvey, and B. McCormack,
1998, Quality in Health Care, 7, p. 153.

The PARIHS framework is not steadfast and has undergone constructive revisions since
its inception. Stetler, Damschroder, Helfrich, and Hagedorn (2011) proposed the most recent
refinement of the PARIHS framework and provided a tangible guide for evidence-based practice
implementation. The objective of the revised PARIHS framework is binary. First, Stetler et al.
sought to guide users in application of the best method to operationalize the framework within
the Quality Enhancement Research Initiative action-oriented approach. Second, the aim was to
concentrate on the identified obstacles to utilization of the framework in the practice setting.
Overall, the revisions added clarity to conceptual and operational definitions in the PARIHS
framework, as well as, incorporated new elements and subelements to the original framework.
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Figure 6. The revised PARIHS framework. Adapted from “A Guide for applying a revised version of
the PARIHS framework for implementation,” by C. Stetler, L. Damschroder, C. Helfrich, and H.
Hagedorn, 2011, Implementation Science, 6, p. 6. Copyright 2011 by BioMed Central Ltd.

Conclusion
The utility of the IMB skills model, the TTM of behavior change, and the revised
PARIHS framework played a specific role in this MI implementation project. The IMB skills
model provided the foundation for the importance of adherence motivation in achieving the longterm outcome of ART adherence and HIV viral suppression. The TTM aided in identifying a
client’s stage of behavior change for the purpose of targeting the intervention towards the
behavior stages most amenable to MI. Finally, the revised PARIHS framework was intended to
guide the inception of this evidence-based intervention into the clinical practice environment.
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CHAPTER 4
Methods
Thus far, supporting evidence has demonstrated the extent and implications of ART
nonadherence in people living with HIV. Motivational interviewing was introduced as a
mechanism for eliciting a client’s intrinsic motivation for adherence behavior. The conceptual
frameworks supporting the intervention included the IMB skills model of ART adherence and
the TTM of behavior change. The focus of this chapter is to introduce the refined project
inquiry, intended target population, and development of the evidence-based practice (EBP) team.
The methodological presentation of this EBP initiative utilized the elements of the revised
PARIHS framework as an implementation guide.
EBP Project Goals
The original research inquiries presented in Chapter 1 focused on the effectiveness and
feasibility of an MI intervention in a local HIV clinic. These inquiries were refined as results of
the integrative review provided ample evidence of the effectiveness of MI in promoting behavior
change and medication adherence. While this organization addressed two main components of
adherence behavior according to the IMB Skills model, findings from the organizational
assessment revealed a need for an intervention aimed at client motivation. Organizational
assessment findings also affirmed that senior leadership and clinicians found value in a MI
intervention and were interested in the effect of MI training on staff perceptions and knowledge
of MI. This EBP project aimed to provide the foundation for a quality improvement (QI)
initiative to implement MI by providing MI training to the multidisciplinary care team.
Specifically, this project evaluated the influence of an introductory MI training course on MI
knowledge, perceived MI effectiveness, perception of client behavior change, and likelihood of
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MI use among care team members. While the long-term patient outcome goal of this MI
intervention was improvement in HIV viral suppression, multiple steps were needed in this QI
initiative. In order to produce the intended patient outcomes, this QI initiative first addressed the
future MI interventionists within the practice environment.
Target Population
The intended population for the MI introductory training was the multidisciplinary care
team at the project site. There were 17 staff members inclusive of the site manager, physicians,
nurse practitioners, pharmacist, registered nurses, case managers, and medical assistants. This
multidisciplinary care team was the ideal target population on whom to focus an intervention to
promote ART adherence, as they are the key stakeholders in adopting the principles and spirit of
MI.
EBP Team Development
Prior to addressing the elements of the revised PARIHS framework, it was paramount to
establish the team within the organization that would foster the development and integration of
MI into the practice setting. This organization had an established QI team led by the nurse
practitioner and an HIV case manager. The remaining members of the QI team represented each
of the disciplines in the clinical setting. The intended approach for integration of this EBP
intervention into this organization was to structure it as a QI initiative and to utilize the existing
QI members as the EBP team. This approach fostered an interdisciplinary and collaborative EBP
team.
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Revised PARIHS Framework: Evidence and Characteristics of Motivational Interviewing
The first step in the transition of MI into practice was assessing the evidence for the EBP
initiative. Evidence is not limited to research outcomes. Forms of evidence also included
clinical and patient experience, local practice data, and characteristics of the intervention (Stetler
et al., 2011).
Research and Published Guidelines
Chapter two provided a thorough investigation of the published literature in support of
MI with medication adherence promotion. There was also support for the use of MI to enhance
ART adherence provided by the DHHS (2014) in “Guidelines for the use of antiretroviral agents
in HIV-1 infected adults and adolescents.” A well-supported evidence base for MI, coupled with
practice guidelines recommending MI as a behavioral adherence intervention, provided a strong
foundation for this EBP initiative.
Clinical Experience and Perceptions
Clinical experience is essential to the knowledge base in support of the need for MI in
this practice setting. The conceptual definition of clinical experience is knowledge that is
expressed and embedded in practice (Stetler et al., 2011). Clinical experience can originate from
the experience of others or one’s personal experience. Evidence derived from clinical experience
is concerned with the strength and nature of the motivation for or against the implementation of
MI, as well as, the extent to which there is consensus among the key stakeholders regarding this
intervention (Stetler et al., 2011). This form of evidence was gathered during a group discussion
after the initial presentation of this EBP initiative to the organization. There were 12 essential
staff members present during the presentation and were comprised of the following professional
disciplines: physicians, nurse practitioner, pharmacist, nurses, medical assistants, and case
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managers. Although the site manager was unavailable for this group discussion, the medical
director of the clinic represented senior leadership.
There were key themes identified from the group discussion pertaining to clinical experience.
The first theme was a multidisciplinary recognition of the problem of ART adherence. The
second emerging theme was the recognition of insufficient proficiency in delivering behavioral
interventions. Professional disciplines involved in direct patient care verbalized a generalized
sense of inadequacy when it came to assisting clients with behavior change. Finally, the need for
an intervention directed at client motivation emerged as the third theme as the professional staff
realized their approach to treatment adherence lacked this important concept.
Patient Experiences, Needs, Preferences and Local Practice Information
Given that MI is a client-centered intervention, inclusion of the patient population in the
formation of the evidence base for this intervention was essential. Organizational patient data
contributed to local practice information while describing the extent of patient needs. The ART
adherence data of clients in this outpatient HIV clinic was above the national reported average.
The CDC (2012) estimated that approximately 36 of 100 persons living with HIV"in the U. S. are
taking ART, and only 28% of persons living with HIV in the U. S. have achieved viral
suppression. According to a CAREWare data report of viral load suppression within the period
of September 1, 2013 to September 30, 2014, a total of 941 patients were actively in medical
care at the project site. The estimated adherence rate within this time period was approximately
86%. CAREWare is a free data collection system offered by the Health Resources and Services
Administration (HRSA) that allows HIV service providers receiving Ryan White CARE Act
funds to collect client-level data (GAO, 2009). The data in the following figure was retrieved
from the CAREWare report.
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Yes
(n = 810)
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mL
(n = 689)

No
(n = 131)
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Figure 7. Client-level data of the project site. Flow chart of the number of patients not
prescribed ART and the number of patients prescribed ART that have not achieved viral
suppression at the outpatient HIV clinic. This data represents the time period between
September 1, 2013 and September 30, 2014. The values in the black boxes represent the
existing gap in HIV viral suppression. It must be noted that the discrepancy between the total
number of patients prescribed ART, n = 810, and the sum of n =689 and n = 71 may be due to
lab values that were not captured through the manual input of data into CAREWare.

HIV viral suppression is one of the HIV/AIDS Bureau performance measures, and the
outcome value of 200 copies/ml is the criterion set forth by HRSA (2013). The decision of
HRSA to adopt a higher value than reported in the literature resides in the fact that there are
multiple viral assays with differing detection limits, and the viral suppression value of 200
copies/ml is inclusive of these various limits (HRSA, 2013). As noted in Figure 7, the
CAREWare client data report also utilizes an HIV serum level of 200 copies/ml or less as the
HIV viral suppression goal. According the the Infectious Disease Society of America (IDSA;
2013), “HIV viral suppression is defined as a viral load persistently below the level of

detection of the assay; however the DHHS guidelines define virologic failure as a
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confirmed viral load > 200 copies/ml” (p. 15). Within the EBP project site, the HIV viral
assay can detect HIV serum levels as low as 40 copies/ml or less, and is thus, the preferred
criterion for HIV viral suppression in this practice.
The current data report revealed that there were approximately 200 clients that were
either not taking ART or had not achieved consistent viral suppression while taking ART. Given
that the CAREWare report utilizes the less than 200 copies/ml criterion for HIV viral
suppression, the number of clients who have not achieved viral suppression may be greater
according to the IDSA guidelines. Despite this possible discrepancy, there were approximately
20% of the patient population who had yet to achieve HIV viral suppression at this outpatient
HIV clinic.
Characteristics of Motivational Interviewing Intervention
The revised PARIHS framework includes the characteristics of the EBP intervention as a
critical subelement of the evidence construct of the framework. The conceptual definition of this
subelement is described as the “attributes or designated features of an EBP that may influence
the likelihood of its adoption” (Stetler et al., 2011, Additional file 1). There are seven key
attributes that should be evaluated by the EBP team before implementation of the targeted
intervention with their patient population. These attributes include the relative advantage,
observability, compatibility, complexity, trialability, design quality, and cost.
Consideration of these specific attributes of MI assisted with the adoption of this intervention.
This project focused on the attributes of trialability, observability, and costs of MI.
Trialability. Within the revised PARIHS framework, trialability refers to “the ability to
test the EBP on a small scale in the organization, and to be able to reverse course (undo
implementation) if warranted” (Stetler et al., 2011, Additional File 4). Given this context, this
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MI implementation project examined the feasibility of incorporating MI into a local HIV clinic
by determining the influence of introductory MI training on staff knowledge, perception, and
likelihood of MI use. Specifically, implementation feasibility studies are concerned with “the
extent, likelihood, and manner in which an intervention can be fully implemented as planned and
proposed, often in an uncontrolled design” (Bowen et al., 2009, p. 453). The following
components will outline the methodology of the MI feasibility project.
Project design, sample, and eligibility criteria. The chosen project design was a onegroup pretest-posttest design. Baseline data were collected immediately prior to the introductory
MI training and a post-test was completed after the two-day training.
The total available target population for this sample was the 17 care team members of the
organizational site. The desired number of team members to participate in the MI training was at
least 10 to 15. Inclusion and exclusion criteria were as follows:
Inclusion criteria.
•

Participant was employed at the project site.

•

Participant was voluntarily willing to participate in the MI training sessions and complete
the MI Survey and demographic form.

•

Participant was able to speak and read English.

Exclusion criteria.
•

Participant was functioning in a business office position at the project site.

•

Participant was not available at the time the MI survey was distributed for completion.
Recruitment methods. The process for recruiting participants began with informing

prospective participants of the project plan. A 45-minute presentation was held during the staff
lunch hour. This presentation informed the staff of the background and significance of ART
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nonadherence, theoretical support for this behavioral intervention, and the proposed QI initiative
of MI implementation. Information regarding the introductory MI training was also provided.
The clinical site supervisor approved staff to receive their hourly wage for attendance at this
meeting. Further efforts at recruitment included the delivery of weekly reminders of the
impending MI training. This was accomplished through announcements during morning huddle,
email notifications, and information posted on the clinic communication board.
Human participant considerations. This QI project did not undergo review by the
Human Research Review Committee of Grand Valley State University, as it was not deemed a
research study. This QI project was not intended to produce generalizable knowledge. The
intention was to gather information regarding the care team members of the project site to guide
the QI team in the uptake of MI. There were no foreseen clinical risks to the participants in this
feasibility project.
Informed consent process. The primary project investigator obtained informed consent
for participation in the project. Participants were given ample time for questions. Participants
were given an implied consent letter prior on the first day of the MI training sessions. This letter
informed participants that completion of the MI survey indicated participant willingness and
consent to participate.
The participants were also informed of the right to withdraw from completing the MI survey
without penalty. The contact information of the primary project investigator was given to the
participants. The project investigator had completed CITI training.
Data management and storage. The MI Survey and demographic forms were kept
secured at the Kirkhof College of Nursing research office. Each participant was assigned a nonidentifiable number that was stored in an electronic enrollment form on an encrypted flash drive.
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The flash drive of participant and survey data was also securely stored at the Kirkhof College of
Nursing research office.
Data collection instruments. There were two self-report questionnaires administered to
participants prior to the start of the MI training on the first day of the two-day training. These
questionnaires included the Motivational Interviewing Survey (see Appendix C) and a brief
demographic form (see Appendix D).
The Motivational Interviewing Survey is a 13-item questionnaire intended to gather
information regarding participant “knowledge of motivational interviewing, perceptions of the
effectiveness of motivational interviewing, the likelihood of utilizing MI strategies,” and
participant perceptions of clients and behavior change (Willits, Albright, Broidy, & Lyons, 2009,
p. 1). This questionnaire was developed and utilized in a study conducted by Willits et al. (2009)
to compare pre- and post- MI knowledge and perceptions after a three-day MI training session.
Permission for use of the Motivational Interviewing Survey is available in Appendix E.
The demographic variables of interest included gender, job role, length of employment at
the organization, and previous history of MI use. Collection of these data did not identify a
particular participant; however, the data allowed the identification of any variation in MI
variables within the demographic variables.
Description of intervention. All 17 care team members were invited to attend a two-day
introductory training in MI by a trainer from the Motivational Interviewing Network of Trainers.
The credentials of the MI trainer include a Master of Arts degree, licensure in professional
counseling, and certification in advanced alcohol and drug counseling. The MI training was
delivered during two, eight-hour sessions on November 14, 2014 and November 21, 2014. The
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MI training included didactic instruction and opportunities for practicing MI skills. The
following modules were included in the training:
•

Day 1:
!

Module 1: Defining MI and the Role of MI Practice

!

Module 2: Why Do People Change? How Can MI Help? The Spirit and
Principles of MI

!
•

Module 3: Conversational Potholes: Responding to Sustain Talk and Discord

Day 2:
!

Module 4: Client-Centered Interviewing Skills: OARS

!

Module 5: The “Zip Code” of Behavior Change: Recognizing Change Talk

!

Module 6: Eliciting and Strengthening Change Talk

!

Conclusion: Integration Efforts/Issues

Statistical analyses. This project utilized IBM© SPSS© Statistics 20 to analyze data.
Descriptive statistical data were calculated to describe participant characteristics, while
inferential statistical analyses informed of differences in pretest-posttest within-group data. The
MI Survey responses were reported as ordinal data as follows: 1 = strongly disagree, 2 =
disagree, 3 = undecided, 4 = agree, 5 = strongly agree. The negatively scored items were reverse
scored. The Wilcoxon signed-rank test for matched pairs was used to assess the magnitude of
the differences in the pretest-posttest data, while Kendall’s tau rank correlation coefficient was
used to explore the relationship between the demographic and MI variables (Field, 2009; Triola
& Triola, 2006).
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Project time frame. The following table provides a timeline of the completed project
procedures.
Table 4
Project Procedures Timeline
Procedure
Presentation of
White Paper for
Participation

October 30, 2014

November 14, 2014

November 21, 2014

X

Review Inclusion/
Exclusion Criteria

X

Participation Letter

X

Motivational Interviewing
Survey

X

X

Motivational Interviewing
Training Session

X

X

Observability. Observability as a characteristic of the EBP intervention is concerned
with the extent to which results or usefulness of MI will be easily available to the users (Stetler et
al., 2011, Additional file 1). It was anticipated the outcomes resulting from the data collection
tools would provide valuable information to the organization. First, data would be available to
determine the effect of a 2-day MI training on MI knowledge, perceived MI effectiveness,
likelihood of MI use, and perception of client behavior change. Second, these data would
provide insight into the overall staff perceptions and understanding of this behavioral
intervention, as well as, future educational needs. An early step of incorporating an EBP
intervention into clinical practice was to promote acceptability and receptivity of the practice
innovation through staff education.
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Costs. The costs associated with this EBP project initiative included the cost of MI
training. The fee for the MI trainer was $900.00 for an eight-hour group training day or $120.00
per hour for MI coaching or supervision. The total expense for the two-day MI training was
$1,800.00. The project site was funded a $10,000.00 grant for staff and patient education. This
grant funded the cost of the MI training.
Contextual Readiness for Targeted Evidence-based Practice Implementation
After evaluation of the evidence for the EBP intervention, the revised PARIHS
framework recommends formal evaluation of the context in which the proposed practice change
is to occur. The framework provides four quantitative measurement instruments to assess the
context of an organization. The Organizational Readiness to Change Assessment (ORCA) tool
was the chosen method to assess the MI implementation and was completed by the project leader
(Helfrich, Li, Sharp, & Sales, 2008). The ORCA tool is a 74-item questionnaire based on the
PARIHS framework. Specifically, the context section of the ORCA tool, consisting of 23 items,
was the portion of the assessment utilized for this step of the EBP project. The context section
has a reliability of ∝ = 0.85 and addresses the elements of culture, leadership, measurement,
readiness for change, and resources of the organization (Helfrich et al., 2008). A copy of the
ORCA tool and permission for its use is available in Appendices F and G, respectively.
Findings from the context assessment of the organization resulted in an overall score of
3.6. The scoring of the ORCA context assessment section ranges from 1 to 5, with 5 indicating
higher readiness to change and 1 indicating lower readiness to change. The scores for each
subsection of the context assessment are provided in Table 5. Overall, the context assessment
score indicated the contextual environment of the project site was relatively ready for a practice
change.
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Table 5
ORCA: Context Assessment Scores

Variable

Score

Leadership Culture
3.7
Staff Culture
4.0
Leadership Practice
3.5
Evaluation/Accountability
3.5
Opinion Leader Culture
4.0
Slack Resources
2.8
Overall Context Score
3.6
Note. The ORCA score ranges from 1 to 5. A score of 1 indicates lower readiness to change, and a score
of 5 indicates higher readiness to change.

Facilitation
The element of facilitation in the revised PARIHS framework is “a deliberate process of
interactive problem solving and support that occurs in the context of a recognized need for
improvement and a supportive interpersonal relationship” (Stetler et al., 2011, Additional file 3).
Facilitation involves the coordination and application of the necessary skills, role, and purpose to
foster the uptake of the implementation.
Formative evaluation of the evidence and context allows for diagnostic assessment of the type
and extent of facilitation required for this EBP implementation. The ORCA tool contains a 39item facilitation section that measures the capacity for internal facilitation within the
organization. The facilitation subscale has a reliability of ∝ = 0.95, and the results are available
in Table 6. There was an overall high capacity for internal facilitation within the project site as
evidenced by an overall ORCA facilitation subscale score of 4.0 (the scoring is similar to the
ORCA context subscale).
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Table 6
ORCA: Facilitation Assessment Scores

Variable

Score

Leadership Roles in Planning
4.0
Project Champion Role
4.8
Leadership Roles in Support
4.0
Implementation Team Roles
3.8
Implementation Plan
3.8
Communication
4.3
Assessment
4.0
Project Resources
3.8
Evaluation
3.8
Overall Facilitation Subscale
4.0
Note. The ORCA score ranges from 1 to 5. A score of 1 indicates lower readiness to change, and a score
of 5 indicates higher readiness to change.

Successful Implementation
The concept of successful implementation within the PARIHS framework involves the
implementation plan and its realization, EBP innovation uptake, and achievement of patient
and/or organizational outcomes (Stetler et al., 2011). For the purpose of this project, the three
subelements of the implementation plan and its realization, EBP innovation uptake, and
organizational outcome were utilized as indicators of successful implementation.
According to the elements of the PARIHS framework, successful implementation of this EBP
project was indicated by:
•

The proportion of staff who completed the two-day introductory MI training
(Implementation Plan and its Realization).

•

The proportion of staff demonstrating a positive change in MI Survey score after the twoday MI training course (EBP Innovation Uptake and Organizational Outcome).

These indicators of successful implementation were intended to contribute to the formulation of
sustainable recommendations for the uptake of MI use in this practice setting.
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Conclusion
This chapter has provided a detailed description of the EBP implementation project
utilizing the PARIHS framework. Embedded within the evidence construct of this framework, a
feasibility project plan was developed to address the trialability of MI in the context of the HIV
clinical setting. It was anticipated that valuable implementation information would derive from
understanding MI knowledge, perceived MI effectiveness, likelihood of MI use, and perceptions
of client behavior change of the multidisciplinary care team. Furthermore, the measures of
successful implementation were anticipated to contribute to the evaluation of the effectiveness of
the MI introductory training. The following chapter will provide the results of the participant
characteristics, MI Survey, and successful implementation measures.
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CHAPTER 5
Results
The purpose of this MI implementation feasibility project was to lay the foundation for
the uptake of MI as an intervention to promote medication adherence in people living with HIV.
This chapter describes the findings of an educational intervention conducted with a
multidisciplinary care team in a Midwest HIV outpatient medical setting. The objectives of the
intervention were to improve MI knowledge, perceived MI effectiveness, the likelihood of MI
use, and perceptions of client behavior change. The success of the implementation project was
measured according to the parameters defined within the PARIHS framework. This chapter will
report the participant characteristics, MI Survey scale results, MI Survey item results, and the
findings of the measures of successful implementation.
Participants
The target population of this implementation project was the multidisciplinary care team
of an outpatient medical setting that serves clients with HIV. The professional disciplines
comprising the care team included physicians, a nurse practitioner, a pharmacist, registered
nurses, medical assistants, case managers, and the clinic supervisor. There were 17 eligible staff
members to participate in the two-day MI introductory training course. Eleven staff members
who volunteered were available to attend the first MI session. Of the 11 participants attending
the first MI session, seven participants completed the second MI session. The six staff members
unavailable to attend the MI training course and the four participants who did not complete
session two were unable due to illness, scheduled vacation time, and patient care responsibilities.
Overall, seven of the 17 staff members completed the two-day MI introductory training course.
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Data were collected from the participants utilizing a demographic form created by the
investigator. To maintain participant anonymity, the variables of interest were gender, job role,
length of employment, and previous MI use. Table 7 provides a description of participant
characteristics at the pretest and posttest data collection periods.
Table 7
Participant Characteristics
Pretesta

Posttestb

% (n)

% (n)

Male

45.5 (5)

57.1 (4)

Job Role
Clinician
Non-Clinician

54.5 (6)
45.5 (5)

42.9 (3)
57.1 (4)

Employment Length
in Years
0-3
4-6
7-9
>9

45.5 (5)
9.1 (1)
0 (0)
45.5 (5)

28.6 (2)
14.3 (1)
0 (0)
57.1 (4)

Variable
Gender

Previous MI Use
Yes
9.1 (1)
14.3 (1)
No
81.8 (9)
71.4 (5)
Unanswered
9.1 (1)
14.3 (1)
Note. Clinician roles may include nurse practitioner, physician, pharmacist, registered nurse, and medical
assistant. Non-clinical roles may include case managers and administrators.
a
N = 11; b n = 7.
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Motivational Interviewing Survey
The MI Survey is a 13-item Likert-type scale intended to capture MI knowledge,
perception of MI effectiveness, likelihood of MI use, and perception of client behavior change
(Willits et al., 2009). The score of the MI Survey ranges from 13 to 65. The results of reliability
testing of the MI Survey were not available in the original study conducted by Willits et al.
(2009). This project leader requested reliability scale results from the original researchers
without success (see Appendix H). The MI Survey posttest results of the seven participants
completing the intervention of this implementation project demonstrated good reliability,
Cronbach’s α = .75. The two subscales, helper-related attitude (6 items) and perception of client
behavior change (7 items), had lower reliability, Cronbach’s α = .50 and α = .51, respectively.
Overall, the MI Survey and its two subscales demonstrated adequate internal consistency for the
purpose of this project.
Motivational Interviewing Survey: Scale Analyses
The statistical analyses of MI survey results were conducted on data collected on the first
day of the MI sessions, prior to the start of MI session one and immediately following the
termination of MI session two. Wilcoxon signed-rank analysis was conducted to test the
difference between the median MI Survey score at baseline and follow-up. The purpose of the
analyses was to measure the effectiveness of the MI training. The result of the Wilcoxon signedrank test reached statistical significance. The baseline median MI Survey score, N = 11,
Mdn = 39.00, was lower than the median MI Survey score at follow-up, n = 7, Mdn = 52.00,
Z = -2.375, p = .018.
A Pearson’s product moment correlation coefficient was utilized to calculate the effect
size as recommended by Field (2009). There is a strong inverse relationship between the median
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pretest score and posttest score, r = - .63. Specifically, the lower the median MI Survey score at
baseline the greater the likelihood of having a higher median MI Survey score after completion
of the intervention. This suggests that participants with decreased MI knowledge, perceived MI
effectiveness, perceptions of client behavior change, and likelihood of MI use were more apt to
improve in these areas after attending the two-day MI training.
Relationship between participant characteristics and MI Survey scale scores.
The investigator was also interested in the association between participant characteristics
and MI Survey scores at baseline and termination. Kendall’s tau coefficient was utilized as the
test statistic based on the small sample size and the large number of tied ranks of pretest and
posttest MI Survey scores (Field, 2009). The findings resulted in a significant positive
relationship between gender and MI Survey posttest results. The median posttest score for
males, n = 4, Mdn = 50, was lower than the median posttest score for the female participants,
n = 3, Mdn = 56, τ = .82, p = .028. It appears that female participants were more likely than
male participants to have a higher MI Survey score after completion of the MI introductory
sessions. Furthermore, a relationship between job role and MI Survey pretest scores approached
significance. Participants employed in a clinician role had a lower median MI Survey score,
n = 6, Mdn = 38, than participants employed in a non-clinician role, n = 5, Mdn = 44, τ = - .54,
p = .052. No significant correlations were found between gender, employment length, previous
MI use and pretest scores nor between job role, employment length, previous MI use and posttest
scores (see Table 8).
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Table 8
Correlation between Participant Characteristics and MI Survey Score
Pretest

Posttest

Variable

τ

p

τ

p

Gender

.230a

.406

.816c

.028*

Job Role

-.537a

.052

-.136c

.714

Employment Length (yrs)

.142a

.597

.378c

.289

Previous MI Use
.156b
.596
.129d
.756
a
b
c
d
Note. τ = Kendall’s tau rank correlation coefficient. N = 11. n = 10. n = 7. n = 6. * p < .05. There
was one participant who did not provide a response to the variable “previous MI use,” resulting in a
sample size of 10 for this variable. Pairwise deletion of the missing data was utilized in this correlational
analysis.

Motivational Interviewing Survey: Item Analyses
The Wilcoxon signed-rank test was also performed to explore the median difference
between response scores of each survey item. There were no significant differences in
participant responses to eight items, while the remaining five survey items demonstrated
statistical significance. The following sections will further describe participant responses to the
individual MI Survey items and provide results of significant correlations between participant
characteristics and MI Survey item responses. Tables 9 and 10 provide descriptive statistics for
the pre and post MI Survey item responses.
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Table 9
Descriptive Statistics for Pretest Item Responses of the MI Survey
Itema
Item 1
Item 2
Item 3
Item 4
Item 5
Item 6
Item 7
Item 8
Item 9
Item 10
Item 11
Item 12
Item 13
All Items
Note. aN = 11.

M
2.36
2.18
1.82
1.82
4.45
2.64
2.91
4.45
4.27
4.18
4.00
3.00
3.00
41.00

SD
1.027
.874
.603
.603
.522
1.120
1.044
.522
.467
.751
.447
1.183
1.183
4.626

Median
2.00
2.00
2.00
2.00
4.00
3.00
3.00
4.00
4.00
4.00
4.00
2.00
3.00
39.00

Table 10
Descriptive Statistics for Posttest Item Responses of the MI Survey
Itema
Item 1
Item 2
Item 3
Item 4
Item 5
Item 6
Item 7
Item 8
Item 9
Item 10
Item 11
Item 12
Item 13
All Items
Note. an = 7.

M
4.57
3.86
2.14
2.43
4.86
4.14
3.86
5.00
4.43
4.86
4.86
4.57
4.00
53.57
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SD
.535
.378
.900
1.134
.378
.378
.690
.000
.535
.378
.378
.535
1.414
4.467

Median
5.00
4.00
2.00
2.00
5.00
4.00
4.00
5.00
4.00
5.00
5.00
5.00
5.00
52.00
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Item 1: I understand the basic ideas and principles of motivational interviewing. At
the start of the first MI training session, approximately 64% of the participants did not have a
foundational understanding of MI, while only 18.2% of participants had a firm understanding of
MI principles. Figure 8 indicates that there was a large shift in MI knowledge post-intervention
based on the responses to item 1. All respondents either agreed or strongly agreed that they had
a basic understanding of MI after completing the MI training. This finding was confirmed by
Wilcoxon signed-rank analysis (see Table 11). There were no significant correlations between
participant characteristics and pre and post responses to item 1.

Percentage of Respondents

60
50
40
30
20
Pretest

10

Post-test

0
Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree

Responses to "I understand the basic ideas and principles of
motivational interviewing"
Figure 8. Percentage of responses to MI Survey item 1 at baseline and intervention
"
termination.
Percentage of pretest responses (n = 11) are as follows: 18.2% strongly
disagree, 45.5% disagree, 18.2% undecided, and 18.2% agree. Percentage of posttest
responses (n = 7) are as follows: 42.9% agree, 57.1% strongly agree.

"
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Table 11
Wilcoxon Signed-Rank Test of Change in Item 1 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 1 – Pretest
Item 1
Negative Ranks
0a
.00
.00
Positive Ranks
7b
4.00
28.00
-2.388d
.017*
Ties
0c
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05

Item 2: I feel proficient and able to use motivational interviewing in my practice.
There was a small percentage of participants who felt proficient in utilizing MI within their
practice setting at baseline. However, Figure 9 demonstrates a major shift in responses postintervention for the agree category with approximately 86% of participants feeling MI proficient.
While an estimated 73% of respondents either disagreed or strongly disagreed to MI proficiency
at baseline, post-intervention responses indicated that no participants confirmed a lack of
perceived MI proficiency at termination. These findings were statistically significant according
to Wilcoxon signed-rank analysis (see Table 12). Furthermore, bivariate correlational analysis
revealed a significant negative correlation between participant job role and responses to item 2 at
baseline. Participants in a clinical job role were more likely to respond that they were not
proficient in MI prior to the training sessions, n = 5, Mdn = 2, compared to participants in a nonclinical role, n = 6, Mdn = 3, τ = -.65, p = .028. There was also a positive correlation between
job role and the change in posttest and pretest responses to item 2 of the MI Survey.
Participants in a clinical job role were more likely to have a higher median difference, n = 5,
Mdn = 3, in response score from baseline compared to non-clinical participants, n = 6, Mdn = 1,

τ = .75, p = .046.
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Responses to "I Feel Proficient and Able to Use Motivational Interviewing in
My Practice"

Figure 9. Percentage of responses to MI Survey item 2 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 18.2% strongly disagree, 54.5% disagree,
18.2% undecided, 9.1% agree. Percentage of posttest responses (n = 7) are as follows: 14.3%
undecided, 85.7% agree.
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Table 12
Wilcoxon Signed-Rank Test of Change in Item 2 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 2 – Pretest
Item 2
Negative Ranks
0a
.00
.00
b
Positive Ranks
6
3.50
21.00
-2.220d
.026*
Ties
1c
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05

Item 3: Lack of motivation for change is a significant frustration for my clients.
Prior to the MI training sessions, most participants perceived their clients to be frustrated from a
lack of motivation for change. Post-intervention results indicated that an estimated 86% of
participants agreed to some degree with item 3, while the remainder of the sample did not agree
with this statement. Wilcoxon signed-rank analysis confirmed the lack of change in participants’
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responses from baseline (see Table 13). There were no significant relationships between

Percentage of Respondents

participants’ characteristics and pre and post responses to item 3.
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Strongly
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Responses to "Lack of Motivation for Change is a Significant Frustration
for My Clients"
Figure 10. Percentage of responses to MI Survey item 3 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 9.1% undecided, 63.6% agree, 27.3%
strongly agree. Percentage of posttest responses (n = 7) are as follows: 14.3% disagree, 71.4%
agree, 14.3% strongly agree.

""

Table 13
Wilcoxon Signed-Rank Test of Change in Item 3 Responses
n
Mean Rank
Sum of Ranks
Z
p
Posttest Item 3 – Pretest
Item 3
Negative Ranks
1a
1.50
1.50
Positive Ranks
2b
2.25
4.50
-.816d
.414
c
Ties
4
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05.
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Item 4: My clients’ lack of motivation for change is a significant frustration in my
work. The majority of participants were frustrated with their clients’ lack of motivation for
change at baseline. Figure 11 indicates a slight decrease in responses to the strongly agree and
agree categories from pretest to posttest data collection periods. Approximately 29% of the
sample did not perceive their clients’ lack of motivation for change to be a significant frustration
in their work after attending the MI training sessions, whereas prior to the MI sessions, this
percentage was zero. Table 14 reveals there were no significant changes in responses from
baseline to post-intervention. Despite this, participant length of employment had a negative
correlation with the response to item 4 at baseline. Participants who worked three years or less,
n = 4, Mdn = 2, tended to agree with item 4, whereas participants who had been employed in
their current position for greater than nine years were in strong agreement with this item, n = 5,
Mdn = 1, τ = -.64, p = .031. It appeared that the longer a participant was employed, the more
likely the participant strongly perceived a client’s lack of motivation to be a frustrating aspect to
their work.
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Responses to "My Clients' Lack of Motivation for Change is a Significant
Frustration in My Work"
Figure 11. Percentage of responses to MI Survey item 4 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 9.1% undecided, 63.6% agree, 27.3%
strongly agree. Percentage of posttest responses (n = 7) are as follows: 28.6% disagree, 57.1%

agree,"14.3%"strongly"agree."
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Table 14
Wilcoxon Signed-Rank Test of Change in Item 4 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 4 – Pretest
Item 4
Negative Ranks
0a
.00
.00
Positive Ranks
2b
1.50
3.00
-1.342d
.180
c
Ties
5
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05
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Item 5: I believe a client’s own level of motivation for change is important.
Participant responses to item 5 were similar before and after the MI training sessions. All
participant responses were either, agree or strongly agree, to this statement. There was an
increase, however, in the proportion of participants who strongly agreed to item 5 following the
MI training compared to the proportion who strongly agreed prior to the training. This finding
failed to reach statistical significance according to Wilcoxon signed-rank analysis

Percentage of Respondents

(see Table 15).
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Responses to "I Believe that a Client's Own Level of Motivation for Change is
Important"
Figure 12. Percentage of responses to MI Survey item 5 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 45.5% strongly agree, 54.5% agree.
Percentage of posttest responses (n = 7) are as follows: 85.7% strongly agree, 14.3% agree.
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Table 15
Wilcoxon Signed-Rank Test of Change in Item 5 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 5 – Pretest
Item 5
Negative Ranks
0a
.00
.00
Positive Ranks
2b
1.50
3.00
-1.414d
.157
Ties
5c
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05

Item 6: If a client is not initially motivated, I do not think that I will be able to
increase his or her motivation. Responses to item 6 varied at baseline. Approximately half of
the participants believed that they were unable to influence client motivation, while the
remaining respondents were either undecided or disagreed with this statement. Figure 13
indicates a shift in participant responses after the MI training, with all participants in
disagreement to some degree with item 6, indicating that they believed they could increase client
motivation. This finding approached statistical significance (see Table 16). There were no
significant correlations between participant characteristics and pre and post responses to item 6.
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Figure 13. Percentage of responses to MI Survey item 6 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 27.3% disagree, 27.3% undecided, 27.3%
agree, 18.2% strongly agree. Percentage of posttest responses (n = 7) are as follows: 85.7%
disagree, 14.3% strongly disagree.
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Table 16
Wilcoxon Signed-Rank Test of Change in Item 6 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 6 – Pretest
Item 6
Negative Ranks
0a
.00
.00
Positive Ranks
4b
2.50
10.00
-1.841d
.066
c
Ties
3
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05
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Item 7: There is limited administrative support for integrating MI into my work.
Participant responses regarding administrative support for integrating MI into their work also
varied at baseline. Approximately 36% of participants did not perceive there to be limitations in
administrative support for MI integration prior to completing the MI training. This proportion
was similar to the proportion of participants who did perceive limitations in administrative
support at baseline. After the completion of MI session two, however, the proportion of
participants who perceived administrative support limitation as a barrier to MI integration
declined to zero and shifted to the undecided, disagree, and strongly disagree response
categories. This finding approached significance with Wilcoxon signed-rank analysis (see Table
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Figure 14. Percentage of responses to MI Survey item 7 at baseline and intervention
termination. Percentage of pretest responses (n = 11) are as follows: 36.4% disagree, 27.3%
undecided, 27.3% agree, 9.1% strongly agree. Percentage of posttest responses (n = 7) are
as follows: 28.6% undecided, 57.1% disagree, 14.3% strongly disagree.
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Table 17
Wilcoxon Signed-Rank Test of Change in Item 7 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 7 – Pretest
Item 7
Negative Ranks
0a
.00
.00
Positive Ranks
4b
2.50
10.00
-1.857d
.063
Ties
3c
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05

Item 8: Motivational interviewing is applicable to my work. All participants
perceived MI to be applicable to their work at baseline. The proportion of participants who
agreed to item 8 was slightly higher than the proportion of participants who strongly agreed to
this statement. After completion of the MI training, all participant responses were in the strongly
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agree category. This difference in responses, however, failed to reach statistical significance.
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Figure 15. Percentage of responses to MI Survey item 8 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 54.5% agree, 45.5% strongly agree.
Percentage of posttest responses (n = 7) are as follows: 100% strongly agree.
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Table 18
Wilcoxon Signed-Rank Test of Change in Item 8 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 8 – Pretest
Item 8
Negative Ranks
0a
.00
.00
Positive Ranks
3b
2.00
6.00
-1.732d
.083
Ties
4c
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05

Item 9: I am a skillful good listener in working with clients. All participants believed
themselves to be skillful listeners prior to attendance of the MI training sessions. There was an
increase from baseline, however, in the percentage of respondents who strongly agreed to item 9

Percentage of Respondents

at the end of the training sessions. This difference was not statistically significant.
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Figure 16. Percentage of responses to MI Survey item 9 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 72.7% agree, 27.3% strongly agree.
Percentage of posttest responses (n = 7) are as follows: 57.1% agree, 42.9% strongly agree.
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Table 19
Wilcoxon Signed-Rank Test of Change in Item 9 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 9 – Pretest
Item 9
Negative Ranks
1a
1.50
1.50
Positive Ranks
1b
1.50
1.50
0.000d
1.000
Ties
5c
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
The sum of negative ranks equals the sum of positive ranks. * p < 0.05

Item 10: I will use motivational interviewing in my work. The distribution of baseline
responses to item 10 varied slightly. While most participants anticipated using MI in their work,
there was a small proportion of individuals who were undecided about MI use at baseline.
Figure 17 indicates a large increase in the percentage of respondents who strongly agreed they
would use MI in their work after the completion of the MI training sessions. Approximately
36% of respondents strongly agreed to MI use in their work at baseline compared to 86% of
participants who strongly agreed they would use MI post-intervention. Wilcoxon signed-rank
analysis confirmed this significant finding. There were no significant relationships between
participant characteristics and pre and post responses to item 10.
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Figure 17. Percentage of responses to MI Survey item 10 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 18.2% undecided, 45.5% agree, 36.4%
strongly agree. Percentage of posttest responses (n = 7) are as follows: 14.3% agree, 85.7% strongly
agree.
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Table 20
Wilcoxon Signed-Rank Test of Change in Item 10 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 10 – Pretest
Item 10
Negative Ranks
0a
.00
.00
b
Positive Ranks
4
2.50
10.00
-2.000d
.046*
Ties
3c
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05
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Item 11: I think that the most effective way to motivate clients or patients to change
is by drawing on their own internal motivations. A large percentage of participants agreed to
item 11 at baseline. Despite this prior belief that a client’s internal motivation is essential for
behavior change, there was still improvement observed in participants’ responses postintervention. In fact, there was a large shift from baseline to post-intervention in the proportion
of participants who strongly agreed to item 11. Table 21 demonstrates the significance of this
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difference in responses.
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Change is by Drawing on Their Own Internal Motivations"
Figure 18. Percentage of responses to MI Survey item 11 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 9.1% undecided, 81.8% agree, 9.1% strongly
agree. Percentage of posttest responses (n = 7) are as follows: 14.3% agree, 85.7% strongly agree.
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Table 21
Wilcoxon Signed-Rank Test of Change in Item 11 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 11 – Pretest
Item 11
Negative Ranks
0a
.00
.00
Positive Ranks
5b
3.00
15.00
-2.121d
.034*
Ties
2c
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05

Item 12: Some clients need to be coerced or pressured to change. At baseline,
slightly greater than half of the participants believed coercion and pressure were needed for
behavior change, while the remainder of the sample disagreed or strongly disagreed with item
12. There was a significant shift in responses after completion of the MI training sessions as
evident in Figure 19 and Table 22. No participants believed coercion and pressure were needed
for client behavior change post-intervention. Bivariate correlational analysis revealed a positive
relationship between gender and responses to item 12 at baseline. Male participants were more
likely to agree with this statement, n = 4, Mdn = 2, compared to female participants, n = 3, Mdn
= 4, τ = .78, p = .011. Furthermore, the relationship between gender and responses to item 12
post-intervention approached significance. While both genders agreed to item 12 postintervention, males were more likely to have responses in the disagree category, n = 4, Mdn = 4,
while females were more likely to strongly disagree to this item, n = 3, Mdn = 5, τ = .75, p = .06.
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Figure 19. Percentage of responses to MI Survey item 12 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 54.5% agree, 36.4% disagree, 9.1% strongly
disagree. Percentage of posttest responses (n = 7) are as follows: 42.9% disagree, 57.1% strongly
disagree.
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Table 22
Wilcoxon Signed-Rank Test of Change in Item 12 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 12 – Pretest
Item 12
Negative Ranks
0a
.00
.00
Positive Ranks
6b
3.50
21.00
-2.232d
.026*
c
Ties
1
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05
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Item 13: Some clients will never change regardless of how I interact with them. The
responses to item 13 were distributed across all response categories at baseline. There was a
large increase in respondents who strongly disagreed with the belief that some clients will never
change their behavior from the pre- and post-data collection periods. This finding, however, did
not reach statistical significance (see Table 23). There were no significant correlations between
participant characteristics and pre and post responses to item 13; however, the relationship
between gender and the difference in pre and post responses approached significance. Males
were more likely to have a lower median difference in pre and post responses to item 13, n = 4,
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Mdn = 0.5, compared to females, n =3, Mdn = 2, τ = .68, p = .067.
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of How I Interact with Them"
Figure 20. Percentage of responses to MI Survey item 13 at baseline and intervention termination.
Percentage of pretest responses (n = 11) are as follows: 9.1% strongly disagree, 27.3% disagree,
27.3% undecided, 27.3% agree, 9.1% strongly agree. Percentage of posttest responses (n = 7) are
as follows: 57.1% strongly disagree, 14.3% disagree, 28.6% agree.
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Table 23
Wilcoxon Signed-Rank Test of Change in Item 13 Responses
n

Mean Rank

Sum of Ranks

Z

p

Posttest Item 13 – Pretest
Item 13
Negative Ranks
1a
2.50
2.50
Positive Ranks
5b
3.70
18.50
-1.725d
.084
Ties
1c
Total
7
a
Note. Posttest Score < Pretest Score. bPosttest Score > Pretest Score. cPosttest Score = Pretest Score.
d
Based on negative ranks. * p < 0.05

Successful Implementation
The indicators of successful implementation of MI within the parameters of this project
were identified in chapter four. The PARIHS framework was utilized as a guide in identifying
the measures required to determine the success of this MI implementation project. As previously
identified, there were two main indicators of successful implementation. The first indicator was
the proportion of staff who completed the MI introductory training, while the second indicator
focused on the proportion of staff who demonstrated a positive change in the overall MI Survey
score. The following sections will provide the results of these inquiries.
Indicator One
The first indicator of successful implementation focused on the completion of the MI
training sessions. Approximately 65% of the 17 eligible staff members volunteered and were
available to attend the first MI session. Of the 11 participants attending the first MI session, 64%
of participants completed the second MI session. Overall, 41% of the 17 eligible staff members
completed the two-day MI introductory training course.
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Indicator Two
The second indicator of successful implementation was measured utilizing the sample of
seven participants who completed both MI training sessions. As indicated in Figure 21, 100% of
the sample demonstrated an improvement in the post MI Survey score from baseline.
70
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Figure 21. Pre and post MI Survey scores for the participants who completed both MI
training sessions, n = 7. The possible MI Survey score range is 13 to 65. Each participant
is represented by an alphabetical letter to ensure anonymity, as the MI surveys were coded
numerically.
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Conclusion
This chapter provided a thorough presentation of the findings pertaining to participant

characteristics, total MI Survey score, MI Survey item scores, and successful implementation
indicators. These findings contributed to the understanding of the MI knowledge and
perceptions of the multidisciplinary care team within this outpatient HIV medical setting. The
next chapter will further explore the implications and significance of these findings.
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CHAPTER 6
Discussion
This implementation project was designed to promote the uptake of MI as an intervention
to increase medication adherence behavior in people living with HIV. One of the first indicators
of successful uptake of an evidence-based intervention is a change in knowledge and perception
of the intervention by the individuals intended to actualize it in clinical practice (Stetler et al.,
2011). This chapter serves several purposes. First, it will discuss the implications and practical
significance of the findings from the MI Survey. Second, the success of the MI implementation
project will be analyzed within the context of the revised PARIHS framework. Next, the policy
implications and limitations of this proposed practice change will be explored. Finally, this
chapter will explicate the various roles enacted by the doctoral student to conduct this project, as
well as, provide recommendations for the full implementation of MI in this setting to improve
antiretroviral medication adherence.
Implications and Significance
The findings of this project revealed important aspects about the anticipated users of MI
in this clinical practice environment. The two-day MI introductory training course had a
profound impact on the care team, such that, all team members had an overall improvement in
MI knowledge, perception of MI effectiveness and behavior change, and the likelihood of
utilizing MI in daily patient care interactions. Specifically, regarding the concept of MI
effectiveness, most care team members believed a client’s internal level of motivation to be
important and the most effective manner in eliciting behavior change prior to attending the MI
sessions. This suggests that the care team had an a priori intuitiveness about the role of internal
motivation in behavior change. Furthermore, there was a collective perception that MI was an
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effective modality for improving client motivation for health behavior change. The beliefs that
internal motivation and MI are catalysts for behavior change are crucial aspects to the uptake of
this intervention in this clinical setting.
The perspective of the care team on client behavior change also provides insight to the
culture of the practice environment. Prior to the MI training, there was a large portion of the care
team who perceived coercion and pressure to be necessary tactics to provoke client health
behavior change. This suggests these care team members may have utilized these unsuccessful
strategies during previous client interactions. Strategic efforts guided by pressure and coercion
may lead to client resistance towards change (Miller & Rollnick, 2002). These beliefs in
coercion and pressure tactics, however, were abandoned after completion of the MI training.
This finding is paramount because it signifies the potential adoption of a new practice approach
to provider-client interactions.
Nevertheless, there is still opportunity for improvement in staff perceptions of client
behavior change. There still remained a portion of the care team who believed some ambivalent
clients would never change their health behavior through interactions grounded in MI principles.
This suggests further education in MI may be a necessary component for the uptake of this
intervention in this practice setting.
There are substantial implications that can be understood about the likelihood of the care
team utilizing MI in their daily work. First, there is evidence that further MI training is
warranted. Although a large portion of the care team felt proficient in applying their new MI
skills with their clients after the MI sessions, there was a small portion of the team who did not
feel proficient, based on the MI Survey results. Moreover, at the end of the MI training course,
all participants of this project verbalized a desire to attend the advanced MI training course to
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enhance their skills. This demonstrates a sense of commitment and investment in MI by the
multidisciplinary care team at this facility.
The second implication associated with the likelihood of MI use is based on the finding
that the majority of the care team expressed a sense of frustration with clients' lack of motivation
before and after the MI training. The training had little effect in altering the frustration felt by
the care team. Specifically, care team members employed for a greater length of time had
stronger feelings of frustration compared to care team members employed for less time in their
current roles. It is apparent that frustration with client lack of motivation exists within this
clinical setting, and this frustration was not amenable to an introductory MI training course for
most care team members. Willit et al. (2009) also found similar results for item four of the MI
Survey in their multisite sample of 405 participants employed in correctional education facilities.
The majority of the participants agreed that a client’s lack of motivation for change was a
significant frustration in their work prior to and after a three-day MI training course. Perhaps,
the HIV care team’s frustration with client lack of motivation will dissipate as the care team
becomes more MI proficient and confident in their ability to assist clients along the behavior
change continuum. This perceived frustration might also be a driving factor for utilization of MI
in this setting.
The final conclusions that can be drawn regarding the likelihood of MI use in this
practice setting provide strong support for future MI use. Prior to the MI training, all participants
believed MI to be applicable to their daily work and that they were good skillful listeners. After
the MI introductory sessions, these beliefs remained consistent with pre-training beliefs. The MI
sessions, however, seemed to solidify participants’ beliefs about MI applicability. All care team
members were in strong agreement that MI was applicable to their client interactions after
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training completion. Listening skills and perceived value in the intervention are prerequisites for
adoption of MI in this clinical setting (Stetler et al., 2011). Moreover, the care team perceived
they had the support from administration to implement MI into their work. This is an essential
finding because leadership support is a component of contextual readiness within the revised
PARHIS framework (Stetler et al., 2011). Most importantly, all care team members agreed to
use MI in their daily work after the introductory MI sessions. This receptivity to MI use is, yet,
another indicator of contextual readiness for the practice change.
There have been some reports by the care team of their attempts in MI utilization during
their client interactions after attending the MI introductory training. In fact, a clinician member
of the HIV care team reported the ability and awareness of identifying ambivalence during client
interactions after attending the MI training sessions. The clinician also reported a personal
increase in the use of reflective listening skills with clients. It was noted that one particular
client benefited from this MI interaction as he moved along the behavior change continuum from
contemplating to preparing to restart his antiretroviral medications during the time frame of one
routine appointment. This suggests that MI is feasible to incorporate into client conversations.
Reports from other HIV care team members, also, support the likelihood of MI utilization. The
majority of the feedback centered on the new awareness and ability to identify ambivalence to
behavior change. The ability to identify client ambivalence and reflective listening are necessary
skills in assisting clients with health behavior change.
This section summarized important information regarding the anticipated users of MI in
this outpatient HIV setting. First, the care team’s beliefs regarding the importance of internal
motivation in eliciting behavior change coincide with MI principles. Second, there appears to be
“buy-in” of the intervention by leadership and the care team. Moreover, there is an opportunity
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for future MI education within this clinical setting, and most importantly, HIV care team
members have begun utilizing their new MI skills during client interactions.
Project Analysis
The revised PARIHS framework was utilized in the analysis of this MI implementation
project. The three sub-elements of successful implementation included the implementation plan
and its realization, the evidence-based practice innovation uptake, and organizational outcomes
achievement. Each of these sub-elements was utilized to gain a better understanding of the
overall success of this MI implementation project.
Implementation Plan and Its Realization
According to Stetler et al. (2011), the evaluation of successful implementation with
respect to the implementation plan and its realization incorporates “the degree to which
implementation strategies are both fielded in the intended form/format and related adoption
activities reach the targeted audience” (Additional File 4). For this reason, the first indicator of
successful implementation was the proportion of staff who completed the MI training. As
indicated in the results section, 41% of the eligible care team members completed the two MI
sessions. However, there was still a large portion of the care team that the intervention did not
reach.
Careful analysis of the influential factors that may have affected the degree of MI training
completion in this setting revealed important information for implementation replication. First,
the facilitator role within this project may have needed to incorporate a better communication
method with the physicians. Many of the physicians did not seem to be aware of the scheduled
MI training until the week prior despite email notifications, announcements made during
morning huddle, a flyer posted on the communication board, and a presentation of the proposed
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MI implementation project by the facilitator. Second, individual conversations with the
physicians revealed they were interested in learning MI, but they felt that an eight-hour training
would be difficult to attend with their patient care responsibilities. Although the training was
scheduled on the least busy clinic day and many physicians did not routinely have clinic
scheduled on this day, they still had inpatient care responsibilities. One of the physicians
inquired about the possibility of attending a MI webinar course that could be completed when
schedules were less busy. Considering that MI is a provider-level change within this
organization, it is imperative that all health care providers have access to the educational sessions
of a new intervention.
Evidence-Based Practice Innovation Uptake
Formative evaluation of MI uptake within the parameters of this project focused on the
prerequisite basis for intervention adoption. The concepts considered necessary for intervention
adoption within the revised PARIHS framework included awareness, knowledge, attitude, and/or
skill (Stetler et al., 2011). Specifically, this project focused on MI knowledge, awareness
(perception of MI and behavior change), and staff attitude as indicated by the likelihood for MI
use. These indicators of MI uptake revealed an overall improvement in MI knowledge and
perception, client behavior change perception, and attitude about MI use in the seven participants
who completed the MI introductory sessions. Moreover, some of the participants had already
incorporated the use of MI skills in their client interactions, despite the fact that the clinical site
was merely in the preliminary planning stages of incorporating this QI initiative.
All participants who completed the entire MI training experienced an overall positive
improvement in the indicators of intervention uptake. Based on this fact, it is likely those care
team members unable to attend the MI training course would also experience an improvement in
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these prerequisites for MI adoption if able to attend the MI sessions. In addition, MI knowledge
did improve after training; however, the staff requested further MI training for skill
advancement. At the time of the writing of this chapter, arrangements were in place to offer the
two-day advanced MI training course to the HIV care team.
Organizational Outcomes Achievement
The final element contributing to the evaluation of successful implementation was
organizational outcomes achievement. Outcomes achievement as defined in the revised PARIHS
framework refers to “the impact or outcome expected to follow adoption or use of the targeted
EBP recommendation” (Stetler et al., 2011, Additional File 4). Within the scope of this project,
the expected impact of the MI training focused on staff outcome. The intended impact of the MI
training, as previously identified, was to improve staff knowledge, perception, and likelihood for
MI utilization. All HIV care team members who completed the MI introductory training
demonstrated an overall improvement in these areas.
Summary
Analysis of the three sub-elements of successful implementation allowed for the
identification of the successful aspects of the project, as well as, the areas in need of
improvement. Although the implementation plan was not effective in reaching all eligible care
team members, the overall success of the MI training was impactful for the participants who did
complete the sessions.
When considering the results of the contextual assessment of the organization (see Table 9)
completed prior to the project implementation, it is not surprising there was preliminary uptake
of MI in this clinical setting. The contextual environment of the clinic demonstrated a strong
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sense of readiness for practice change, a well-established system of quality improvement, and the
financial resources to fund staff education.
Policy Implications
This project was designed to lay the foundation for the uptake of MI in an outpatient HIV
clinic. Although the actual implementation of this first phase of MI utilization did not involve
organizational policy changes, full MI implementation within this practice site may need to
consider these implications. Considerations for organizational policy may be necessary if full
MI implementation with ambivalent clients does improve ART adherence in this practice setting.
For example, the organization would need to determine to what extent health care delivery at the
provider level would incorporate MI principles and how this would be monitored. In the event
that MI is successful with improving patient outcomes, organizational policy may need to
incorporate MI as a standard of care to ensure uniformity and quality in utilization across health
care providers. Furthermore, there is potential for MI dissemination within other outpatient
health care facilities within the larger parent organization. Written policy regarding the MI
education of health care staff may be required to ensure consistency and quality of MI training.
A process and budgetary system would, also, need to be in place to ensure new employees are
properly trained as well.
Limitations
There were various limitations to this MI implementation project. First, the actions taken
by the facilitator to endorse and communicate the date of the MI training failed to reach potential
key players – the physicians. It may be that the physicians are more responsive to face-to-face
communicative interactions. The MI announcements made during morning huddle were not
inclusive of all physicians. This is because some physicians were already attending to patients in
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the hospital during the morning huddle, which was located in the outpatient clinic. To
accommodate for their absence, the MI training information was sent via email and posted on the
communication board located in the HIV outpatient clinic. However, these methods did not
seem to enhance communication. A second facilitative factor associated with poor physician
attendance of the MI training was the failure to consider the difficulty for the physicians in this
practice to commit to an eight-hour training day. Perhaps an alternative training method or
schedule, such as a webinar or half-day sessions, would have increased physician attendance.
Nevertheless, collaboration between the coordinator and physicians is essential in identifying the
best approach to MI training format and scheduling.
The MI Survey scale also created a limitation to this project. The scale was not tested for
internal consistency reliability by its original authors, and the scale did not demonstrate optimal
internal reliability with the data obtained from the participants of this project. While the MI
Survey did demonstrate adequate reliability, the results with this sample suggested the MI
Survey might have items that did not well represent the concepts of interest.
The small sample of participants also limited the statistical analyses of this project. This
project was not intended to produce generalizable knowledge; however, a larger sample size may
have provided useful information about the multidisciplinary care team.
Data obtained from more participants would better represent the care team, with respect to the
change in MI knowledge, perceived MI effectiveness, perception of client behavior change, and
likelihood of MI use, following the MI training. This should be taken into consideration when
developing a quality improvement MI initiative based on findings from the MI Survey.
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Roles of the Doctor of Nursing Practice Student
The enactment of three roles was necessary for the completion of this evidence-based
practice initiative. These roles included that of scholar, leader, and innovator. The doctorallyprepared practice scholar demonstrates an advanced knowledge base and critical inquiry into the
gaps in health care delivery (Dreher & Glasgow, 2011). The basis for this implementation
project derived from clinical experience in this HIV outpatient setting. Antiretroviral therapy
nonadherence was a health care issue with substantial consequences, and many times, with
unsuccessful adherence strategies. Enactment of the practice-scholar role involved a critical
review of this evidence-based intervention, an application of findings to this practice
environment, and utilization of theoretical frameworks to foster the success of the translation of
knowledge into practice (AACN, 2006). Introduction of a new practice change also required the
roles of leader and innovator. As a leader, the doctorally-prepared advanced practice nurse must
understand the complexities of the health care environment and promote interprofessional
collaboration to address population health care needs (Montgomery & Porter-O’Grady, 2010).
Recommendations
The final recommendations, derived from the integrative review, organizational
assessment, and project analysis, are intended to promote future sustainability of MI in this
outpatient HIV clinic. The scope of this MI implementation project was to lay the foundation for
the actual uptake of MI as an ART adherence intervention in this clinical practice setting.
There are indications of MI feasibility in this clinical environment as evidenced by the high
likelihood of MI use, reported staff accounts of utilizing MI skills, and the financial support to
fund staff education. These recommendations address the education, implementation, and
evaluation of MI and may be used as a guide for the QI team to proceed with utilizing this
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intervention to promote ART adherence with clients. The recommendations for further MI
education are as follows:
•

Motivational interviewing education of the care team should proceed with advanced
training in MI skills. The cost of this advanced training is $1,750, which is within the
allotted funding limit for staff education.

•

Alternative MI training formats should be considered for the physicians of this practice.
A combination of webinars and a half-day group format with a MINT trainer may be a
better alternative for the schedule demands of the physicians. There is a five-session
(one hour/session) MI webinar available at
http://www.healthsciences.org/MI-Health-Coaching-Webinar-Series. The cost is $250
per person or $200 per person for groups of five or more participants. The MINT trainer
involved in this implementation project is currently in the process of developing a
webinar series for MI training as well. It may be of value to have the physicians
participate in the webinar offered by the same MI trainer who worked with the other care
team members.

•

The care team members of this clinic should have access to individual MI coaching as
needed for skill enhancement and reflection with an MI expert. The cost of MI coaching
is approximately $100-$120/hour.

•

This organization should purchase resources for the care team to further foster MI use in
this setting. The MINT trainer recommended the following books:
o Motivational Interviewing in Health Care: Helping Patients Change Behavior by
Stephen Rollnick, William R. Miller, and Christopher C. Butler (The cost is
$27.20 through Guilford Press)
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o Building Motivational Interviewing Skills: A Practitioner’s Workbook by David
B. Rosengren (The cost is $40.80 through Guilford Press)
The recommendations for MI implementation are as follows:
•

A process needs to be established for the identification of clients in need of MI for ART
adherence. CAREWare data reports should be utilized to establish this target population.
The Stage of Change questionnaire (Willey et al., 2000) should be incorporated as a
mechanism for identifying clients in the precontemplation, contemplation, and
preparation stages of behavior change. These will be the clients most amenable to this
intervention.

•

There needs to be a documentation process established for the MI client interactions that
fosters continuity of care between the different professional disciplines of the care team.
The ideal process would include utilization of the electronic health record to document
(1) MI processes and skills incorporated during the MI interaction, (2) the client’s
stage of change, and (3) the action plan. Access to this information in the electronic
health record will allow, for example, the clinician to continue with the MI interaction
that was previously started by the HIV case manager or pharmacist.

•

Motivational interviewing conversations should be delivered in a manner that
fits the needs of the client. This intervention has been shown to be effective with face-toface and telephone interactions, as well as, a combination of the two methods (Lundahl et
al., 2013; VanBuskirk & Wetherell, 2013).

•

The actual number of MI interactions will depend on client needs. However, more MI
interactions are more likely to produce sustainable client outcomes (Burke et al, 2003;
Hettema et al., 2005; Lundahl & Burke, 2009).
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The recommendations for MI evaluation are as follows:
•

The clients’ stage of change should be utilized as a process indicator. The Stage of
Change questionnaire will indicate client progression on the behavior change continuum.

•

Outcome indicators for MI evaluation should include HIV viral load and a medication
adherence self-report measure that is not time-consuming in this busy practice.
Conclusion
This evidence-based practice project introduced a client-centered adherence intervention

to the multidisciplinary care team of an outpatient HIV clinic. These health care
professionals have experienced the clinical difficulties associated with clients’ lack of
motivation for ART adherence. Based on the IMB Skills Model of ART adherence, it was
apparent that the lacking variable needed to achieve adherence behavior and viral
suppression was adherence motivation. The organizational assessment revealed a readiness
for practice change, and the PARIHS framework functioned as the implementation and
evaluation guide for MI uptake in this setting. The two-day introductory MI training was an
effective method for improving MI knowledge, perception of MI effectiveness, perception of
client behavior change, and likelihood of MI use in this HIV care team. Motivational
interviewing is a feasible adherence intervention with potential for sustainability. Given the
strict adherence requirements of ART and the implications of untreated HIV infection, this
HIV clinic should proceed with the implementation of MI with clients ambivalent about
taking ART.
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Appendix A
Integrative Literature Review Tables
Table A1

Search Domain 1: Meta-analyses and Systematic Reviews of Motivational Interviewing
Review Type

Objective

Eligibility
Criteria

Systematically
review RCTs
that investigated
MI effectiveness
in ↓ body mass

• Age ≥ 18y
• BMI ≥ 25
• MI intervention
• CG
• Outcome of
body mass
(weight or
BMI)
• RCT

Citation
Armstrong,
Mottershead,
Ronksley,
Sigal,
Campbell, &
Hemmelgran
(2011)

M

S

C
X

Variables
Analyzed

Databases
Searched

• Weight in kg
• BMI
*The authors
use ‘body mass’
to refer to both
weight and/or
BMI

MEDLINE,
EMBASE,
PsychINFO,
CINAHL,
CENTRAL,
and an
ancestry
search of
relevant
articles

# of Studies
total N

Summary
Measure

N = 12 for
qualitative
synthesis

Pooled
effect
estimate

N = 11 for
meta-analysis

Randomeffects
Model

(n = 1448 total
subjects,
n = 801 in IG,
n = 651 in CG)

Results
Effect of MI on ↓
in body mass:
SMD = -0.51
(95% CI, -1.04,
0.01: p = .053)
with significant
heterogeneity
2
I = 95.0%
p < 0.001
Studies with wt.
loss as 1° or 2°
outcome:
1°: SMD = -.83
(95% CI -1.91,
0.25)
2°: SMD = -.13
(95% CI -.29,
0.21)
Effect of MI on
↓ in weight and
BMI
Weight:
WMD = -1.47kg
95% CI -2.05,
-0.88; p < .01
2
I = 54.7%
BMI:
WMD = -0.25kg
95% CI -0.50,
0.01; p = .058;
2
I = 24.5%

Findings
• MI had a
medium ES
on ↓ BMI,
however
there was
significant
heterogeneity in this
pooled ES.
• The factors
contributing
to increased
wt. loss
included MI
tx duration >
6 mo., use
of an
attention
control, and
MI tx fidelity.
• MI as an
adjunct to
wt. loss
program
resulted in
the most wt.
loss

Note.!AMI- adaptations of motivational interviewing; !BESD- binomial effect size display; C- combined meta-analysis and systematic review;!CABS- coronary artery bypass surgery;
CG- comparison/control group;!CR – cardiac rehabilitation; DBP- diastolic blood pressure; DUK- Diabetes United Kingdom; EASD- European Association for the Study of Diabetes;
IDF- International Diabetes Federation; M – metal-analysis; MISC- Motivational Interviewing Skill Code; MITI- Motivational Interviewing Treatment Integrity; S-systematic review; SBPsystolic blood pressure; SD- significant difference; SMD- standardized mean difference; WMD- weighted mean difference
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Table A1 (continued)
Review
Type

Citation
Burke,
Arkpowitz, &
Menchola
(2003)

M
X

S

C

Objective

Eligibility
Criteria

1. present the
basic
characteristi
cs of RCTs
of AMIs
2. evaluate the
evidence for
the efficacy
of AMIs
3. examine
evidence of
sustained
efficacy of
AMIs
4. explore the
evidence of
clinical
impact of
AMIs
5. to identify
moderator
variables
across
studies

• The
intervention had to
include
Miller &
Rollnick’s
MI
principles
• MI
delivered
on an
individual
face-to-face
basis
• The study
design met
the criteria
for a RCT

Variables
Analyzed
Multiple

Databases
Searched
Ancestry
search of 3
prior MI metaanalyses, the
MI website,
psychInfo, and
electronic
message to all
MINT for
published and
unpublished
research
Keywords:
Motivational
interviewing
No search time
period specified

# of Studies
&
Characteristics
n = 30
Alcohol: 15
Smoking: 2
Drugs: 5
HIV-risk: 2
Diet: 4
Adherence: 1
Eating Disorder:
1
• n of each RCT
ranged 22-952
with m = 206
• 19 RCTs used
control groups,
4 used active
treatments, and
5 used both.
• Dose of AMI
ranged 15-240
min. with a m =
99 min.
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Summary
Measure

Results

• Individual
ES
• Combined
ES
• Multiple
regression

Combined ES
In RCTs
comparing AMIs
with no
treatment, the
combined ES
ranged from
0.25 – 0.56 with
a 95% CI in
favor of AMIs.

Results
Individual ES
(within-AMI)
11 RCTs had
at least 1
significant ES
in favor of
AMI ranging
from 0.22 –
1.94 with a
95% CI
Combined
within-AMI
ES = .82

The RCTs
comparing AMIs
with active
treatment did not
produce a
statistically
significant
combined ES.
Multiple
Regression
n = 23
Dose ß= .39
Problem area ß=
2
.35, R = .38
p < .05
AMI dose and
problem area
accounted for
38% of the
variance in
outcomes.

Findings

The effects of
AMI seem to
persist over
time.
The % of
people
displaying an
improvement
in the problem
area after AMI
was significant
(51% vs. 37%;
df =1,
2
X = 10.95, p <
.01).
AMI alone or in
combination
with UC
appeared to
improve
success rates
from ~ 33% to
50% overall.
AMI appeared
to produce the
same effects
as other
treatments
but in < time

!
Table A1 (continued)
Review
Type

Citation
Hettema,
Steele, &
Miller (2005)

M
X

S

C

Objective

Eligibility
Criteria

Provide an upto-date
summary of the
evidence base
for MI

• Group or
individual
intervention with MI
compo-nent
• @ least one
posttreatment
outcome
measure
• @ least 1
control or
comparison group
with no MI
• a procedure
to provide
equivalent
groups

Variables
Analyzed

Databases
Searched

IV = MI
DV = various
outcome
measures
(health
behavior,
addiction,
adherence)

PsychInfo,
hand-search
bibliographies
from MI
website,
previous
reviews

Other study
variables
analyzed:
Type, goal,
format, setting,
intervention
agent, treatment
components,
sample
characteristics

# of Studies
&
Characteristics
n = 72
N = 14,267
Target
Problems:
alcohol (31)
smoking (6)
HIV (5)
Drugs (14)
Adherence (5)
Gambling (1)
Intimate
relationships(1)
Water safety (4)
Eating disorder
(1)
Diet/exercise (4)
• m = 198.16
sample size
per study
• Age m = 34
• Male 54.77%
• MI dose:
r = 15-720 min.
m = 2.24hrs
• CG dose:
r = 0-28hrs
m = 2.89hrs

Summary
Measure

Results

Combined
ES reported
by target
problem
across all
follow-up
points and @
follow-up
points ≤ 3 mo

Combined ES
for individual
studies ranged
from -0.19 to
3.25 (m = .43,
SD = .62) across
all study points.
58% of the
studies showed
a significant
effect favoring
MI (p < .05)
ALL STUDIES
(95% CI)
0-1 month
dc= 0.77
(0.35, 1.19)
>1-3 months
dc= 0.39
(0.27, 0.50)
>3-6 months
dc= 0.30
(0.16, 0.43)
>6-12 months
dc= 0.11
(0.06, 0.17)
MI + UC vs. UC

Findings

The effects of
MI appear to
persist or ↑over
time when MI
added to an
active Tx.
Synergistic
effect of MI +
active Tx
seems to stem
from the effect
of MI on Tx
adherence and
retention.
MI alone may
have ↑effects
with booster
sessions.
MI used as a
prelude to
active Tx
appears to
endure across
time.
Variation in MI
delivery
appears to
have impact
on outcome.
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Table A1 (continued)
Review Type

Objective

Eligibility
Criteria

Variables
Analyzed

Databases
Searched

# of Studies
total N

Summary
Measure

Evaluate
effectiveness
of MI in
physical
healthcare
settings

• Population
suffering
from or at
risk for a
physical
illness
• Studies
using MI to
promote
behavior
change
• RCTs and
non-RCTs

Multiple
variables
including:
psychologicalcognitive (15
studies
psychologicalemotional,
life-style
change, and
physiological

(2002-2004)
Amed,
CINAHL,
EMBASE,
MEDLINE,
Psychinfo, ISI
Web of
Science, and
SIGLE

8 total: 4
RCTs, 3 pilot
studies, 1 nonrandom
controlled trial

Avg. of 7.5
outcomes
measured
per study
ranging
from
psychological,
lifestyle
change,
and physiological.

Citation
Knight,
McGowan,
Dickens, &
Bundy (2006)

M

S
X

C

Cochrane
Library, NRR,
DAI, HTA, and
CHI
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DM (3)
asthma (1)
HTN (1)
Lipids (1)
CABS (1)
CR (1)

17 of 21
total
measures
were
validated.

Results
MI had a positive
effect on
psychological,
physiological, and
life-style change
outcomes in the
majority of the 8
studies.

Findings
MI was
delivered by
various health
care
disciplines.
The # of MI
sessions
ranged from 16 among the 8
studies.
Authors
concerned with
low internal
content validity
of RCTs and
other studies,
suggesting
that the
evidence does
not support
general
MI implementation across
health
facilities.
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Table A1 (continued)
Review Type

Objective

Citation
Lundahl &
Burke (2009)

M

S
X

C

To review the
research
support for MI
to allow
practitioners to
make informed
decisions
about the utility
of MI in
practice.

Eligibility
Criteria

Variables
Analyzed

Databases
Searched

Meta-analysis • MI effective-ness
of MI effective- • MI Dose
ness
• MI Durability
• MET effect
• MI format
• Utilization of a MI
manual

Not reported
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# of Studies
total N
4 metaanalyses:
1. Hettema et
al. (2005)
2. Burke et al.
(2003)
3. Vasiliki et
al. (2006)
4. Lundahl et
al. (2009)

Summary
Measure
N/A

Results
N/A

Findings
• 14%-20% of
people treated
with 1 to 2 MI
sessions can
expect to do better
than clients not
receiving MI
treatment.
• Overall, evidence
suggests that MI
is as effective as
other active
treatments.
• MI appears to be
effective in shorter
duration (by 2-3
sessions)
compared to other
treatments.
• MI effects are
durable up to 1
year post-tx.
• MI dose appears
to be correlated
with outcomes.
• MI appears to be
a versatile
treatment that can
be used in
different formats

!
Table A1 (continued)
Citation

Lundahl,
Kuntz,
Brownell,
Tollefson, &
Burke
(2010)

Review
Type
M
X

S

C

Objective

Eligibility Criteria

Variables
Analyzed

1. Examine the
degree to
which MI
can help
clients
change
2. Investigate
the unique
effect of MI
compared
with other
Tx or
controls

• 1984-present
• comparison with
waitlist or control
group
• MI vs. TAU
• MI + TAU vs.
TAU
• MET
• Comparison
group included
dissemination of
material

IVs
MI or MET

***Studies from
ProjectMATCH
were excluded to
avoid sampling
bias

↓ in risk-taking
behavior,
depression,
and anxiety

DVs
ETOH use
Marijuana use
Tobacco use
Drug use
↑ in physically
healthy
behavior

Databases
Searched
• Bibliography of MI
research compiled
by Dr. Miller
• Ancestry search of
other meta-analyses
• PsychInfo,
PsychArticle
Psychology &
Behavior, Medline,
CINAHL, ERIC,
Business Source
Premier, PubMed
Academic Search
Premier, Social
Services Abstracts,
Sociology Abstracts

# of
Studies
n = 119

Summary
Measure
Hedge’s g
(nonbiased
ES)

Results

g = 0.22
(CI, .17-.27)
z = 8.75
p < .001
ES
Distribution
25%: g = 0
50%: g = 0.22
75%: g = 0.50
ES Variability
ES contained
significant
heterogeneity
Qw = 228.71
P > .001
Moderator
Analyses
MI vs. weak CG
show ↑ ES
compared to MI
vs. strong CG
Qb = 13.58
P < .001
MET (g = 0.32)
produced positive
change compared
to MI (g = 0.19) in
studies comparing
MI vs. weak CG
Qb = 4.97(1)
P < .03
Findings
- MI produces
small, significant
positive effects in
various outcome
domains.
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Findings

• MI is likely to
produce
significant
positive
results
toward
behavior
change in
less amount
of time
compared to
other EIs
• The effects
of MI appear
to be durable
across time,
demonstrating
significance
up to 1-2 yrs.
post-tx
• When
compared to
weak CG, MI
had a
significant
positive
relationship
between
dose and
effect.
• MET
produces
better results
than MI
alone in
promoting
behavior
change.
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Table A1 (continued)
Citation
Lundahl et
al. (2013)

M

Review
Type

Objective

Eligibility
Criteria

S

1. Clarify the
general
efficacy of MI
in medical
setting
2. Determine
whether MI
effects in
medical
setting are
moderated by
type of
medical
problem, MI
delivery,
patient
characteristic,
or study
design
3. Provide future
research
guidance

• MI or MET
• RCT with
control group
• Conducted in
medical
setting

C
X

Variables
Analyzed

Databases
Searched

# of
Studies

Summary
Measure

Multiple
medical
outcomes
• Delivery site
• Provider
type
• MI durability

1983-2000
PubMed,
MedLine,
CINAHL, Health
Source,
PsychArticles,
PsychINFO,
Scopus, Social
Work Abstracts,
Web of
Knowledge, MI
bibliography
from MINT

n = 48
N = 9, 618
participants

Odds Ratio
expressed as the
BESD

•

2. Medical
Outcome:
Qb = 130.02
P < 0.001

Results
ES Analysis
• OR = 1.55
95 % CI
[1.40, 1.71]
z = 8.67
p < 0.001
Heterogeneity
Test
Qw = 521.68
P < 0.001
2
I = 90.42
Moderator
Analysis
* 95% CI
1. Measurement
Methods:
Biophysical
Indicators:
OR = 1.18,
[1.09,1.28]
Medical Records:
OR = 1.48,
[1.24, 1.78]
Self-Report:
OR = 1.69
[1.55,1.84]
Qb = 33.28
P < 0.001
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Results
(cont.)

3. MI Dose:
Total MI minutes
approached
significance at
P = 0.06 as a
continuous
moderator of MI
effect
• 63% of studies
comparing MI vs.
comparison were
statistically
positive for MI
effect
• According to the
BESD, 56% of
participants
improved with MI
and 44% of
participants
improved with
comparison
intervention.
Findings
• The omnibus OR
suggested a 55%
increased chance
that MI will
produce a positive
effect on the
intended outcome.

Findings
(cont.)
• MI has
produced
positive
outcomes in a
variety of
medical
outcomes.
• MI was not
able to
produce
statistically
significant
results in
decreasing
blood glucose,
heart rate, and
medication
adherence
• This study
demonstrated
that MI and
MET are
equally
effective in
producing
intended
outcomes.
• MI can be
delivered by a
variety of
professions,
regardless of
training time or
supervision,
and in
numerous
types of
medical
facilities.
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Table A1 (continued)
Citation
Martin &
McNeil
(2009)

M

Review
Type

Objective

S

Evaluate
empirical studies
testing
effectiveness
and clinical utility
of MI in 3 health
areas:
• Diabetes
• Diet & exercise
Oral health

X

C

Eligibility
Criteria
Not
explicated

•
•
•
•
•

Variables
Analyzed

Databases
Searched

# of Studies

Summary
Measure

MI effect
MI training
Tx fidelity
MI dose
MI delivery

Not explicated

n = 37
• 24 diet &
exercise
• 9 diabetes
4 oral health

N/A
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Results

Findings

MI Training
• This system-atic
Ongoing practice
review lacked
and feedback may
explicit
be needed to
description of
maintain MI
eligibility criteria
proficiency.
and the
Tx Fidelity
methodology.
Many of the studies
• This makes it
failed to assess tx
difficult to
fidelity or did not
ascertain
report this
whether a
assessment. There
rigorous,
are two validated MI
systematic
tx integrity tools:
approach was
1) MISC 2.1
utilized and
2) MITI 3.0
whether the
MI Dose
articles included
Although it is
in the review
proposed that MI
accurately
dose is related to
address the
behavior change, the
study
authors reported that
objectives.
many studies failed
• Despite this, the
to report length of MI
authors
sessions.
concluded that
MI Delivery
MI has a clear
The authors reported
indication for a
that MI session
variety of health
content is rarely
behavioral
provided in studies.
problems.
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Table A1 (continued)
Review
Type

Citation
Mulimba &
ByronDaniel
(2013)

M

S
X

C

Objective

Evaluate
effectiveness of
MI in improving
health behaviors
in diabetic
patients by
assessing:
1. lifestyle and
nonpharmacological selfmanagement
techniques
2. the quality of
the research

Eligibility Criteria

Variables
Analyzed

Databases
Searched

• adults 16 yrs. and
over with T1DM or
T2DM
• MI intervention or
variant
• Comparison group
with no
intervention or
non-MI
intervention
• Outcome of
improvement in
health behavior
including 1 or > of
following:
Weight
management,
physical activity,
healthy eating,
smoking
cessation,
medicine
adherence, alcohol
reduction, and
glucose, blood
pressure, and
cholesterol
monitoring
• RCTs and nonRCTs

MI dose,
MI
Training
& quality
control,
participant
uptake,
follow-up,
and
outcome

Cochrane Central
Register of
Controlled Trials,
Medline, Embase,
Science Direct,
CINAHL,
Dissertation
Abstracts
International, NHS
Evidence in Health
and Social Care,
Google,
www.motivationalint
erviewing.org, and
ancestry search of
similar reviews
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# of
Studies
n=8
6 RCTs,
1 cohort
study,
1 experimental
design

Summary
Measure

Results

Findings

EPHPPQA
tool to
assess
internal and
external
validity of
each study to
rate methodologic rigor.

Summary of
Studies

• 2 of 7 studies
found significant
MI effects for
lowering BG.
• 2 of 5 studies
found significant
MI effect for
improving
dietary intake.
• 1 of 5 studies
had a significant
MI effect on
weight loss.
• 1 of 2 studies
reported a
significant MI
effect on
smoking
cessation for
patients with
diabetes.
• 4 of 8 studies
found a positive
MI effect on
DSM.
• Concluded not
enough
evidence to
support MI use
in this
population.

• 4 of 6 RCTs were
methodologically
strong studies.
• 3 of 6 RCTs
outlined methods
for randomization
• 2 of 6 RCTs
reported a
calculation of
sample size
requirement
based on power.
• No studies
discussed an
upper age limit
for their study
participants.
• 1 study included
only female
participants.
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Table A1 (continued)
Review
Type

Citation

Ren, Yang,
Browning,
Thomas, &
Liu (2014)

M
X

S

C

Objective

Eligibility Criteria

• Evaluate
effects of MI
on BP control
in high cardiac
risk population

• RCT
• Adult ≥ 18
yrs. with ≥ 1
cardiac risk factor
• MI delivered in 1°
care setting
• MI was the 1°
intervention
• Outcome
measured included
∆ in BP reported
as mean
difference pre- and
postinterven-tion
or as intervention
effect with 95% CI

Variables
Analyzed

IV = MI
DVs = SBP,
DBP

Databases
Searched

Ovid Medline,
Embase,
PsychINFO,
Scopus, Cochrane
Library, CINAHL
plus, and Web of
Science

# of
Studie
s
n=7

Summary
Measure

Combined
WMD

Results

SBP
* 95% CI
After Intervention
-2.61 mmHg
[-3.96, -1.27]
Z = 3.81
P = 0.001
Postintervention
Follow-up
-1.64 mm HG
[-2.75, -0.53]
Z = 2.90
P = 0.004
DBP
*95% CI
After Intervention
-0.90 mm Hg
[-1.75, -0.06]
Z = 2.10
P = 0.04
Postintervention
Follow-up
-0.58 mm Hg
[-1.25, 0.09]
Z = 1.70
P 0.09
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Findings

MI is an effective
approach in
controlling SBP,
however the
authors
concluded that
more research is
needed to
confirm the effect
on DBP.
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Table A1 (continued)
Review
Type

Citation
Rubak,
Sandbaek,
Lauritzen, &
Christinsen
(2005)

M

S

C
X

Objective

Evaluate
effective-ness
of MI in
different areas
of disease

Eligibility
Criteria
RCT,
MI vs.
traditional
advice,
MI based on
Miller &
Rollnick

Variables
Analyzed

Databases
Searched

Intervention
characteristics,
study design,
area of
intervention, and
outcome
measure

16 databases,
conference
proceedings
b/w 1997-2004
from the ADA,
DUK, EASD,
and the IDF
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# of
Studies
Systematic
n = 72
Metaanalysis
n = 19

Summary
Measure

Results

Findings

Combined
ES estimate
with 95% CI

Systematic
• 74% (53/72) RCTs
demonstrated an MI
effect
• 94% of 72 RCTs
used individual
interviews
• Median duration of
MI was 60 min.
(Range 10-120 min.)
• 32 RCTs delivered
MI for 60 min. 81%
of these RCTs were
effective.
• 11 RCTs delivered
MI for 20 min. 64%
of these were
effective.
Meta-analysis
(* 95% CI)
HbA1c (n=243)
ES = 0.43
p = 0.155
(-0.16-1.01)
CHOL (n=1358)
ES = 0.27
p = 0.0001
(0.20-0.34)
SBP (n=316)
ES = 4.22
p = 0.038
(0.23-8.99)

• The likelihood
of an effect
from MI
increased with
the # of
encounters.
• MI can be
effective in
brief
encounters of
only 15
minutes.
• MI is effective
in different
areas of
intervention,
such as
adherence and
behavior
change.
• MI is equally
effective when
delivered by
different
disciplines.
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Table A1 (continued)
Citation
VanBuskirk &
Wetherell
(2013)

Review
Type
M

S

C
X

Objective

Eligibility
Criteria

Variables
Analyzed

Databases
Searched

Determine if
MI is effective
in improving
behavioral
modification in
patients
seeking tx for
health
conditions in
the 1° care
setting

• RCT
• MI as the 1º
tx arm or MI
as dualfocused tx
• Articles in
English
• Control could
be TAU,
waitlist, or
other
intervention

Intervention
characteristics,
interventionist,
study design,
area of
intervention, and
outcome
measure

MEDLINE,
PsychInfo,
Cochrane
library Review,
EBSCO Host,
Society of
Behavioral
Medicine, MINT
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# of
Studies
n = 12

Summary
Measure
Total
combined
ES and
combined
ES for
subgroups
based on
outcome
group

Results

Findings

Systematic Review
• 75% of studies
showed significant MI
effect
• 67% of studies used 3
or < MI sessions
• 58% of studies used
telephone to deliver
MI
Meta-Analysis
(* 95 % CI)
ALL STUDIES:
ES = 0. 18
[. 03, . 33]
p = .02
Q = 75. 32
P < .01
Adherence:
ES = 0.19
[.01, .37]
p = .04
Q = 1.20
p > .05
* Remaining 4 outcome
subgroups did not have
significant ES but
ranged b/w .07 and .47
Moderator Analysis:
MI Deliver:
ß = .26 [.08, .44]
p = .004

• Total clinical
contact was
not a
significant
moderator of
MI effect size.
• Telephonedelivered MI
sessions
appear to be
effective in
achieving
outcome.
• It is possible
that the
qualification of
the MI
deliverer may
affect
achieving the
target
outcome.
• MI appears to
be effective for
a variety of
behavioral
outcomes with
primary care
population.

!
Table A2

Search Domain 2: Motivational Interviewing and Chronic Disease
STUDY DETAILS

Author
&
Year

Barkhof,
Meijer, de
Sonneville,
Linszen, &
de Haan
(2013)

Chronic Dx,
Group sizes,
&
characteristic
s
Dx: T2DM
Sample Size
I = C = 111
Age
m = 58.92 ±
10.22
Gender
Female
50.2%
Male 49.8%
Baseline
HbA1c
m = 8.71±
2.00

INTERVENTION DETAILS

Conceptual
Framework
&
Study Design

Who
intervened?

Intervention
&
Measure(s)

No framework

Research
with nursing
background

MI vs. UC

RCT
Pretestposttest
design

Length of
Time

45-60
min.

IV= MI
°

1 DV =
HbA1c
Measures
°
1 HbAlc

final data
collected
@ 3 mo.
postintervention

Subjects
recruited b/w
7/9/0811/8/08 from
DM clinic in
Taiwan

RESULTS

# of
sessions

1

Timing

2 weeks
after
baseline
data
collected

Intervention
group

Control/
comparison
group

Baseline HbA1c
m = 8.97± 2.17

Baseline
HbA1c
m = 8.53± 1.82

3 mo. HbA1c
m = 8.16± 1.73

3 mo. HbA1c
m = 8.48± 1.78

t = 5.38
p < 0.01

t = 0.57
p = 0.56

Comments

MI did improve
significantly
HbA1c levels
in individuals
with a baseline
value greater
than 7.62
compared to
usual care.
Although this
study did have
a large sample
size, it was
limited by the
short 3-month
duration of the
study period.

Note. HBM – health belief model; CKD – chronic kidney disease; CPAP – continuous positive airway pressure; DSME – diabetes self-management education; LCP- licensed clinical
psychologist; MA – medication adherence; MEMS- medication event monitoring system; MGLT- Morisky- Green- Levine Test; MPR – medication possession ratio; OSA – obstructive
sleep apnea; SAT- Survey of Adherence to Treatment; SMTS-Self-reported Medication Taking Scale; SOC – stage of change; TAQPH- Treatment Adherence Questionnaire of
Patients with Hypertension; T2DM – type 2 diabetes mellitus; TTM – transtheoretical model of change
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Table A2 (Continued)

Author
&
Year

Cook,
Emiliozzi,
and
McCabe
(2007)

STUDY DETAILS
Chronic Dx,
Conceptual
Group sizes,
Framework
&
&
characteristics Study Design

Dx:
osteoporosis

No
Conceptual
Framework

Who
intervened?

RN

INTERVENTION DETAILS
Intervention
# of
& Measure(s)
Length of
sessions
Time

Telephone MI
counseling
(ScriptAssist)

Minutes per
phone call:
m = 15.3

n = 402
participants
from 57
HCPs that
prescribe
risedoronate
sodium
across the
U. S.

QuasiExperimental
design
Consecutive
sampling
method b/w
6/2003 –
9/2004

IV = MI
DV = MA
Measures
˚
1 = refill hx
˚
2 = interview
w/ 2
questions

3-5
based on
low to
moderate
risk

Timing

Q 4 mo.
for a
range of
0-14 mo.

RESULTS
Intervention
Control/
group
comparison
group

Intent-to-treat
analysis:
3 month data
I = 76.7%
2
X = 7.32
P = .007
6 month data
I =68.8%
2
X = 6.75
P = .009
Moderate ES
of 0.19 across
both time
periods
°
2 Outcome:
3 month data
I = 81.8%
2
X = 31.3
P < .001
6 month data
I = 69.8
2
X = 196.1
P < .001

Age
m =66.9
SD = 12.5
Gender
94% female
no race or
ethnicity data
collected
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Comparison
data from
NBDO
C = 67.5%

C = 40.5%

C = 67.5%

C = 40.5%

Comments

Telephonebased MI
counseling
was effective
in increasing
MA compared
to population
baseline
adherence
rates for
osteoporosis.

!
Table A2 (Continued)

Author
&
Year

Chen,
Creedy, Lin,
& Wollin
(2012)

STUDY DETAILS
Chronic Dx,
Conceptual
Group sizes,
Framework
&
&
characteristics Study Design

Dx: T2DM
Sample Size
I = 104
C = 111
Age
m = 58.92 ±
10.22
Gender
Female
50.2%
Male 49.8%
Baseline
HbA1c
m = 8.71±
2.00

No framework
RCT
Pretestposttest
design

Who
intervened?

Research with
nursing
background

INTERVENTION DETAILS
Intervention
# of
&
Length of
sessions
Measure(s)
Time

MI vs. UC

45-60 min.

IV= MI

final data
collected @
3 mo. postintervention

°

1 DV =
HbA1c
Measures
°
1 HbAlc

1

Timing

2 weeks
after
baseline
data
collected

RESULTS
Intervention
Control/
group
comparison
group

Baseline
HbA1c
m = 8.97± 2.17

3 mo. HbA1c
m = 8.16± 1.73
t = 5.38
p < 0.01

Subjects
recruited b/w
7/9/0811/8/08 from
DM clinic in
Taiwan

Baseline
HbA1c
m = 8.53± 1.82
3 mo. HbA1c
m = 8.48± 1.78
t = 0.57
p = 0.56

Comments

MI did improve
significantly
HbA1c levels in
individuals with
a baseline
value greater
than 7.62
compared to
usual care.
Although this
study did have
a large sample
size, it was
limited by the
short 3-month
duration of the
study period.
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Author
&
Year

GarcíaLlana,
Remor, del
Peso,
Celadilla, &
Selgas
(2014)

STUDY DETAILS
Chronic Dx,
Conceptual
Group sizes,
Framework
&
&
characteristic
Study Design
s
Dx: CKD

TTM

Sample Size
n = 42
Age
m = 64 ±
15.87
Gender
Female 40%
Male 60%

Pretestposttest
design
Non-random
sample of
subjects from
clinic in Spain

Who
intervened?

Health psychologist

INTERVENTION DETAILS
Intervention
# of
&
Length of
session
Measure(s)
Time
s

Individual
Intervention
Program
utilizing MI
IV= MI
intervention
program

90
min./sessio
n with 45
min. of MI in
each
session

Multiple
DVs
adherence
QOL
Clinical
markers
Adherence
Measures
• SAT
• MGLT
• SOC
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6

Timing

Monthly
sessions
x6
months

RESULTS
Intervention group
Control/
comparison
group

Within-group ∆
Adherence
Measure Results
SAT score: (Pre)
m = 27. 12
SD = 2.74
(Post)
m = 31.45
SD = 2.05
Mean ∆ = -4.33
t = - 10.29
p < 0.001
MGL score: (Pre)
29 % nonadherent
(Post)
16% nonadherent
2
X = 3.36
P < 0.001
SOC score: (Pre)
39% in Action
stage
(Post)
60% in Action
stage
2
X = 1.79
P < 0.001

No
comparison
group

Comments

• Limitations to
the study
include lack of
randomization
and a control
group.
• This study
incorporated a
theoretical
framework, the
TTM, and
utilized the
Stages of
Change tool to
measure the
clients’
progress
through
behavioral
change.
Overall, there is
promising utility
of a MI program
in progressing
clients through
the change
continuum and
with adherence
to oral
medications.

!
Table A2 (Continued)

Author
&
Year

Interian,
LewisFernandez,
Gara, &
Esbobar
(2013)

STUDY DETAILS
Chronic Dx,
Conceptual
Group sizes,
Framework
&
&
characteristics Study Design

Dx:
depression
Sample Size
I = 26
C = 24
- Latino men
and women,
- English
and/or
Spanishspeaking

RCT with
block
randomization
of sample

Intervention &
Measure(s)

- 1 LCP &
3 psychology
doctoral
students
*Tx fidelity
assessed by
the MITI code

INTERVENTION DETAILS
What did
# of
they do
Length of
sessions
and What
Time
measures
used?
META
Vs. UC

5 month
study period

IV= MI
DV= MA
Measures
˚
1 =MEMS
˚
2 =SMTS

Three 60
minute
sessions

Timing

Two
sessions
b/w
baseline
and 5
wks. and
session 3
b/w wk 5
and 5
mo.

RESULTS
Intervention
Control/
group
comparison
group

Unadjusted
mean at wk. 5
m = 72.9%
F(1, 48) =
10.51
p = .002
(ES) d = 0.92
Unadjusted
mean at 5 mo.
m = 61.5%
F(1,48) = 9.4
p = .004
(ES) d = 0.87
Adjusted mean
at wk. 5
m = 71.94
95% CI (58.5185.37)
p = .003
Adjusted mean
at 5 mo.
m = 59.81%
95% CI (46.7072.91)
p = .008
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Unadjusted
mean at wk. 5
m = 40.8%

Comments

Adjusted mean
at wk. 5
m = 41.72
95% CI (27.7555.73)

Although a
small sample
size, this study
produced
statistically
significant
results in
support of MI in
increasing MA
prior to and
after adjusting
for baseline
adherence and
having attended
at least one
therapy session
during the study
period.

Adjusted mean
at 5 mo.
m = 33.57%

Study does not
capture longterm effects of
MI.

Unadjusted
mean at 5 mo.
m = 31.7%

!
Table A2 (Continued)

Author
&
Year

LewisFernández
et al.
(2013)

STUDY DETAILS
Conceptua
Chronic Dx,
l
Group sizes, &
Framework
characteristics
&
Study
Design

Dx:
Depression
Sample Size
n = 50
Age
m = 39.8 ±
12.2 years
Gender
Female 52%
Male 48%

No framework but
used MI
principles
to guide
development of
motivational
pharmaco
-therapy
Open-trial,
pre-post
pilot Study

Who
intervened?

Psychiatrist

INTERVENTION DETAILS
Intervention
# of
&
Length of
sessMeasure(s)
Time
ions

MI sessions
IV= MI
°

1 DV =
treatment
retention
Measures
• Continuous
measure of
retention
defined as #
of days in tx
• Dichotomous
measure of
retention
defined as:
1. premature
termination
2. missing 2
consecutive
appts
3. off meds ≥
7 days
Other
measures
included HDS,
SDS, and QOL

Session 1
avg. was
36.7
minutes
Session 2,
4, and 8
avg. was
24.3
minutes
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4

Timing

@ wk 0,
1, 4, and
8

data
collected
@
baseline
and 12
wks.
postintervention

RESULTS
Intervention group
(no comparison group)

12 wks results
• Non-retention proportion
was 10/50 (20%)
• Days in MI
pharmacotherapy:
m = 74.2
SD = 23
88.3%, 95% CI
[80.98, 95.9]
(Total possible days was 84)
• Non-retention was not
significantly r/t age (p =
0.23), gender (p = 0.49), or
education level (p = 0.64)
• 80 % of participants ended
st
the study on their 1
antidepressant prescribed at
the start of study
HAMD17
Baseline:
m = 23.6
SD = 3.5
Week 12:
m = 7.7
SD = 7.0
Change:
m = - 15.9
t = 14.2
p < 0.001*

Comments

• It must be noted
that the
continuous
measure of
antidepressant
retention is NOT a
measure of
medication
adherence, but
rather, the number
of days retained in
the program.
• Inclusion of MI
and
pharmacotherapy
for depression in a
low-income, lowacculturated
Latino sample
resulted in a low
non-retention
proportion.
Limitations of this
study include lack of
randomization, a
control group, and
small sample size.

!
Table A2 (Continued)

Author
&
Year

Ma, Zhou,
Zhou, &
Huang
(2014)

STUDY DETAILS
Chronic Dx,
ConcepGroup sizes,
tual
&
FrameCharacterwork
istics
&
Study
Design
Dx: HTN
SCT
Sample
Size
I = 60
Age
m = 59.17
± 11.42
Female
48.3%
Male 51.7%

RCT
Subjects
recruited
from 2
health
centers
in China

Who
intervened?

Nurses
trained in
MI

INTERVENTION DETAILS
Intervention
# of
&
Length
sessMeasure(s)
of Time
ions

MI vs. UC

30-40
min.

8

Intervention group

Comments
Timing

Not
indicated

IV= MI
°

1 DV =
Treatment
adherence

RESULTS
Control/ comparison group

24-week
study
period

Measures
TAQPH
SBP
DBP

Within-group
Differences
TAQPH score @
baseline:
m = 75.91
@ 6 months:
m = 80.94
p = 0. 019*
SBP @ baseline:
m = 153.17
@ 6 months:
m = 141.81
p = 0. 019*

C = 60
Age
m = 58.35
± 10.63
Female
53.5%
Male 46.7%

DBP @ baseline:
m = 89.01
@ 6 months:
m = 82.55
p = 0.036*
Between-group
Differences
TAQPH score @ 6
months:
m = 80.94
p = 0.032*
SBP @ 6 months:
m = 141.81
p = 0.011*
DBP @ 6 months:
m = 82.55, p = 0. 027*
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Within-group
Differences
TAQPH score @ baseline:
m = 76.40
@ 6 months:
m = 78.22
p = 0. 363
SBP @ baseline:
m = 150.28
@ 6 months:
m = 146.73
p = 0.054
DBP @ baseline:
m = 88.65
@ 6 months:
m = 85.13
p = 0.079
Between-group
Differences
TAQPH score @ 6
months:
m = 78.22
p = 0.032*
SBP @ 6 months:
m = 146.73
p = 0.011*
DBP @ 6 months:
m = 85.13
p = 0.027*

• The clients
in the MI
group were
able to
demonstrat
ea
positive MI
effect in
improving
medication
adherence
and
decreasing
both SBP
and DBP.
Limitations
to this study
include small
sample size,
attrition, and
use of selfreported
adherence
measure

!
Table A2 (Continued)

Author
&
Year

Ogedegbe
et al. (2008)

STUDY DETAILS
Chronic Dx,
Conceptual
Group sizes,
Framework
&
&
characteristics Study Design

Dx: HTN
Sample Size
I = 95
C = 95
AA recruited
from 2
communitybased clinics
in New York;
Age
m = 54
Gender
88% female
Baseline BP
m = 144/86

RCT

Who
intervened?

Trained RAs

INTERVENTION DETAILS
Intervention
# of
&
Length of
sessions
Measure(s)
Time

MI vs. UC

12 months

IV= MI
DV= MA
Measures
˚
1 =MEMS
˚
2 = BP
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4

RESULTS
Intervention
Control/
group
comparison
group

Timing

Q 3 mo.

°

1 Outcome:
Completer
Analysis
I = 60%
p = .0054
95% CI (-.0227%)
Intent-to-treat
Analysis
Within group
difference prepost:
1.1%
t = 0.24
df =159
p = .810
º
2 Outcome:
• SBP (withinsubject ∆)
-7.7± 19.8
mmHg (t =
3.04, df = 60,
p = 0.003)
• DBP (withinsubject ∆)
-4.25±10.6
mmHg (t =
3.13, p = .003)

°

1 Outcome:
Completer
Analysis
C = 47%

Intent-to-treat
Analysis
Within group
difference prepost:
-12.9%
t = -2.89
df = 159
p = 0.004
º
2 Outcome:
• SBP (withinsubject ∆)
-9.7±22.2
mmHg (t = 3.14, df = 51, p
= .003)
• DBP
(within-subject
∆)
-4.60±14.1
mmHg
(t = 2.36,
p = .022)

Comments

MI prevented the
decline in
adherence rates
over time
compared to UC
when delivered
every 3 months
in the clinical
setting.
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Table A2 (Continued)

Author
&
Year

Olsen,
Smith, Oei,
& Douglas
(2011)

STUDY DETAILS
Chronic Dx,
Conceptual
Group sizes,
Framework
&
&
characteristics Study Design

Dx: OSA

HBM

Sample Size
I = 50
Age
m = 55.14
Gender
19 female
31 male

RCT

C = 50
Age
m = 57.74
Gender
12 female
38 male

Who
intervened?

RN

INTERVENTION DETAILS
Intervention
# of
&
Length of
sessions
Measure(s)
Time

MI
sessions

Sessions 1
& 2 were 30
min.

IV= MI
Consecutive
sampling b/w
5/2007 –
12/2008

DV =
adherence
to CPAP
treatment

Session 3
was 20 min.

Measures
# of hours
per night
CPAP was
used
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3

Timing

every 4
weeks

RESULTS
Intervention
Control/
group
comparison
group

1 month data
I = 4.85 hr
p = .003
d = .59
2 month data
I = 4.73 hr
p = .005
d = .56
3 month data
I = 4.63 hr
p = .005
d = .55
12 month data
I = 4.21
p = .061
d = .38

1 month data
C = 3.25 hr

2 month data
C = 3.22

3 month data
C = 3.16

12 month data
C = 3.00

Comments

Participants
who received
the MI
intervention
were more
likely to
adhere to
CPAP for a
greater
number of
hours per
night.
Although there
was an
insignificant
difference in
mean hours of
CPAP use
between the I
and C groups
at 12 months,
there was a
moderate
effect size in
favor of the I
group.
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Table A2 (Continued)

Author
&
Year

Russell et
al. (2011)

STUDY DETAILS
Chronic Dx,
Conceptual
Group sizes,
Framework
&
&
characteristics Study Design

Dx: CKD
n = 29

No
conceptual
framework

convenience
sample of
patients from
HD clinic in
central U. S.

Pilot Study
with pre-post
test quasiexperimental
design

Age
m = 66.41
SD = 13.9
Gender/Race
53% female
68% White

Who
intervened?

All staff:
nurses,
technicians,
dieticians,
social
workers

INTERVENTION DETAILS
Intervention &
# of
Measure(s)
Length of
sessions
Time

MI session
during dialysis
treatment
IV = MI
DV = nonadherence to
dialysis
treatment

3 months

Not
specified

Timing

Not
Specified

RESULTS
Intervention
Control/
group
comparison
group

Pre-Post
Results:
Missed Appts.
26% improved
68% Ø change
Shortened
Treatment
47% improved
27% Ø change
p < .05
IDWG
11% improved
68% Ø change

Measures
1. missed
appts.
2. Shortened
treatment
3. IDWG
4. Serum
phosphate
5. Serum
albumin

Serum
Phosphate
32% improved
47% Ø change
Serum Albumin
21% improved
73% Ø change
The only
statistically
significant
change was in
shortened
treatment.
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None

Comments

Although only 1
of 5 measures
had a
significant
improvement
post –
intervention,
missed
treatments also
favored
improvement
after the MI
intervention.
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Table A2 (Continued)

Author
&
Year

Solomon et
al. (2012)

STUDY DETAILS
Chronic Dx,
Conceptual
Group sizes,
Framework
&
&
characteristics Study Design

Dx:
Osteoporosis
Sample Size
I = 1046
C = 1041
-low income
older adults
on Medicare
in
Pennsylvania
-convenience
sample
Age
m=77.8
SD = 6.4
Gender/Race
98% female
90% White

RCT with no
conceptual
framework

Who
intervened?

Health
educators (no
indication of
educational
background)

INTERVENTION DETAILS
Intervention
# of
&
Length of
sessions
Measure(s)
Time

MI vs. UC
Delivered
via
telephone

12 months

IV=MI
DV= MA
Measures
˚
1 =MPR
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10

Timing

Not
indicated

RESULTS
Intervention
Control/
group
comparison
group

median MPR =
49%
(IQR 7-88%)
Kruskal-Wallis
test
p = .07

median MPR=
41%
(IQR 2-86%)
Kruskal-Wallis
test
p = .07

Comments

-MI did not
statistically
improve MPR
compared to
UC. However,
there was an
8% increase in
MPR between
the I & C
groups. The
power analysis
for sample size
was calculated
to detect an
absolute
difference of
10%.
- This is a
telephonebased
intervention that
was conducted
by health
educators that
received a ½
day of MI
training. This
questions
intervention
fidelity.
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Table A2 (Continued)
Author
&
Year

Welch,
Zagarins,
Feinberg,
& Garb
(2011)

STUDY DETAILS
Chronic Dx,
Conceptual
Group sizes, & Framework
characteristics
&
Study
Design
Dx: T2DM
Sample Size
n = 234
I = 118
C = 116
Age
m = 55.7 ±
10.2 yrs.
Gender
Female 59%
Male 41%
Baseline
HbA1c
m = 8.9 ±
1.2%

RCT

Who
intervened?

4 certified
diabetic
educators

INTERVENTION DETAILS
Intervention
# of
&
Length of
sessions
Measure(s)
Time

4 experimental
groups:
1. MI Alone
2. MI with
report
3. DSME
4. DSME
with report
IV= MI
°

Session 1:
60 min.
Session 24:
30 min.
data
collected @
baseline &
6 mo. postintervention

1 DV =
HbA1c
Measures
°
1 HbAlc

4
m = 3.3

Timing

0, 1, 3,
&6
months

RESULTS
Intervention
Control/
group
comparison
group

HbA1c ∆ @
6 months

HbA1c ∆ @
6 months

Group 1:
m = -0.41%
p < 0.01

Group 3:
m = -0.59%
p < 0.01

Group 2:
m = -0.32%
P < 0.14

Group 4:
m = -0.95%
p < 0.01

Group 1 & 2:
m = -0.37 ±
1.35%
p = 0.01
Multiple
Regression
ß ± SE:
0.41 ± 0.19
t = 2.10
p = 0.037
*sig. negative
effect of MI on
HgbA1c ∆

!
!
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Group 1 & 2:
m = -0.78 ±
1.29%
p < 0.01

Comments

• This study was
unable to support
the clinical use of
MI in lowering
HgbA1c level in
patients with
T2DM.
• The two groups
that did not use MI
showed a
significantly greater
improvement in
HgbA1c than the
two groups that
used MI.
• The CDEs did not
reach proficiency
on all MI skills
according to the
MINT.
• The CDEs failed to
use comprehensive
reflection skills or to
consistently
address
ambivalence.
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Table A3

Author
&
Year

Cook,
McCabe,
Emiliozzi,
& Pointer
(2009)

Search Domain 3: Motivational Interviewing and ART Adherence
STUDY DETAILS
Conceptual
Group sizes,
Framework
&
&
characteristics Study Design

Dx: HIV

Prochaska’s
TTM

n = 98
Age
m = 43.5
SD = 9.3
Range = 2373
Gender
38.8%
female
• 78.6% atrisk for
nonadherence
• 21.4% at
low risk for
nonadherence
58% lost to
attrition by 6
mo. f/u

Quasiexperiment
with
pre-post test
design and
nonequivalent
control group

Who
intervened

RN

INTERVENTION DETAILS
Intervention &
# of
Measure(s)
Length of
sessions
Time

Telephone MI
counseling
(ScriptAssist)
* median of
3.6 phone
calls per
completed call

Length of
phone call
m = 7.5
min. (SD =
11.7 min.)

Median of
3 per
patient

Timing

Low Risk
1 followup call
@6
months
High
Risk
4 followup calls

IV = MI
DV = MA

Measures
Self-report
capturing tx
persistence
and
adherence
percentage

RESULTS
Intervention
Control/
group
comparison
group

≥ 95% MA
After 6
months
IG = 76%
z = 3.12
p = .001
ES = .25

≥ 95% MA
after 6
months

CG = 50%

* Comparison
data was
obtained
from the
expected
population
rates based
on the
literature

Comments

A greater
percent of
patients had
> 95%
medication
adherence
than
expected for
this
population
after 6
months of
treatment.
The primary
measure
provides
subjective
data, which
limits the
objectivity of
the data
collected

Note. AATVAS – Adherence to Antiretroviral Therapy Visual Analog Scale; AGAS – Antiretroviral General Adherence Scale; HAKLQ – HIV/AIDS Knowledge Level Questionnaire;
HBRAQ- Health Belief Regarding ART Questionnaire; LW-IMB-AAQ – Life Windows Information Motivation Behavioral Skills ART Adherence Questionnaire
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Author
&
Year

DiIorio et
al. (2003)

STUDY DETAILS
Conceptual
Group sizes, &
Framework
characteristics
&
Study Design

(IG) n=10
(CG) n=10
Adult HIV+
Age
range = 2653
Gender
53.9% male
Ethnicity
87.5% AA

Randomized
controlled
pilot study

Who
intervened?

RN

INTERVENTION DETAILS
Intervention &
Length of
# of
Measure(s)
Time
sessions

Timing

MI counseling
sessions

Q2
weeks

Measure

20-90 min
sessions,
total study
period=8wk

1. AGAS
2. # of
missed
doses in
last 2 wks
3. # of
missed
doses in
last 30
days

3

RESULTS
Intervention
Control/
group
comparison
group

(self-report)
baseline to f/u
1. AGAS
m=26.50,
t=-1.27, p=.224,
no SD but
ES=.59

(self-report)
baseline to f/u
1. AGAS
m=23.44

2. Missed med
in last 2 weeks,
m = .06,
t = 1.42,
p =.198, no SD
but ES = .67

2. Missed med
in last 2
weeks, m = .18

3. Missed med
in last 30 days,
m = .13,
t = 1.42,
p = .198, no SD
but ES = .75
4. 12.5% in past
30 days unable
to take meds,
2
χ = 5.13,
p = .024
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3. Missed med
in last 30 days,
m = .35

4. 66.7% in
past 30 days
unable to take
meds,
2
χ = 5.13,
p = .024.

Comments

MI has
potential to
increase
med
adherence.
Outcome
measured
by selfreport.
More
objective
measures
may be
needed.
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Table A3 (Continued)

Author
&
Year

DiIorio et
al. (2008)

STUDY DETAILS
Conceptual
Group sizes, & Framework
characteristics
&
Study
Design
Allocated
(I) n = 125
(C) n = 122
Analyzed
(I) n = 107
(C) n = 106
HIV + adult
men &
women
Age
m = 41

RCT

Who
intervened?

RN

INTERVENTION DETAILS
Intervention &
# of
Measure(s)
Length of
sessions
Time

MI counseling
st
sessions; 1
session inperson, session
2-5 in-person or
telephone;
Get Busy Living
program

40-45
min/session,
total
intervention
period=12wk
s, total study
period=12
mo.

Measure
1. MEMS
2. VL
3. CD4

5

Timing

Did not
specify
how
often MI
given

RESULTS
Intervention
Control/
group
comparison
group

Baseline to
12mo. f/u

Baseline to
12mo. f/u

MEMS data:
(GE x TE)

MEMS data:
(GE x TE)

1. % DT:
m = 64%
95% CI
[57, 70]
p = 0.023

1. % DT:
m = 55%
95% CI
[49,62]

Gender
65% male

2. % DTS:
m = 41%
95% CI
[34, 47]
p = 0.005

Ethnicity
89% AA

VL data @ 6
mo.:
%
undetectable
58%
95% CI
(41, 76)
p < 0.001
*No SD in CD4
outcome
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2. %DTS:
m = 24%
95% CI
[18, 31]
VL data @ 6
mo.:
%
undetectable
47%
95% CI
(31, 64)

Comments

Overall,
results
provide
support for
MI as
intervention
to increase
HAART
adherence.
This study
captured the
potential of
MI in
producing
long-term
adherence
outcomes.

!
Table A3 (Continued)

Author
&
Year

Golin et al.
(2006)

STUDY DETAILS
Conceptual
Group sizes, &
Framework
characteristics
&
Study
Design
Allocated
(I) n = 74
(C) n = 66

SCT

RCT
Analyzed
(I) n = 59
(C) n = 58

Who
intervened?

Master level
health
educator (did
not specify
type of
profession)

INTERVENTION DETAILS
Intervention
# of
&
Length
sessions
Measure(s)
of Time

MI sessions;
program
called PACT

12wks

Measures
1. CAS
2. VL

2

Timing

@ wk
4&8

RESULTS
Intervention group
Control/
comparison
group

wks 4 - 12 data
CAS:
• mean adherence
improved by 4.5%
(p = .10)
• 29% achieved
>95% adherence
(p = .13)

HIV+ adult male
& females

Post-hoc:
After controlling for
ethnicity, 2.75x
higher odds of
>95% adherence
p = .045
95% CI
[1.023, 7.398]

Mean Age
I = 39.91
C = 40.46
Gender
I = 69.4% male
C = 63.1% male
Ethnicity
I = 76.8% AA
14.5% White
C = 54.6% AA
30.3% White

Baseline to 12wks
Viral Load:
52% undetectable
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wks 4 - 12 data
CAS:
• mean
adherence
decreased by
3.83%
(p = .10)
• 17%
achieved
>95%
adherence
(p = .13)
Baseline to
12wks
Viral Load:
44%
undetectable

Comments

Two MI
sessions
may not be
sufficient to
produce a
sustained
result in
HAART
adherence.

!
Table A3 (Continued)
Author
& Year
Hill &
Kavookjian
(2012)

Study Design
& Objective
Systematic
Review
Objectives:
1. Determine the
effect of MI on
ART
adherence.
2. Determine
which
characteristics of
intervention
are most and
least effective.
3. Determine
existing gaps
in literature for
research and
practice
implications.

Eligibility
Criteria

Variables
Analyzed

Inclusion:
• MI
intervention
• HIV + adults
on HAART
• RCTs or
rigorous
non-RCTs
• Target
outcomes of
VL, CD4,
and
adherence
• English
studies b/w
1990November
2010

Study
design,
sample,
MI dose,
adherence
measure,
outcome

Databases
Searched
&
Keywords
• Medline
• Academic
Search Premier
• CINAHL
• Psych Articles
• PsychINFO
• ISI Web of
Science
• EBSCO
• Cochrane
Database of
Systematic
Reviews
• Cochrane
Controlled
Trials Register
• International
Pharmaceutical
Abstracts
• Miller &
Rollnick
reference list
Keywords:
Adherence,
compliance, HIV,
AIDS,
Motivational
interviewing,
medication,
HAART, ART

# of
studies

5 RCTs
4 studies
from US,
1 study
from
France
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Results

Concerns

Comments

• 3/5 studies used
MI in-person
• Intervention period
varied between 2-6
months
• Frequency of MI
sessions varied
between 2 and 8
sessions
• Overall risk of bias
was low among
the 5 studies
• 3/5 studies
reported significant
adherence
changes postintervention
• The 2 studies
without significant
findings reported
concerns with
methodology

• Most studies had
disproportionate
number of males
vs. females
• Small sample
sizes
• Variation in length
of MI training
• Lack of standard
MI training
method
• Variation in
adherence
measures among
studies
• Gaps in literature
pertaining to MI
effect on QOL
and economic
outcomes

The results of this
systematic review
indicate that MI is a
promising intervention
for HAART adherence.
There needs to be
further research,
however, with larger,
diverse samples of
patients to increase
the generaliz-ability of
the outcomes.

!
Table A3 (Continued)

Author
&
Year

KonkleParker,
Erlen,
Dubbert,
& May
(2012)

STUDY DETAILS
Conceptual
Group sizes &
Framework
Characteristic
&
Study
Design
(I) n = 33

IMB Model

(C) n = 23

Randomized
controlled
pilot study

HIV + adult
Age
m = 34.6
Gender
62% male
38% female
Ethnicity
89% AA

Who
intervened?

Nurse
practitioner

INTERVENTION DETAILS
Intervention
# of
&
Length
sessions
Measure(s)
of Time

HIV
education,
Video,
MI,
Feedback,
cognitive
skills
training,
adherence
devices,

30-60
min.

Avg. <
10 min.

1º
Measures
VAS
Refill rate
2º
Measures
VL
IMB Scale
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Timing

2

@ wks.
1&2

6

@ wks.
3,4,6,
10,16,
24

RESULTS
Intervention group
Control/
comparison
group

1º Measures

1º Measures

1. VAS
m = 13.45,
SD = 9.99
p > 0.05, d = 0.22
2. Refill rate
m = 0.93,
SD = 0. 23
p > 0.05, d = .04
3. 90% adherent
by VAS
n = 21, 86%
p > 0.05, OR = 1.08

1. VAS
m = 11.69
SD = 9.99
2. Refill rate
m = 0.92
SD = 0.27
3. 90%
adherent
by VAS
n = 15
87%

2º Measures
1. VL
m = - 3.86, SD =
2.15
t = 2.416, p < 0.022
d = 0.27
2. VL < 400
n = 20, 80%
OR = 1.45, p > 0.05
3. IMB Scalemotivation
m = 3.43, SD =
6.78
p > 0.05, d = 0.18

2º Measures
1. VL
m = - 3.31
SD = 1.82
2. VL < 400
n = 15
73%
3. IMB Scalemotivation
m = 2.22
SD = 7.05

Comments

This adherence
intervention
included MI as
one component.
Difficult to
ascertain direct
effect of MI on
MA, but IMB is
promising
model to
approach MA.
This
intervention
produced
nonstatistically
significant
improvements
in MA and VL.
Some factors
contributing to
this are the high
percentage of
MA prior to
study, high
attrition, and low
statistical
power.

!
Table A3 (Continued)

Author
&
Year

KrummenAcher,
Cavassini,
Bugnon, &
Schneider
(2011)

STUDY DETAILS
Conceptual
Group sizes,
Framework
&
&
characteristic
Study Design
s
n = 104
HIV + adults
Age
m = 39
Gender
43% =male
61%=female

SCT
Observational study

Who
intervened?

Pharmacist

INTERVENTION DETAILS
Intervention &
# of
Measure(s)
Length of
sessions
Time

In-person
semistructured MI
sessions
Measures
˚
1 = MEMS
˚
2 = VL

Avg. 35
min/visit
Total study
period=4yrs
(8/04-4/08)

# visits
different
per client,
total of
1388 visits
for all
clients

RESULTS
Comments

Timing

avg.= 0.9
per
month

Overall
adherence
rate= 83% at
end of study
period.
Logistic
GEE
results:
variable time
x time
indicated
adherence
increased at
end of study,
Z= 2.14
95% CI
(.0007,
.0152)
p = .0321

Ethnicity
44%= black
54%=white

% with VL
undetectable
@ endpoint
Tx Naïve:
n = 24
88%
p = 0. 000
New ART @
start:
n = 23
74%
p = 0. 000
No ∆ in ART
during study
period:
n = 45
71%
p = 0. 001
Changes in
ART regimen:
n = 12
58%
p = 0. 002
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MI used as 1
of 4
components
in adherence
intervention
shows
promise in
increasing
adherence.

!
Table A3 (Continued)

Author
&
Year

Maneesriwongul,
Prajanket,
& Saengcharnchai,
(2012)

STUDY DETAILS
Conceptual
Group sizes
Framework
&
&
Characteristics
Study
Design
n = 90
MI group
n = 30
mean age = 40
yrs
73.3% male
Education
Group
n = 30
mean age =
42.3 yrs
66.7% male
Usual Care
n = 30
mean age =
39.3 yrs
73.3% male

Based on MI
principles
RCT
Pretestposttest
design with
3
intervention
groups

Who
intervened?

Nurse

INTERVENTION DETAILS
Intervention
&
Length of
# of
Measure(s)
Time
sessions

Group 1:
MI counseling + UC
Group 2
HIV
educational
video + UC
Group 3
UC only
Measures
1. AATVAS
2. HAKLQ
3. HBRAQ

Session 1
40 min.
Face-toface
Session 2
25-30 min.
Telephone
Session 3
30 min.
Face-toface

3

RESULTS
Comments

Timing

Q2
wks

Adherence Within-group
Results
MI Group
Pretest
m = 85.6
SD = 11.6
Posttest
m = 97.1
SD = 3.3
t = 5.44
p < 0.001

Education Group
Pretest
m = 86.7
SD = 14.1
Posttest
m = 98.7
SD = 1.6
t = 4.83
p < 0.001

Between-group Posttest
Mean Scores
Group 1 = 97.1
Group 2 = 98.7
Group 3 = 89.8
F = 18. 58, p < 0.001
Between-group Mean
Differences
Group 1 = 11.5, Group 2 = 12.0
Group 3 = 2.9
F = 31.97, p = 0.001

Adult HIV +
patients from
Thailand
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Both the MI
and education
interventions
produced
positive
adherence
outcomes.
There was no
significant
difference
between these
two groups on
adherence.
This study
produced
short-term MI
effects. It
would be
interesting to
test the longterm effects of
MI compared
to education
on adherence.

!
Table A3 (Continued)

Author
&
Year

Pradier
et al.
(2003)

STUDY DETAILS
Conceptual
Group size
Framework
&
&
Characteristic Study Design

Adult HIV +
in SE France

Based on MI
principles

(I) = 123
Age:
Mdn = 40y

RCT

Gender:
87% male
40% HS
graduate
41%
undetectable VL
(C) = 121
Age:
Mdn = 38y
Gender:
91% Male
36% HS
graduate

Who
intervened

Nurses

INTERVENTION DETAILS
Intervention Length
# of
&
of
sessMeasure(s)
Time
ions

Combined
MI
counseling
and HIV
education
sessions

45-60
min.

3

Measures
1. proportion of
patients
with 100%
adherence
@ 6 mo.

RESULTS
Intervention group
Control/
comparison group

Q2
months

@ 6 mo.
1. proportion
adherent:
75%, p = 0.04
*Participants
receiving 3 sessions
(n =59) had higher
adherence
compared to
patients receiving 1
or 2 sessions (83%
vs. 63%,
p = .05)
2. ∆ in VL:
Within Group
m = - 0.22, SD =
0.86
p = 0.013
Between Group
m = -0.22, p = 0.002

.

2 ∆ in VL
b/w
baseline
and 6 mo.
3. % of
patients
with
VL < 40
copies/mL
@ 6 mo.

3. % patients w/ VL
< 40 copies/mL:
47%, p = 1.00
Subgroup
Analysis
Mean difference of
VL b/w baseline and
6 mo. in pts w/ HIV >
40 copies/mL @
baseline:
m = -0.48, p = 0.001

40%
undetectable VL
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Comments

Timing

@ 6 mo.
1. proportion
adherent:
61%

2. ∆ in VL:
Within Group
m = 0. 12
SD = 0.90
p = 0.14
Between Group
m = 0.12
3. % patients w/
VL < 40
copies/mL:
48%
p = 1.00
Subgroup
Analysis
Mean difference of
VL b/w baseline
and 6 mo. in pts
w/ HIV > 40
copies/mL @
baseline:
m = 0.15

This was a
combined MI and
education
intervention,
making it difficult
to ascertain the
true MI effect.
Nevertheless, the
intervention
appears to be
successful in
increasing selfreported HAART
adherence. It may
be more beneficial
in patients with
detectable
baseline viral
loads. Finally, this
study suggests
that the more
intervention
sessions the
greater the
outcome.

!
Appendix B
Permission to Use IMB Model
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!
Appendix C
Motivational Interviewing Survey
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!
Appendix D
Demographic Form
Please circle your answer to the following questions.

1. Gender:

Female

Male

2. Job Role:

Clinician

Non-Clinician

(For the purpose of maintaining confidentiality, role categories have been designated to
de-identify those staff members who serve as the only member of their professional
discipline. If you are a physician, pharmacist, nurse practitioner, or nurse, please circle
CLINICIAN. If you are a case manager or administrator, please circle
NON-CLINICIAN.

3. Length of Employment at this HIV clinic:

0-3 years

4-6 years

7-9 years

4. Have you ever used motivational interviewing?
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> 9 years

Yes

No

!
Appendix E
Permission to Use the Motivational Interviewing Survey
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!
Appendix F

ORCA Tool
II. Context Assessment
For each of the following statements, please indicate how frequently you have observed
the following sets of behaviors, from 1 (very infrequently) to 5 (very frequently).
How frequently have you observed
senior leadership/clinical
management in this clinical practice
setting:
a) reward clinical innovation and
creativity to improve patient care
b) solicit opinions of clinical staff
regarding decisions about patient
care
c) seek ways to improve patient
education and increase patient
participation in treatment

How frequently have you observed
staff members in this clinical practice
setting:
a) have a sense of personal
responsibility for improving patient
care and outcomes
b) cooperate to maintain and
improve effectiveness of patient
care
c) are willing to innovate and/or
experiment to improve clinical
procedures
d) are receptive to change in clinical
processes

very
infrequently

1

1

1

very
infrequently

1

1

1

1

173!

infrequently

2

2

2

infrequently

2

2

2

2

neither
frequently
nor
infrequently

frequently

very
frequently

Don’t
know/
Not
Applicable

3

4

5

99

3

4

5

3

4

5

neither
frequently
nor
infrequently

frequently

very
frequently

3

4

5

3

4

5

3

4

5

3

4

5

99

99

Don’t
know/
Not
Applicable

99

99

99

99

!
How frequently have you observed
senior leadership/clinical
management in this clinical practice
setting:
a) provide effective management for
continuous improvement of
patient care
b) clearly define areas of
responsibility and authority for
clinical managers and staff
c) promote team building to solve
clinical care problems

very
infrequently

1

1

1

d) promote communication among
clinical services and units

1

How frequently have you observed
senior leadership/clinical
management in this clinical practice
setting:

very
infrequently

a) provide staff with information on
the clinic’s performance measures
and guidelines
b) establish clear goals for patient
care processes and outcomes
c) provide staff members with
feedback/data on effects of
clinical decisions
d) hold staff members accountable
for achieving results

1

1

1

1
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infrequently

2

2

2
2

infrequently

2

2

2

2

neither
frequently
nor
infrequently

frequently

very
frequently

Don’t
know/
Not
Applicable

3

4

5

3

4

5

3

4

5

99

3

4

5

99

neither
frequently
nor
infrequently

frequently

very
frequently

Don’t
know/
Not
Applicable

3

4

5

3

4

5

3

4

5

3

4

5

99

99

99

99
99

99

!
How frequently have you
observed opinion leaders in
this clinical practice setting:

very
infrequently

a) express belief that the
current practice patterns
can be improved
b) encourage and support
changes in practice
patterns to improve patient
care
c) demonstrate willingness to
try new clinical protocols
d) work cooperatively with
senior leadership/clinical
management to make
appropriate changes

In general in this clinic, when there is
agreement that change needs to
happen, how frequently have you or
your colleagues:
a) had the necessary support in
terms of budget or financial
resources
b) had the necessary support in
terms of training

infrequently

neither
frequently
nor
infrequently

frequently

very
frequently

3

4

5

3

4

5

3

4

5

3

4

5

2

1

2

1

very
infrequently

1

1

c) had the necessary support in
terms of facilities

1

d) had the necessary support in
terms of staffing

1
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99

99

2

1

99

99

2

1

Don’t
know/
Not
Applicable

infrequently

2

2

2

2

neither
frequently
nor
infrequently

frequently

very
frequently

Don’t
know/
Not
Applicable

3

4

5

3

4

5

99

3

4

5

99

3

4

5

99

99

!

III. Facilitation Assessment:
For each of the following statements, please rate the strength of your agreement with
the statement, from 1 (strongly disagree) to 5 (strongly agree).
For this project, senior
leadership/clinical management have:

strongly
disagree

a) proposed a project that is
appropriate and feasible

1

b) provided clear goals for
improvement in patient care

1

c) established a project schedule and
deliverables

1

d) designated a clinical champion for
the project

1

The project clinical champion:

strongly
disagree

a) accepts responsibility for the
success of this project

1

b) has the authority to carry out the
implementation

1

c) is considered a clinical opinion
leader

1

d) works well with the intervention
team and providers

1

Senior leadership/clinical
management/staff opinion leaders:

strongly
disagree
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disagree

2

2

2

2

disagree

2

2

2

2

disagree

agree

strongly
agree

Don’t
know/
Not
Applicable

3

4

5

99

3

4

5

99

3

4

5

99

3

4

5

99

neither
agree nor
disagree

agree

strongly
agree

Don’t
know/
Not
Applicable

3

4

5

99

3

4

5

99

3

4

5

99

3

4

5

99

agree

strongly
agree

neither
agree nor
disagree

neither
agree nor
disagree

Don’t
know/
Not
Applicable

!
a) agree on the goals for this
intervention

1

b) will be informed and involved in the
intervention

1

c) agree on adequate resources to
accomplish the intervention
d) set a high priority on the success of
the intervention

The implementation team members:

1
1

strongly
disagree

a) share responsibility for the success
of this project

1

b) have clearly defined roles and
responsibilities

1

c) have release time or can
accomplish intervention tasks within
their regular work load
d) have staff support and other
resources required for the project

The implementation plan for this
intervention:

1

1

strongly
disagree

a) identifies specific roles and
responsibilities

1

b) clearly describes tasks and
timelines

1

c) includes appropriate
provider/patient education

1

d) acknowledges staff input and
opinions

1
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2

2
2
2

disagree

2

2

2

2

disagree

2

2

2

2

3

4

5

99

3

4

5

99

3

4

5

99

3

4

5

99

neither
agree nor
disagree

agree

strongly
agree

Don’t
know/
Not
Applicable

3

4

5

99

3

4

5

99

3

4

5

3

4

5

99

neither
agree nor
disagree

agree

strongly
agree

Don’t
know/
Not
Applicable

3

4

5

99

3

4

5

99

3

4

5

99

3

4

5

99

99

!
Communication will be maintained
through:
a) regular project meetings with the
project champion and team
members
b) involvement of quality management
staff in project planning and
implementation
c) regular feedback to clinical
management on progress of project
activities and resource needs
d) regular feedback to clinicians on
effects of practice changes on
patient care/outcomes

Progress of the project will be
measured by:
a) collecting feedback from patients
regarding proposed/implemented
changes
b) collecting feedback from staff
regarding proposed/implemented
changes
c) developing and distributing regular
performance measures to clinical
staff
d) providing a forum for
presentation/discussion of results
and implications for continued
improvements

strongly
disagree

1

1

1

1

strongly
disagree

1

1

1

1
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disagree

2

2

2

2

disagree

2

2

2

2

neither
agree nor
disagree

agree

strongly
agree

3

4

5

3

4

5

3

4

5

3

4

5

neither
agree nor
disagree

agree

strongly
agree

3

4

5

3

4

5

3

4

5

3

4

5

Don’t
know/
Not
Applicable

99

99

99

99

Don’t
know/
Not
Applicable

99

99

99

99

!
The following are available to make the
selected plan work:

strongly
disagree

a) staff incentives

1

b) equipment and materials

1

c) patient awareness/need

1

d) provider buy-in

1

e) intervention team

1

f) evaluation protocol

1

Plans for evaluation and improvement
of this intervention include:

strongly
disagree

a) periodic outcome measurement

1

b) staff participation/satisfaction
survey

1

c) patient satisfaction survey

1

d) dissemination plan for performance
measures

1

e) review of results by clinical
leadership

1

IV.

disagree

2
2
2
2
2
2

disagree

2
2
2
2

2

agree

strongly
agree

Don’t
know/
Not
Applicable

3

4

5

99

3

4

5

99

3

4

5

99

3

4

5

99

3

4

5

99

3

4

5

99

neither
agree nor
disagree

agree

strongly
agree

Don’t
know/
Not
Applicable

3

4

5

99

3

4

5

99

3

4

5

99

3

4

5

99

3

4

5

99

neither
agree nor
disagree

Respondent information:

The Organizational Readiness to Change Assessment (ORCA) was developed by the
Ischemic Heart Disease Quality Enhancement Research Initiative of the Veterans
Health Administration. For more information contact Christian Helfrich,
christian.helfrich@va.gov or (206) 277-1655.
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Appendix G
Permission to Use the ORCA Tool
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!
Appendix H
Request for the Motivational Interviewing Survey Reliability Scores
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